e10vkza
Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K/A
(Amendment No. 1 to Form 10-K)
Annual Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
     
For the fiscal year ended September 30, 2004   Commission File No. 1-6651
HILLENBRAND INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)
     
Indiana   35-1160484
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
     
1069 State Route 46 East    
Batesville, Indiana   47006-8835
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (812) 934-7000
Securities registered pursuant to Section 12(b) of the Act:
     
Title of Each Class   Name of Each Exchange on Which Registered
     
Common Stock, without par value   New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
     Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
         
Yes þ       No o
     Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.
         
Yes o       No þ
     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
         
Yes þ       No o
     Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o
     Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).
         
Yes þ       No o
State the aggregate market value of the common stock held by non-affiliates of the registrant.
      Common Stock, without par value — $3,869,555,300 as of March 31, 2004
     Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.
      Common Stock, without par value — 61,989,311 as of November 19, 2004.
     Documents incorporated by reference.
      Portions of the Proxy Statement for the 2005 Annual Meeting of Shareholders — Part III.
 
 

 


Table of Contents

EXPLANATORY NOTE
This Amendment No. 1 on Form 10-K (“Form 10-K/A”) to our Annual Report on Form 10-K for the year ended September 30, 2004, initially filed with the Securities and Exchange Commission (“SEC”) on December 7, 2004 (“Original Filing”), reflects a restatement (“Restatement”) of the Consolidated Financial Statements of Hillenbrand Industries, Inc. as discussed in Note 17 to the Consolidated Financial Statements.
This Form 10-K/A only amends and restates Items 6, 7, 8 and 9A of Part II of the Original Filing and we have revised language in these Items from the Original Filing to reflect the Restatement. No other information in the Original Filing is amended hereby. The foregoing items have not been updated to reflect other events occurring after the Original Filing or to modify or update those disclosures affected by subsequent events. Other events occurring after the filing of the Original Filing or other disclosures necessary to reflect subsequent events have been addressed in the Company’s reports filed with the SEC subsequent to the filing of the Original Filing, including the Quarterly Reports on Form 10-Q for the periods ended December 31, 2004, March 31, 2005 and June 30, 2005, which have previously been filed. In addition, the exhibit list in Item 15 of Part IV has not been updated except to reflect that an updated consent of our independent registered public accounting firm and currently dated certifications from our Interim President and Chief Executive Officer and Chief Financial Officer, as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, are filed with this Form 10-K/A as Exhibits 23, 31.1, 31.2, 32.1 and 32.2.
With this filing, the Company has amended the Original Filing. As such, the consolidated financial statements as of and for the fiscal years ended September 30, 2004 and 2003, the quarterly periods presented and the report of independent registered public accounting firm and related financial information contained in the Original Filing should no longer be relied upon. In addition, the fiscal 2005 and 2004 financial information contained in the Company’s quarterly reports on Form 10-Q for the periods ended December 31, 2004, March 31, 2005 and June 30, 2005, as previously filed, should no longer be relied upon.

2


Table of Contents

HILLENBRAND INDUSTRIES, INC.
Amendment No. 1 to Annual Report on Form 10-K/A
September 30, 2004
TABLE OF CONTENTS
         
    Page  
PART II
       
    4  
    6  
    40  
    45  
    97  
 
       
       
 
       
    98  
    105  
 Consent of Independent Registered Public Accounting Firm
 Certification of Chief Executive Officer
 Certification of Chief Financial Officer
 Certification of Chief Executive Officer
 Certification of Chief Financial Officer

3


Table of Contents

Item 6. SELECTED FINANCIAL DATA
The following table presents selected consolidated financial data of Hillenbrand Industries, Inc., for the fiscal years ended September 30, 2004, September 30, 2003 and the ten month period ended September 30, 2002. Fiscal years 2004 and 2003 have been restated pursuant to the items disclosed in Note 17 to the Consolidated Financial Statements included in Item 8 of this Form 10-K/A. Fiscal years 2000-2001 are presented based on our previous fiscal year-end of the Saturday nearest November 30. Also presented are comparable unaudited data for the twelve-month periods ended September 30, 2002 and 2001. Prior years’ financial data has been restated to reflect Forethought as a discontinued operation.
                                                         
    Fiscal     Fiscal                     Ten Months        
    Year     Year     Twelve Months Ended     Ended     Fiscal Year Ended  
    Ended     Ended     September 30,     September 30,     December 1,     December 2,  
    2004     2003     2002     2001     2002     2001     2000  
    (As     (As     (Unaudited)                     (53 weeks)  
    Restated)     Restated)     (In millions except per share data)                  
Net revenues (a)
  $ 1,829     $ 1,695     $ 1,736     $ 1,674     $ 1,393     $ 1,673     $ 1,637  
 
                                                       
Income (loss) from continuing operations (a)
  $ 188     $ 181     $ 56     $ 130     $ (17 )   $ 169     $ 130  
 
                                                       
(Loss) income from discontinued operations (a)
    (45 )     8       (12 )     23       7       1       24  
 
                                                       
Net income (loss) (a)
  $ 143     $ 189     $ 44     $ 153     $ (10 )   $ 170     $ 154  
 
                                                       
Income (loss) per share from continuing operations — Basic (a)
  $ 3.02     $ 2.91     $ 0.90     $ 2.06     $ (0.28 )   $ 2.70     $ 2.06  
 
                                                       
(Loss) income per share from discontinued operations — Basic (a)
    (0.72 )     0.14       (0.20 )     0.38       0.12       0.01       0.38  
 
                                                       
Net income (loss) per share-Basic (a)
  $ 2.30     $ 3.05     $ 0.70     $ 2.44     $ (0.16 )   $ 2.71     $ 2.44  
 
                                                       
Income (loss) per share from continuing operations — Diluted (a)
  $ 3.00     $ 2.90     $ 0.90     $ 2.05     $ (0.28 )   $ 2.69     $ 2.06  
 
                                                       
(Loss) income per share from discontinued operations — Diluted (a)
    (0.72 )     0.14       (0.20 )     0.38       0.12       0.01       0.38  
 
                                                       
Net income (loss) per share-Diluted (a)
  $ 2.28     $ 3.04     $ 0.70     $ 2.43     $ (0.16 )   $ 2.70     $ 2.44  
 
                                                       
Total assets
  $ 2,069     $ 5,475     $ 5,455     $ 4,949     $ 5,455     $ 5,072     $ 4,597  
 
                                                       
Long-term debt
  $ 360     $ 155     $ 322     $ 302     $ 322     $ 305     $ 302  
 
                                                       
Cash dividends per share
  $ 1.08     $ 1.00     $ 0.98     $ 0.83     $ 0.77     $ 0.84     $ 0.80  
Note: Certain per share amounts may not accurately add due to rounding.
 
(a)   The selected financial data presented above includes a number of non-recurring and special charges. Following is a summary of these charges, on a net-of-tax basis. The amounts are summarized based upon the line items within the Statements of Consolidated Income (Loss) impacted. Further discussion regarding these adjustments can be found in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

4


Table of Contents

                                                         
    Fiscal     Fiscal                     Ten Months        
    Year     Year     Twelve Months Ended     Ended     Fiscal Year Ended  
    Ended     Ended     September 30,     September 30,     December 1,     December 2,  
    2004     2003     2002     2001     2002     2001     2000  
    (As     (As     (Unaudited)                     (53 weeks)  
    Restated)     Restated)     (In millions except per share data)                  
Items Net-of-Tax:
                                                       
 
                                                       
Net Revenues
                                                       
 
                                                       
CMS claims resolution
          (2 )                              
 
                                                       
Litigation Charge
                                                       
 
                                                       
Litigation charge
                158             158              
 
                                                       
Special Charges
                                                       
 
                                                       
Severance and benefit costs, asset impairments and other realignment activities
    4       6       3       18       3       14       2  
 
                                                       
Operating Expense
                                                       
 
                                                       
Write-off of technology asset
                4             4              
 
                                                       
Other (Income) Expense, net
                                                       
 
                                                       
Net realized capital (gains) losses and impairments
          11       7             7              
 
                                                       
Loss on extinguishment of debt
    4       11                                
 
                                                       
Income Taxes
                                                       
 
                                                       
Reversal of tax reserves and adjustments to valuation allowance
                (32 )           (6 )     (26 )      
 
                                         
 
                                                       
Impact on continuing operations
  $ 8     $ 26     $ 140     $ 18     $ 166     $ (12 )   $ 2  
 
                                         
 
                                                       
Discontinued Operations
                                                       
 
                                                       
Net realized capital (gains) losses and impairments
  $ (2 )   $ 21     $ 30     $ 1     $ 11     $ 20     $ 1  
 
                                                       
Severance and benefit costs, asset impairments and other realignment activities
                7                   7        
 
                                                       
Loss on impairment of discontinued operations
    71                                      
 
                                                       
Other
                (6 )           (6 )            
 
                                         
 
Impact on discontinued operations
  $ 69     $ 21     $ 31     $ 1     $ 5     $ 27     $ 1  
 
                                         

5


Table of Contents

Item 7.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis should be read in conjunction with our audited Consolidated Financial Statements and accompanying notes included under Item 8 of this Form 10-K/A.
This Form 10-K/A reflects a restatement (the “Restatement”) to our Annual Report on Form 10-K for the years ended September 30, 2004 and 2003, initially filed with the Securities and Exchange Commission (“SEC”) on December 7, 2004 (the “Original Filing”), as further discussed in Note 17 to the Consolidated Financial Statements.
In the preparation of this Form 10-K/A, we have revised language within Management’s Discussion and Analysis of Financial Condition and Results of Operations from the Original Filing only to reflect the Restatement. No other information has been amended or updated to reflect other events occurring after the Original Filing or to modify or update those disclosures affected by subsequent events. Information contained herein continues to speak as of the date of the Original Filing, and the Company has not updated the disclosures contained herein to reflect events that occurred at a later date.
OVERVIEW
Hillenbrand Industries is organized into two major operating companies serving the health care and funeral services industries. Hill-Rom is a manufacturer of equipment for the health care industry, a provider of associated systems for wound, pulmonary and circulatory care and a provider of biomedical equipment rentals and other services to enhance the operational efficiency and asset utilization of health care facilities. Batesville Casket serves the funeral services industry and is a manufacturer of caskets and cremation-related products.
Over the course of the past four years, Hillenbrand Industries has embarked on a strategy to create value for shareholders, customers, suppliers and employees. The cornerstone of this strategy is our commitment to create and accelerate shareholder value and growth by identifying and implementing initiatives that will help realize the potential of our existing portfolio of businesses and position us for future growth, both organically and through acquisitions. The five key elements of our strategy and its impact on the business are outlined as follows:
  1.   Profitable revenue growth: Profitable revenue growth is critical to our overall commitment to build shareholder value. Actions taken to achieve this objective include higher research and development spending, a more strategic approach to new product development, an increased focus on higher margin products and a more profitable product mix. These efforts have resulted in numerous product line extensions, new product platforms, gross margin improvement and a foundation for future revenue growth.
 
      During the second quarter of fiscal 2004 we launched two new bed platforms in North America, the VersaCareä and CareAssistä beds. The VersaCareä platform is a more feature-rich replacement to our current Advantaä product offering, which is Hill-Rom’s single largest product. The CareAssistä product is an entry-level offering at a lower price point than the VersaCareä or Advantaä products, providing increased flexibility to our customers that need fewer features on their bed platforms. While we believe these products will be successful in the marketplace, their introduction had an impact on the timing of orders and shipments as many customers delayed purchasing decisions as they evaluated the new product offerings, resulting in lower revenues and gross profit from health care in fiscal 2004. Hill-Rom also introduced the ComLinxÒ LPM wireless locating and tracking system, the PrimeAireâ-ARS wound prevention surface and the Vocera wireless hands-free nurse communication system during the first six months of

6


Table of Contents

      2004. We also introduced new products in the architectural products, communications and furniture lines during the last half of fiscal 2004, replacing outdated products and enhancing workflow solutions.
 
      In 2004, Batesville Casket continued its focus on new product development by introducing several new veneer products aimed at various price points in both the burial and cremation markets, reintroducing select premium wood caskets under the MarsellusÔ brand name and introducing the Dimensions by BatesvilleÒ product line in response to the growing demand for caskets associated with the increasing size of Americans. In addition to these items, Batesville Casket continued its focus on the increasing opportunity to personalize funerals by introducing several new theme caskets, LifeSymbols corners and cap panels, along with various columnar displays for these and other products used by our customers to show products in their selection rooms.
 
      We are also committed to growth through selective health care acquisitions, such as the acquisitions of ARI, Mediq and NaviCare. In October 2003 we completed the acquisition of ARI, a manufacturer and distributor of non-invasive airway clearance products and systems. ARI complements Hill-Rom’s existing pulmonary expertise, expands Hill-Rom’s home-care product line, and provides opportunity for growth through leveraging of its clinical sales force. In January 2004, we completed the acquisition of Mediq, a company that provides peak-needs rentals and asset management of moveable biomedical equipment and services. This acquisition expands Hill-Rom’s product and service offerings, strengthens its after-sales service capabilities and should allow increased leverage of its global service center network. Also in January 2004, we completed the acquisition of the remaining 84 percent equity interest of NaviCare that we did not already own. NaviCare provides operations management, resource optimization and dynamic workflow solutions for health care enterprises and supplements Hill-Rom’s goal of offering products, services and solutions to enhance the efficiency and effectiveness of the patient care environment.
 
      We have also entered into two important technology relationships that augment the benefits of the Mediq and NaviCare acquisitions. First, in August 2003 we entered into a supply agreement with Visonic Technologies Americas, Inc. and Elpas Electro-Optic Systems, Ltd. to provide us with access to Visonic’s wireless locating technology. This technology supports our recently introduced ComLinxÒ LPM wireless locating and tracking system, which allows us to tag and track equipment and personnel in health care facilities. In January 2004 we entered into a distribution agreement with Vocera Communications, Inc. permitting Hill-Rom to sell, service and support Vocera’s wireless voice communication solution, which will allow wireless voice communication among health care facility workers throughout a facility. These technology relationships, along with the Mediq and NaviCare acquisitions provide the foundation for long-term growth and competitive advantage in Hill-Rom’s service business. Our strategy for growth in this business is based on the recognition that health care providers will face increasing demand in coming years as the baby boom generation ages and at the same time will face continued pressure to control health care costs. In this environment, we believe health care providers will need to increase patient throughput with higher levels of utilization of existing assets. We believe we now can facilitate dramatic improvements in asset utilization and in-patient flow, and we can provide flexibility to health care providers in achieving those objectives by offering them capital purchases, rental arrangements and comprehensive asset management programs across a broader range of products.
 
      The ARI and Mediq acquisitions resulted in significant increases in health care rental revenues and gross profit. The effect of the acquisitions on gross profit as a percentage of revenue has been negative, as lower margin rates associated with Mediq’s business more than offset the higher margin rates at ARI. We used cash on hand to purchase

7


Table of Contents

     
ARI and NaviCare and borrowings under our revolving credit facilities to fund the majority of the purchase price for Mediq, which were refinanced with a long-term borrowing in the third quarter of fiscal 2004.
     
During 2005 we plan to complete the integration of the acquisitions made in 2004. We also plan to focus development efforts on filling remaining product line gaps relating to connectivity and integration in the patient care environment, enhancement of operational efficiency and asset utilization of health care facilities and non-invasive clinical therapies that have a close relationship to our current strengths.
 
  2.   Improved asset management: We continually strive to improve the efficiency and return on our assets and capital. Key components of this effort include business process simplification, asset rationalization and achieving an optimal sales structure. Significant progress has been made in all these areas. In business process simplification, we are continuing our efforts to move to a common technology platform with our Enterprise Resource Planning implementations at Hill-Rom and Batesville Casket.
 
      The recent sale of our piped-medical gas business and infant care products business are examples of the asset rationalization strategy. These businesses were selected for divestiture as they no longer fit within our strategic portfolio because they had limited future growth potential, possessed unique sales channels and research and development requirements, had low profit margins and would have required significant investment to achieve their limited growth potential. Additionally, in July we sold Forethought, a specialty insurance holding company serving the pre-need financial services market. Following a comprehensive review of strategic alternatives, we concluded that the best interests of our shareholders, customers and employees would be served by the sale of Forethought, allowing us to focus our resources on future growth opportunities in the health care marketplace and maintain our longstanding commitment to Batesville Casket. Managing a large insurance and financial services company is very different from managing companies that manufacture products and provide related services. Additionally, a financial services company is subject to a variety of outside influences, including exposure to financial market volatility, that have made it difficult for our investors to compare and forecast our operating performance at times in the past. Moreover, Forethought’s strategic priorities and opportunities were inconsistent with those of Hillenbrand. Proceeds from the disposition of these businesses have been reinvested as part of our acquisition growth strategy.
 
  3.   Lower cost structure: We are committed to increasing shareholder value through the reduction of costs and waste in all areas of our business and the streamlining of processes for higher performance. Strategic sourcing and supply arrangements with key suppliers have resulted in significant reductions in raw material costs while maintaining quality over the last several years. However, over the past six months, we have experienced some significant pricing pressure with respect to steel, red metals, solid wood and fuel that has negatively impacted our financial results during the 2004 fiscal year by approximately $15 million and are anticipated to continue into 2005. The cost increases have been caused by price increases and surcharges that have been implemented by our suppliers due to strong worldwide demand, strained production capacity, a weak U.S. dollar and uncertain economic conditions. If strong worldwide steel demand continues, the strained production capacity could also pose a risk with respect to the timing and availability of steel deliveries from our suppliers. We also continue to reduce operating expenses as a result of work force and other realignment activities.
 
      With respect to non-operating expenses, we completed the repurchase of approximately $157 million and $47 million of our outstanding long-term debt in the fourth quarter of 2003 and the third quarter of 2004, respectively. This debt carried interest rates

8


Table of Contents

      ranging from 6.75 percent to 8.5 percent. We incurred charges of $16 million and $6 million, respectively, related to these repurchases. These repurchases will provide approximately $8 million in annual interest rate savings.
     
Moreover, in addition to previously announced restructurings, we announced a restructuring in the fourth fiscal quarter of 2004, resulting in a charge of $7 million intended to better align Hill-Rom’s financial and personnel resources to fully support its growth initiatives, decrease overall costs, and improve performance in Europe. The charge included the elimination of approximately 130 salaried positions in the U.S. and approximately 100 positions in Europe. These actions should result in an approximate $16 million annualized gross benefit once the action is fully completed toward the end of our 2005 fiscal year.
 
      During 2005 we plan to pay for our investments to grow the business, offset material cost increases and stabilize margins by continuing to cut costs and achieve increased efficiencies. For example, as part of our ongoing strategic sourcing efforts, Hill-Rom recently centralized its global supply chain to optimize its supply chain for manufacturing operations and maximize purchasing power with suppliers, and, during 2005, Batesville Casket plans to ramp up its Mexican manufacturing capability to expand its low-cost manufacturing capabilities.
 
  4.   Strategic portfolio management: We continue to manage our portfolio of operating companies under a unified corporate structure. Under this approach, each operating company plays a specific role in the fulfillment of our overall strategy. Batesville Casket is responsible for developing management talent and providing earnings and cash flow to fund Corporate growth. Hill-Rom’s role is to provide, in addition to cash flow and earnings, profitable growth through new product innovation, expansion into new areas and acquisitions in its respective adjacent health care businesses.
 
  5.   Leadership excellence: We have continued the aggressive development of talent in the organization through developmental assignments, inter-organizational transfers and special executive development training experiences. In 2003 we launched a unique performance development facility to enhance executive capabilities. During 2004, we continued to incorporate new learning and processes to expand the capabilities of this facility to individuals as well as team peak performance. During 2003, we performed comprehensive evaluations of our compensation and benefit programs, which we continued to evaluate in 2004, to assure marketplace competitive programs and practices, as well as proper alignment with our shareholder value creation objectives.
The charges and expenditures incurred to implement these initiatives partially offset the achieved benefits, but such benefits are expected to continue in future periods. We expect further benefits to be achieved as we continue to pursue our strategy, with a primary focus on the following elements of the strategy in 2005:
  1.   Increasing customer focus: We are committed to increasing customer focus by responding to their needs, solving their problems, and providing the right products and services better than anyone else. Resource allocation and investments in current businesses, new products and acquisition targets will be driven by increasing our customer focus in each of our businesses. Hill-Rom has made substantial progress towards its objectives of increasing the number of sales representatives by approximately 50. Batesville Casket’s strategy to enhance the customer experience during 2005 will include an increased focus on more uniquely serving the individual funeral homes through increasing delivery frequency and flexibility, expanding the number of sales territories to increase our exposure with individual accounts and funeral directors, enhancing product selection, strengthening executive relationships with key accounts across the country and becoming easier and simpler to do business with at all customer touch points and with all customer interactions.

9


Table of Contents

  2.   Product quality, innovation and new product development: We are focused on our product quality and new product development initiatives, increasing funding levels and the speed of research and development and manufacturing cycle times. The ultimate goal of these initiatives is to provide meaningful innovative solutions to customers. During 2004, Hill-Rom introduced the BasicCareä, CareAssistä and VersaCareä bed frames designed for a variety of medical/surgical applications, a premium furniture extension, the Contour and Imagebuilder headwall systems, PrimeAire® ARS therapy surface, ComLinx® LPM (which provides wireless tracking of equipment, patients, and caregivers) and Vocera® for hands free voice communication. Additionally, in 2004, Batesville Casket continued its roll-out of veneer products by introducing several new engineered wood casket products manufactured under its revolutionary new process for veneers and completed the reintroduction of select premium wood caskets under the Marsellus brand name to customers. Batesville Casket is in the process of introducing its new Dimensions product line targeted at the increasing population of overweight and obese individuals.
 
  3.   Streamlining business for higher performance: We plan to continue to rationalize and exit poor performing product lines and businesses and divest of under-performing assets. Batesville Casket’s Enterprise Resource Planning (ERP) system implementation, providing a common technology platform aimed at speeding productivity gains and process improvements, was completed during the 2004 fiscal year and is fully functional. Implementation efforts related to the ERP system at Hill-Rom will continue, where three out of four phases were complete at the end of fiscal 2004. Improving performance with the Hill-Rom EMEA business will also be a focus in fiscal 2005.
 
  4.   Accelerating top line growth through new business development: While organic growth is important, we recognize that we will not be able to consistently meet our long-term strategic objectives without the benefit of acquisitions. During 2005 we plan to complete the integration of the acquisitions made in 2004. We also plan to focus development efforts on filling remaining product line gaps relating to connectivity and integration in the patient care environment, enhancement of operational efficiency and asset utilization of health care facilities and non-invasive clinical therapies that have a close relationship to our current strengths.
In addition to the effects of the continued execution of our overall Corporate strategy, other trends in our businesses which have impacted and may continue to impact performance are outlined below.
The health care products industry is diverse and highly competitive. Over the long term, patient demand for services is rising as a result of a number of factors, including an aging population, increasing life expectancy, enlightened consumers and technological advances. These long-term trends should create pressure for existing facilities to upgrade and increase efficiency, caregiver safety and productivity in order to maintain profitability and meet demand in a period of staffing shortages. Hill-Rom believes that in order for it to achieve its goals of revenue growth and improved profitability, it will be required to continue to provide innovative, high quality customer solutions on a cost-effective basis.
In addition, health care providers are under continued pressure to control costs. As a result, purchasers of health care products and services such as those offered by our health care businesses continue to demand more cost effective products and services that improve the quality and efficiency of patient care and service. Specifically, the federal budget deficit is causing increasing pressure to control costs in the Medicare and Medicaid programs, increasing the likelihood of health care reform and changes in reimbursement practices. At the state level, while some easing of budgetary pressures has been noted, fiscal challenges largely remain present with Medicaid expenditures claiming increasing portions of state budgets. Additionally, health care providers face cost control pressures due to increasing numbers of

10


Table of Contents

uninsured patients and increasing supply costs. Premium increases to health care plans and the rising uninsured population further exacerbate a difficult reimbursement and economic environment for providers. In the aggregate, these cost control pressures can also impact the relative industry-wide demand for sales versus rental options in various product segments, which in turn can affect the sales versus rental mix of many products in our portfolio.
We continue to monitor implementation of the Medicare Modernization Act. While all of the implications of this far-reaching law are not yet clear, our current assessment continues to be that the Act is largely positive to Hill-Rom in the short term due to a variety of favorable hospital reimbursement provisions. Moreover, increased cost projections associated with the Medicare reform legislation, along with the growing federal deficit and other factors, could combine to create what we believe to be conditions favorable to Medicare cost containment measures in 2005 and beyond.
We derive significant revenues through GPOs. GPOs have come under increasing scrutiny regarding contracting practices, which have included various Congressional hearings. Over the past year, in response to Congressional inquiries, the industry had imposed numerous reforms contained in an industry-designed code of conduct. Despite this effort, federal legislation has been proposed this year that would direct the Department of Health and Human Services (HHS) to promulgate rules further defining ethical conduct for GPOs. Observance of these rules, through a certification process designed by HHS, would be a precondition for GPOs to accept administrative fees from hospital suppliers. Additionally, those fees would be capped at 3 percent. We believe the likelihood of passage this year is remote. However, the issue is likely to be revisited by the next Congress. While it is not possible to determine the full impact of potential legislation, based on our understanding of the bill’s intent, we do not anticipate a significant impact to our business in the near future.
We have been subject to increasing competitive pressure in areas in which we have not brought sufficient new products and features to market in the past. Hill-Rom’s increased commitment to new product development is expected to generate additional growth opportunities in 2005 and beyond.
Fundamentally, Hill-Rom’s strategy is aimed at providing three value propositions that management believes should directly address long-term customer needs: improving the operational efficiency of health care facilities; providing improved patient outcomes, thereby reducing length of stay and costs; and, improving caregiver safety and efficiency. Management believes substantial opportunity exists to grow in these areas by utilizing Hill-Rom’s global rental service center network, its clinical sales force and its strong position in capital equipment. The recently completed acquisitions of ARI, Mediq and NaviCare aim to take advantage of these opportunities. Because of our concentration in sales of capital equipment, we are susceptible to short-term demand fluctuations resulting from economic and regulatory changes and the timing of new product introductions. We intend to accelerate our efforts in non-capital products and services, which we believe will provide a more stable revenue stream. Meanwhile, Hill-Rom continues to focus on increasing its cost competitiveness in light of growing price pressures and low cost competitors, particularly in low- to mid-range products.
Hill-Rom sales and profitability have historically been disproportionately weighted toward the latter part of each quarter and generally weighted toward the latter part of each fiscal year, due to a combination of sales incentives, which influence certain customers to accelerate purchases otherwise planned for future periods, compensation practices and customer capital equipment buying patterns. However, there is no assurance that these patterns will continue.
In the funeral services products industry, the demand for burial caskets in North America appears to be gradually but steadily declining as the result of lower age-adjusted mortality rates and a continued increase in the rate of cremations. The popularity of cremations continues to grow at a rate of approximately one percentage point each year, now estimated at approximately one-third of total deaths. Also, Batesville continues to participate in an

11


Table of Contents

increasingly competitive environment where overcapacity exists and competitors respond with greater price concessions (discounts) and more flexible service. Management expects each of these trends, which have resulted in declines in the volume of casket sales for Batesville over the past three years, to continue in the future. Although Batesville offers a broad line of cremation products, these products result in lower revenue and carry overall lower margins than the average burial product. Partially offsetting these negative trends is a growing demand for enhanced personalization of funeral products and increased manufacturing and other operational efficiencies. Based on these trends and factors, Batesville’s strategy to improve profitability in the funeral services products industry will require Batesville to continue to differentiate its products on the basis of customer service, quality, innovation and personalization, while at the same time continuing to control costs through manufacturing efficiencies, strategic sourcing and other cost reduction efforts.
RESULTS OF OPERATIONS
Effective for fiscal year 2002, we changed our fiscal year-end to September 30 from the Saturday nearest November 30 of each year. As a result of this change, the Statements of Consolidated Income (Loss), Statements of Consolidated Cash Flows and Statements of Consolidated Shareholders’ Equity and Comprehensive Income presented in this Form 10-K/A reflect the Fiscal Years Ended September 30, 2004 and 2003, and the Ten Months Ended September 30, 2002.
As a result of the change in fiscal year-end, for purposes of Management’s Discussion and Analysis of Financial Condition and Results of Operations, the following periods of operations are presented and discussed:
    Fiscal Year Ended September 30, 2004 compared to Fiscal Year Ended September 30, 2003
 
    Fiscal Year Ended September 30, 2003 compared to the unaudited Twelve Months Ended September 30, 2002
 
    Fiscal Year Ended September 30, 2003 compared to Ten Months Ended September 30, 2002
The discussion of results for the Fiscal Year Ended September 30, 2003 to the unaudited Twelve Months Ended September 30, 2002 is presented for comparative purposes only. Management considers this to be a more meaningful presentation than the comparison of the Fiscal Year Ended September 30, 2003 to the Ten Months Ended September 30, 2002. As a result, the explanations related to the comparative results of the Fiscal Year Ended September 30, 2003 to the Ten Months Ended September 30, 2002 are more abbreviated than for the other comparisons included herein. Unless otherwise noted, the factors affecting the results for the Ten Months Ended September 30, 2002 are consistent with those affecting the unaudited results for the twelve months ended on this same date.
Unless otherwise indicated, references to 2002 in the comparative discussions below correspond to the periods set forth in the heading of each section. Further, the operating results for the divestitures completed in 2004 (the infant care and piped-medical gas businesses of Hill-Rom as well as Forethought) are presented as discontinued operations within our Consolidated Statement of Income (Loss). Under this presentation, the revenues and variable costs associated with these businesses are removed from the individual line items comprising the Consolidated Statement of Income (Loss) and presented in a separate section entitled, “Discontinued Operations”. In addition, fixed costs related to the businesses that were eliminated with the divestitures are also included as a component of discontinued operations. The results of discontinued operations are not necessarily indicative of the results of the businesses if they had been operated on a stand-alone basis. Except as otherwise indicated, all discussions and presentations of financial results within Management’s Discussion and Analysis are presented based on our results from continuing operations.

12


Table of Contents

The following table presents comparative operating results for all periods discussed within Management’s Discussion and Analysis:
                                                                 
(Dollars in millions except                                    
per share data)   Fiscal           Fiscal       Twelve       Ten    
    Year Ended           Year Ended       Months Ended       Months Ended    
    September 30,   % of   September 30,   % of   September 30,   % of   September 30,   % of
    2004   Revenues   2003   Revenues   2002   Revenues   2002   Revenues
    (As Restated)   (As Restated)   (Unaudited)                        
Net Revenues
                                                               
Health Care sales
  $ 737       40.3     $ 749       44.2     $ 787       45.3     $ 615       44.2  
Health Care rentals
    452       24.7       318       18.8       328       18.9       268       19.2  
Funeral Services sales
    640       35.0       628       37.0       621       35.8       510       36.6  
 
Total Revenues
  $ 1,829       100.0     $ 1,695       100.0     $ 1,736       100.0     $ 1,393       100.0  
 
Gross Profit
                                                               
Health Care sales
  $ 355       48.2     $ 379       50.6     $ 394       50.1     $ 304       49.4  
Health Care rentals
    203       44.9       157       49.4       156       47.6       127       47.4  
Funeral Services sales
    350       54.7       349       55.6       336       54.1       275       53.9  
 
Total Gross Profit
    908       49.6       885       52.2       886       51.0       706       50.7  
Other operating expenses
    582       31.8       544       32.1       585       33.7       485       34.8  
Litigation charge
                            250       14.4       250       17.9  
Special charges
    6       0.3       9       0.5       5       0.3       4       0.3  
 
Operating Profit (Loss)
    320       17.5       332       19.6       46       2.6       (33 )     (2.3 )
Other income (expense), net
    (12 )     (0.7 )     (52 )     (3.1 )     (27 )     (1.5 )     (22 )     (1.6 )
 
Income (Loss) from Continuing Operations Before Income Taxes
    308       16.8       280       16.5       19       1.1       (55 )     (3.9 )
Income tax expense (benefit)
    120       6.5       99       5.8       (37 )     (2.1 )     (38 )     (2.7 )
 
Income (Loss) from Continuing Operations
    188       10.3       181       10.7       56       3.2       (17 )     (1.2 )
(Loss) income from discontinued operations
    (45 )     (2.5 )     8       0.5       (12 )     (0.7 )     7       0.5  
 
Net Income (Loss)
  $ 143       7.8     $ 189       11.2     $ 44       2.5     $ (10 )     (0.7 )
 
Income (loss) per common share from continuing operations
  $ 3.00       N/A     $ 2.90       N/A     $ 0.90       N/A     $ (0.28 )     N/A  
(Loss) income per common share from discontinued operations
    (0.72 )     N/A       0.14       N/A       (0.20     N/A     0.12       N/A  
 
Net Income (Loss) per Common Share — Diluted
  $ 2.28       N/A     $ 3.04       N/A     $ 0.70       N/A     $ (0.16 )     N/A  
 
The financial results presented herein include a number of other items which impact the comparability between periods. A summary of these items is as follows:
                                 
    Fiscal Year   Fiscal Year   Twelve Months   Ten Months
    Ended   Ended   Ended   Ended
    September 30,   September 30,   September 30,   September 30,
    2004   2003   2002   2002
(Dollars in millions)   (As Restated)   (As Restated)                
 
Pre-tax Items:
                               
Net Revenues
                               
CMS claims resolution
  $     $ (3 )   $     $  
Litigation charge
                250       250  
Special charges
    6       9       5       4  
Operating Expense
                               
Write-off of technology asset
                5       5  
Other (Income) Expense, net
                               
Loss on extinguishment of debt
    6       16              
Net realized capital (gains) losses and impairments
          17       11       11  
Income Taxes:
                               
Reversal of tax reserves and adjustments to valuation allowance
                (32 )     (6 )
 
                               
Discontinued Operations
                               
Items (net-of-tax):
                               
Net realized capital (gains) losses and impairments
    (2 )     21       30       11  
Special charges
                7        
Loss on impairment of discontinued operations
    71                    
Other
                (6 )     (6 )

13


Table of Contents

In the following sections, we provide a high level summary of our consolidated results of operations for the periods indicated. Immediately following each summary section is a more comprehensive discussion of revenues and gross profit by operating company.
Fiscal Year Ended September 30, 2004 Compared to Fiscal Year Ended September 30, 2003
Summary
Consolidated revenues of $1,829 million in 2004 increased $134 million, or 7.9 percent, compared to $1,695 million in 2003. The increase in revenue was predominantly related to the 2004 acquisitions, from which ARI and Mediq increased Health Care rental revenues by $61 million and $80 million, respectively, and Mediq and NaviCare increased Health Care sales by $15 million collectively. Excluding acquisitions, Health Care sales decreased by $27 million and Health Care rental revenues decreased by $7 million, but were partially offset in consolidation by the increase in Funeral Services sales of $12 million. Health Care sales experienced declining volumes due to product transitions, and pricing pressures further compounded the effect of lower volumes on revenues. Funeral Services continued to experience declining volumes due to a lower death rate and higher cremations along with unfavorable product line mix, but favorable price realization and cremation and product accessory growth drove the year-over-year increase in revenues. 2003 revenues also benefited from the resolution of outstanding claims with the Center for Medicare and Medicaid Services (CMS) related to previously reserved past due receivables in the amount of approximately $3 million. In 2005, Health Care sales should benefit from the 2004 new product introductions partially offset by continued competitive pricing pressures. Health Care rentals are expected to increase resulting from the full year inclusion of acquired businesses plus additional capital spending. Funeral Services revenues are expected to continue to be effected by the 2004 items previously mentioned.
Consolidated gross profit increased $23 million or 2.6 percent over the prior year period, again driven by the acquisitions in Health Care rentals. As a percentage of total revenues, consolidated gross profit margins of 49.6 percent in 2004 decreased from 52.2 percent in 2003. The lower gross margin as a percent of revenues was driven by a mix shift from higher margin capital products to lower margin rental products, especially the MediqÒ product lines, lower volumes at both Hill-Rom and Batesville Casket and significantly increased material costs driven by higher prices for steel, red metals and solid woods. Excluding the acquired MediqÒ product lines, gross profit margins in 2004 would have been 50.9%.
Other operating expenses increased 7.0 percent to $582 million in 2004 compared to $544 million in 2003. Other operating expenses consist of selling, marketing, distribution and general administrative costs. The higher expense levels were essentially due to the acquisitions of ARI, Mediq and NaviCare, which added operating expenses of $41 million. Operating expenses have also increased in 2004 as a result of higher information technology costs associated with the continued roll-out of our enterprise-wide technology platform, a higher foreign exchange impact on European operating expenses, higher transportation fuel costs and legal fees. These increases were partially offset by lower incentive compensation expense of $46 million in 2004 versus 2003 driven by the results falling short of our targeted incentive levels, as well as realized compensation and benefit savings associated with the third quarter 2003 Hill-Rom business realignment. In the fourth quarter of 2003, a pension curtailment charge of approximately $3.5 million was recognized related to a previously announced pension choice program. As a percentage of revenues, operating expenses decreased to 31.8 percent in 2004 from 32.1 percent in 2003 as a result of the additional revenues and synergies from acquired companies, and the lower compensation expense discussed above. In 2005, other operating expenses are expected to increase resulting from a full year of acquired business expenses, a higher level of information technology expenses and an increase in incentive compensation expense. As in 2004, incentive compensation will depend on financial results in 2005. These

14


Table of Contents

increases are expected to be partially offset with continued synergies achieved from acquisition integrations and lower compensation and benefit savings associated with the 2003 and 2004 Hill-Rom restructuring activities.
Special charges were recognized in both the 2004 and 2003 reporting periods. In 2004, a net special charge of $6 million was recorded related to restructuring charges at Hill-Rom. In the third quarter of 2003, a charge of $9 million was recorded related to severance and benefit-related costs associated with a new business structure at Hill-Rom.
Other Income and Expense
                         
    Fiscal Year   Fiscal Year    
    Ended   Ended    
    September 30,   September 30,    
(Dollars in millions)   2004   2003   % Change
 
Interest expense
  $ (15 )   $ (19 )     21.1  
Investment income
    9       9        
Loss on extinguishment of debt
    (6 )     (16 )     62.5  
Other
          (26 )     100.0  
 
Other Income (Expense), Net
  $ (12 )   $ (52 )     76.9  
 
Interest expense decreased $4 million to $15 million in 2004 compared to $19 million in 2003. This decrease resulted from debt actions taken during the 2003 and 2004 fiscal years. We repurchased $157 million of debt, with interest rates ranging from 6.75 percent to 8.5 percent in the fourth quarter of fiscal 2003, followed by the repurchase of an additional $47 million in the third quarter of 2004. In July 2004, we issued $250 million of 4.5 percent debentures. The debt repurchases described above resulted in charges for the extinguishment of debt of $6 million in 2004 and $16 million in 2003, primarily resulting from premiums paid on the repurchases, partially offset by recognition of a portion of the deferred gains resulting from the termination of certain interest rate swaps in 2003 on the associated debt. Other expenses decreased year over year, primarily resulting from other investment write-downs in 2003, and the investment losses generated by the private equity limited partnerships retained upon the sale of Forethought.
Income tax expense of $120 million was recognized in 2004 compared to income tax expense of $99 million in 2003. The effective tax rate for 2004 approximated 38.9 percent while in 2003 the tax rate approximated 35.4 percent. The increase in 2004 resulted in part from the establishment of valuation allowances on deferred tax assets due to both continued losses in France and capital losses realized from the divestitures. This increase was also due to additional accruals related to audit activity by the Internal Revenue Service and various states. These were partially offset with the benefit from a strategy to restructure the French operations and the recognition of a related deferred tax asset. The 2003 rate included the effect of a valuation allowance of approximately $4 million provided in the fourth quarter. The allowance was provided in response to concerns regarding the utilization of certain foreign deferred tax assets resulting from continued deterioration in operating results and generally weak economic conditions in certain foreign tax jurisdictions. Excluding the effect of this valuation allowance, the effective income tax rate for 2003 would have approximated 34 percent.
Income from continuing operations increased in 2004 to $188 million, or $3.00 per diluted share, compared to $181 million, or $2.90 per diluted share in 2003. The increase related to the decrease in other income and expense partially offset by the increase in income tax expense in 2004. Considering the effect of the pre-tax items outlined in the table of unusual items, income from continuing operations was adversely impacted by $12 million in 2004 and $39 million in 2003.
In February 2004, we entered into a definitive agreement for the sale of Forethought. At that time an impairment on discontinued operations of $96 million, net of a $33 million income tax

15


Table of Contents

benefit, was recorded based on the terms of the deal. With the subsequent completion of the sale in the fourth quarter, the net loss was adjusted to $89 million. The lower loss was the result of closing adjustments associated primarily with an increase in proceeds related to an increase in the statutory adjusted book value of Forethought, partially offset by additional acquisition costs. In September 2003, we entered into a definitive agreement to sell the piped-medical gas business of Hill-Rom. Also in September 2003, we announced an agreement to sell the Air-Shields infant care business of Hill-Rom. The sale of the piped-medical gas business closed in October 2003 while the sale of the infant care business closed in the third quarter of fiscal 2004. Net gains were recognized on the divestitures of both businesses in the combined amount of $18 million.
As a result of these divestitures, and in accordance with Statement of Financial Accounting Standards (SFAS) No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets”, we have reported these businesses as discontinued operations for all years presented. The results from discontinued operations reflect a net loss of $45 million in 2004 compared to net income of $8 million in the prior year. The net loss in 2004 included the $89 million loss (net-of-tax) on impairment of discontinued operations related to Forethought, partially offset by the $18 million in gains (net-of-tax) recognized on the dispositions of Hill-Rom’s piped-medical gas and infant care businesses. The loss was further offset by income from operations at Forethought of $22 million (net-of-tax), which increased from the prior year due to an improvement in net capital gains and losses recognized at Forethought, along with income from operations for the piped-medical gas and infant care businesses of a combined $4 million (net-of-tax). (See Note 3 to Consolidated Financial Statements for further details).
Operating Company Results of Operations
Health Care
                         
    Fiscal     Fiscal        
    Year Ended     Year Ended        
    September 30,     September 30,        
(Dollars in millions)   2004     2003     % Change  
 
Revenues:
                       
Health Care sales
  $ 737     $ 749       (1.6 )
Health Care rentals
  $ 452     $ 318       42.1  
 
                       
Cost of revenues:
                       
Health Care sales
  $ 382     $ 370       3.2  
Health Care rentals
  $ 249     $ 161       54.7  
 
                       
Gross profit:
                       
Health Care sales
  $ 355     $ 379       (6.3 )
% of revenues
    48.2 %     50.6 %        
Health Care rentals
  $ 203     $ 157       29.3  
% of revenues
    44.9 %     49.4 %        
Health Care Sales
Health Care sales decreased $12 million in 2004 compared to 2003. In Americas/Asia Pacific, revenues were lower by $35 million, driven by the impact of lower volumes of $34 million and unfavorable pricing of $16 million, partially offset by the favorable impact of the current year acquisitions of Mediq and NaviCare of $15 million. EMEA revenues increased $23 million due to favorable effects of exchange rates of $15 million and higher volumes.

16


Table of Contents

In Americas/Asia Pacific, lower patient platform volumes partially resulted from market delays in customer orders caused by the second quarter 2004 introduction of the VersaCareä bed platform, which replaced our largest selling Advantaä platform with a more feature-rich product. The patient platform order trends are improving and the backlog as of September 30, 2004 was 13 percent above prior year.
In addition to the disruptions resulting from the introduction of the VersaCare™ platform, we also believe our platform revenues have been negatively impacted by competition across the product range, particularly in the lower price range product lines. This is specifically the product range in which the CareAssistä bed, which was also launched during the second quarter of 2004, competes.
In our non-patient platform product offerings, we experienced lower volumes as a result of non-differentiated products and sales constraints as a result of the focus and prioritization of the new bed platform launches. In the third quarter, we introduced new headwall architectural products and completed a new furniture supply agreement which was launched in the fourth quarter of fiscal 2004. During the fourth quarter we also added sales personnel to further accelerate the sales of recently introduced products.
EMEA results increased from favorable foreign exchange mentioned above and increased volumes of approximately $9 million resulting from the relaunch of the new AvantGuard™ bed platform. Higher revenues were experienced in all major European markets, with the exception of Germany and Austria. The Middle East and Africa revenues declined $3 million from the prior year.
Gross profit from Health Care sales decreased $24 million from the prior year. As a percentage of sales, gross profit was 48.2 percent in 2004 compared to 50.6 percent in 2003. The decrease in gross profit dollars was primarily associated with lower volumes, along with a general decline in margin rates compared to prior year, partially offset by a $4 million increase resulting from the favorable effects of exchange rates. Contributing to the decline in margin rates were continued pricing pressures, cost pressures in raw material pricing, inflationary wage and benefit expenses, and unfavorable product mix. The mix of European revenues to total revenues was also higher in 2004 than in the prior year, negatively impacting overall margin rates, as European sales generate lower margin rates.
Health Care Rentals
Health Care rental revenue increased $134 million. The overall increase in rental revenue was attributable primarily to the ARI and Mediq acquisitions made during the first two quarters of 2004. ARI increased rental revenues by $61 million, while Mediq contributed $80 million. Excluding the impact of recent acquisitions, the core rental business revenues in Americas/Asia Pacific were down nearly $9 million compared to the prior year period due to lower units in use of approximately $6 million and lower pricing of $3 million. Units in use were down in the wound business segment primarily in low-end units that experienced increased competition and a shift from rental to purchase, and the pulmonary market segment, resulting from a shift toward purchase of pulmonary units, partially offset by increased units in the bariatric area. EMEA rental revenues were up $2 million, driven by favorable effects of exchange rates amounting to $4 million partially offset by lower units in use.
Health Care rental gross profit increased $46 million in 2004. The increase in gross profit dollars was attributable to the acquisitions of ARI and Mediq, which contributed a combined $54 million to the improvement. Excluding acquisitions, the core business declined nearly $8 million due to lower volumes and pricing, partially offset by an approximate $1 million increase resulting from the favorable effects of exchange rates. As a percentage of sales, gross profit was 44.9 percent of revenues in 2004 compared to 49.4 percent of revenues in the prior year. Margin rate declines resulted from higher sales and service costs on lower core volumes and

17


Table of Contents

the lower margin rates of the acquired Mediq® product lines. Only partially offsetting the impact of these items was the generally higher margin rates experienced at ARI.
Health Care Operating Profit
Health Care sales and rentals combined for an operating profit of $173 million in 2004, which was a $22 million decline from an operating profit of $195 million in 2003. The primary driver for the decrease in operating profit was higher operating expenses, which increased by $48 million. The acquisitions of ARI, Mediq and NaviCare added operating expenses of approximately $41 million. Related integration costs totaled approximately $6 million for 2004. In addition, operating expenses increased as a result of higher information technology depreciation costs and distribution fuel costs. These increases were partially offset by a reduction of approximately 400 core business positions (excluding the impact of acquisitions) resulting from the Hill-Rom business restructuring in the third quarter of 2003, decreased incentive compensation expense and favorable selling commissions. In addition, an increase in gross profit was provided by the acquisitions of ARI and Mediq.
Health Care operating results in 2004 included net special charges of $6 million primarily related to severance and benefit-related costs associated with a restructuring announced in the fourth quarter 2004, as previously discussed. In 2003, Health Care operating results included a special charge of $9 million related to severance and benefit-related costs associated with the new business structure previously discussed. This charge was partially offset by the resolution of outstanding claims with CMS of approximately $3 million.
Funeral Services
                         
    Fiscal   Fiscal    
    Year Ended   Year Ended    
    September 30,   September 30,    
(Dollars in millions)   2004   2003   % Change
 
Funeral Services
                       
Revenues
  $ 640     $ 628       1.9  
 
                       
Cost of Revenues
  $ 290     $ 279       3.9  
 
                       
Gross profit
  $ 350     $ 349       0.3  
% of revenues
    54.7 %     55.6 %        
Funeral Services product sales increased $12 million. Favorable price realization (that is, net revenues after discounts) of $22 million and increased cremations products and other miscellaneous product accessory revenues of $6 million were partially offset by a 2 percent or $6 million decline in burial volume, along with $10 million in less favorable mix within product lines reflecting the continuing broad industry-wide downward mix trend. We believe the decline in volume is primarily attributable to a soft market due to lower death rates as indicated by preliminary Center for Disease Control (CDC) death estimates along with the gradual year-over-year estimated increase in cremations.
Funeral Services gross profit was essentially flat. The decrease in margin as a percent of revenue was due to lower burial volumes, significantly higher material costs associated with steel, red metal and solid wood, a gradual product mix shift to products carrying lower margin percentages, increased fixed manufacturing costs, initial inefficiencies associated with expanding our manufacturing capabilities in Mexico and higher benefit and insurance costs. These were partially offset by improved price realization and a reduction of other variable manufacturing costs. Gross profit percentages are exclusive of distribution costs of $86 million, up from $85 million in the prior year period, but approximately 13.5 percent of revenues in each year. Despite the decline in volume, distribution costs increased slightly due

18


Table of Contents

primarily to increased fuel costs of approximately $1 million. Such costs are included in Other operating expenses for all periods.
Funeral Services operating profit of $186 million in 2004 increased $4 million. This slight year-over-year increase was driven by favorable price realization, manufacturing and production cost productivity improvements and decreased operating expenses due primarily to lower incentive compensation expense and lower bad debt expense resulting from the 2003 bankruptcy by one of our customers. These favorable items were almost entirely offset by the lower burial volume, unfavorable product line mix, higher material costs driven by significant commodity price increases and higher operating expenses for customer visitation, ERP amortization, new product development, fuel and legal costs for labor negotiations.
Fiscal Year Ended September 30, 2003 Compared to Twelve Months Ended September 30, 2002
Summary
Consolidated revenues of $1,695 million in 2003 decreased $41 million compared to $1,736 million in 2002. The decline in revenue was due, in part, to the impact of the change in fiscal year-end to September 30 from the Saturday nearest November 30 of each year. This change in year-end had an adverse impact on the comparison of sales volume to the prior year, as we had record monthly revenues in November 2001. Also contributing to the revenue decline was the inclusion of an additional month of sales for certain foreign operations in 2002 as Hill-Rom discontinued consolidating such operations on a one-month lag in September 2002. This change benefited 2002 revenues by nearly $17 million. Partially offsetting the decline in revenues were favorable movements in foreign currency exchange rates of approximately $24 million. 2003 revenues also benefited from the resolution of outstanding claims with the Center for Medicare and Medicaid Services (CMS) related to previously reserved past due receivables in the amount of approximately $3 million.
Consolidated gross profit was flat in 2003 compared to the twelve months ended September 30, 2002. As a percentage of total revenues, consolidated gross profit margins of 52.2 percent in 2003 increased from 51.0 percent in the twelve months ended September 30, 2002 resulting from favorable price realization on funeral service revenues and improved manufacturing efficiencies.
Other operating expenses decreased 7.0 percent to $544 million in 2003 compared to $585 million in 2002. As a percentage of revenues, operating expenses decreased to 32.1 percent in 2003 from 33.7 percent in 2002. In the fourth quarter of 2003, a pension curtailment charge of approximately $3.5 million was recognized related to a previously announced pension choice program. Other operating expenses consist of selling, marketing, distribution and general administrative costs. The decrease in operating expenses is primarily attributable to lower incentive compensation, legal and selling-related expenses. The decreased legal expenses are associated primarily with the Kinetic Concepts, Inc. (KCI) antitrust litigation, which was settled in December 2002. These decreases were partially offset by increased engineering and product development spending of $10 million in accordance with our business plan and strategy. In addition, a fourth quarter 2002 operating expense charge of $5 million was recognized related to the write-off of a separate technology asset with no continuing value at Hill-Rom.
Special charges were recognized in both the 2003 and 2002 reporting periods. In the third quarter of 2003, a charge of $9 million was recorded related to severance and benefit-related costs associated with the new business structure at Hill-Rom. In 2002, a net special charge of $5 million was recorded related to continued streamlining efforts at all Hillenbrand companies. Also affecting operating results in 2002 was the $250 million, $158 million net-of-tax, KCI antitrust litigation charge.

19


Table of Contents

Other Income and Expense
                         
    Fiscal Year   Twelve Months    
    Ended   Ended    
    September 30,   September 30,   %
(Dollars in millions)   2003   2002   Change
 
Interest expense
  $ (19 )   $ (18 )     (5.6 )
Investment income
    9       12       (25.0 )
Loss on extinguishment of debt
    (16 )           N/A  
Other
    (26 )     (21 )     (23.8 )
 
Other Income (Expense), Net
  $ (52 )   $ (27 )     (92.6 )
 
Interest expense increased $1 million to $19 million in 2003 compared to $18 million in 2002. This increase was primarily related to the amortization of debt issuance costs and other expenses associated with our revolving credit facilities and related amendments. We continued to realize the benefits of interest rate swaps that converted $150 million of long-term debt from fixed to variable interest rates as a result of the favorable interest rate environment. In late June 2003, one of the interest rate swaps was terminated, with the remaining two swaps being terminated in July 2003. Investment income of $9 million declined from $12 million in 2002, as a result of lower cash and cash equivalents and the lower interest rate environment. The lower cash and cash equivalents related primarily to the $175 million, $111 million net-of-tax, payment made in January 2003 associated with the KCI settlement. As previously mentioned, we incurred a charge in Other expense of approximately $16 million in conjunction with the completion of a bond tender offer in the fourth quarter of 2003, which resulted in the retirement of approximately $157 million of our long-term debt. This charge was composed primarily of the premium paid to repurchase the outstanding bonds, partially offset by recognition of a portion of the gain associated with the termination of the interest rate swaps. Other expenses increased year over year, primarily resulting from other investment write-downs and the investment losses generated by the private equity limited partnerships that we retained upon the sale of Forethought.
Income tax expense of $99 million was recognized in 2003 compared to an income tax benefit of $37 million in 2002. The effective tax rate for 2003 approximated 35.4 percent. This rate included the effect of a valuation allowance of approximately $4 million provided in the fourth quarter. The allowance was provided in response to concerns regarding the utilization of certain foreign deferred tax assets resulting from continued deterioration in operating results and generally weak economic conditions in certain foreign tax jurisdictions. Excluding the effect of this valuation allowance, the effective income tax rate for 2003 would have approximated 34 percent. The tax benefit in 2002 resulted from the loss recognized in 2002, resulting from the $250 million KCI antitrust litigation charge, and the release of approximately $32 million of previously provided tax reserves. These reserves were released as a result of the resolution of certain domestic and foreign tax matters. Excluding the impact of the prior year KCI antitrust litigation charge and the release of tax reserves, the effective tax rate in 2002 would have approximated 32.1 percent.
Income from continuing operations increased in 2003 to $181 million, or $2.90 on a diluted earnings per share basis, compared to $56 million, or $0.90 on a diluted earnings per share basis in 2002. The increase related primarily to the KCI litigation charge of $250 million, $158 million net-of-tax, taken in 2002. In addition, 2003 income was adversely impacted by a charge of $16 million, $11 million net-of-tax, in Other expense associated with the completion of a bond tender offer. Considering the effect of the pre-tax items outlined in the table of unusual items, income from continuing operations was adversely impacted by $39 million in 2003 and $271 million in 2002. Income in 2002 was favorably impacted by the release of approximately $32 million of previously provided tax reserves.
We have reported divested businesses as discontinued operations for all years presented. The results from discontinued operations reflect net income of $8 million in 2003 compared to a net

20


Table of Contents

loss of $12 million in the prior year. The comparative results for discontinued operations were favorably impacted by lower capital losses at Forethought in 2003 compared to 2002, $21 million compared to $30 million, respectively, both on a net-of-tax basis, along with general improvements in the underwriting business and higher investment income at Forethought. The reported loss in 2002 also included $7 million of special charges related to discontinued businesses, offset by a favorable patent litigation settlement in the amount of approximately $6 million, both on a net-of-tax basis. The fiscal 2002 loss was also impacted by a higher than normal effective tax rate associated with the provision of approximately $5 million of deferred tax liability associated with Forethought’s decision to surrender company-owned life insurance policies. (See Note 3 to Consolidated Financial Statements for further details).
Operating Company Results of Operations
Health Care
                         
    Fiscal   Twelve    
    Year Ended   Months Ended    
    September 30,   September 30,    
(Dollars in millions)   2003   2002   % Change
 
Revenues:
                       
Health Care sales
  $ 749     $ 787       (4.8 )
Health Care rentals
  $ 318     $ 328       (3.0 )
 
                       
Cost of revenues:
                       
Health Care sales
  $ 370     $ 393       (5.9 )
Health Care rentals
  $ 161     $ 172       (6.4 )
 
                       
Gross profit:
                       
Health Care sales
  $ 379     $ 394       (3.8 )
% of revenues
    50.6 %     50.1 %        
Health Care rentals
  $ 157     $ 156       0.6  
% of revenues
    49.4 %     47.6 %        
 
Health Care Sales
Health Care sales decreased $38 million, or 4.8 percent, in 2003, to $749 million from $787 million in 2002. As briefly outlined above, the decline in revenues related primarily to lower volumes of approximately $55 million, due in part to the change in year-end to September 30, and the inclusion of a 13th month of sales in 2002 for certain foreign operations which increased capital sales an estimated $15 million. During the fourth quarter of 2002 we discontinued consolidating such operations on a one-month lag basis. The lower volumes included a year-over-year decline in North American sales of $27 million, primarily associated with long-term care, maternal care and architectural products, along with general declines in European volume levels in select markets of $31 million, most notably in France and Germany. Pricing pressures also negatively impacted revenues by approximately $3 million in 2003. These declines in revenue were partially offset by the favorable impacts of foreign currency movements of approximately $20 million.
Gross profit from Health Care sales decreased to $379 million in 2003 from $394 million in the prior year, a decrease of 3.8 percent. As a percentage of sales, gross profit was 50.6 percent in 2003 compared to 50.1 percent in 2002. The decrease in gross profit dollars was primarily associated with lower volumes, due in part to the change in fiscal year-end as discussed above. Lower volumes contributed to approximately $25 million of the decline in gross profit. Also contributing to the decline were continued pricing pressures in low- to mid-range product offerings. Lower costs resulting from continuing quality initiatives and improved

21


Table of Contents

manufacturing efficiencies resulted in the overall improvement in gross profit as a percentage of sales.
Health Care Rentals
Health Care rental revenue decreased $10 million, or 3.0 percent, to $318 million in 2003 compared to $328 million in 2002. Negative experience in terms of realized rate of $13 million, most notably in home care where prior year revenues were favorably impacted by the collection of certain previously reserved receivables, was a key driver of the decline. This negative experience in realized rate was net of the resolution of outstanding claims of approximately $3 million with CMS related to previously reserved past due receivables. The other key driver for the decline in revenue was lower volume of $16 million. The additional month of revenues in 2002 for certain foreign operations also had a negative impact on the year-over-year rental revenue comparison of approximately $2 million. Offsetting these decreases was favorable product mix of $14 million, resulting primarily from the planned transition from the Efica to the TotalCare rental solution. Foreign currency movements also favorably impacted revenue by nearly $4 million.
Health Care rental gross profit remained relatively flat in 2003. As a percentage of sales, gross profit was 49.4 percent of revenues in 2003 compared to 47.6 percent of revenues in the prior year. The improvement in gross profit margin was attributable to continued improvements in overall field service and selling costs and the fiscal fourth quarter resolution of outstanding claims of approximately $3 million with CMS previously discussed, partially offset by the negative effect of higher specific product warranties in 2003 than in 2002. Lower realized rate, most notably in home care where the prior year included collections on receivables previously written off, along with lower volumes partially offset the gross profit improvement.
Health Care Operating Profit
Health Care operating profit of $195 million in 2003 improved from an operating loss of $76 million in 2002. The primary driver for the increase in operating profit was the prior year $250 million KCI antitrust litigation charge previously mentioned. Also contributing to the increase were lower operating expenses, which decreased by $46 million, primarily related to decreased incentive compensation, legal, bad debt and selling-related costs. Partially offsetting the improvement in operating expenses was the decline in Health Care sales gross profit, primarily the result of lower volumes and continued pricing pressures, which more than offset the impact of other efficiencies and the overall improvement in gross margin rates as a percentage of sales.
Health Care operating results in 2003 included a special charge of $9 million related to severance and benefit-related costs associated with the new business structure previously discussed. This charge was partially offset by the resolution of outstanding claims with CMS of approximately $3 million. Operating results in 2002 were impacted by the KCI antitrust litigation charge of $250 million, net special charge activity of essentially zero and a fourth quarter operating expense charge related to the write-off of a separate technology asset of approximately $5 million. During 2002, a realignment action in Germany was essentially offset by the reversal of prior special charge provisions in excess of actual requirements.

22


Table of Contents

Funeral Services
                         
    Fiscal   Twelve    
    Year Ended   Months Ended    
    September 30,   September 30,    
(Dollars in millions)   2003   2002   % Change
 
Funeral Services
                       
Revenues
  $ 628     $ 621       1.1  
 
                       
Cost of Revenues
  $ 279     $ 285       (2.1 )
 
                       
Gross profit
  $ 349     $ 336       3.9  
% of revenues
    55.6 %     54.1 %        
 
Funeral Services product sales increased $7 million to $628 million in 2003 from $621 million in 2002. Favorable price realization (that is, net revenues after discounts) of $24 million and increased revenue from cremation products and other miscellaneous product accessory revenues of $6 million were partially offset by a decline in volume of nearly 5 percent across virtually all product lines along with a slightly unfavorable product mix. The decline in volume was attributable to continued lower death rates, an estimated one-point increase in cremation rates and management’s decision to exit some unprofitable product lines in Canada.
Funeral Services gross profit increased 3.9 percent from $336 million, or 54.1 percent of revenue, in 2002 to $349 million, or 55.6 percent of revenue, in 2003. This increase was due to improved price realization, continued efficiencies in manufacturing and production costs, savings on purchased materials related to strategic sourcing efforts and lower inventory provisions related to excess, obsolete and discontinued product lines than in the prior year. These benefits were partially offset by lower volumes across essentially all product lines, expected inefficiencies due to the introduction of a new product line at one of our plants and increased steel prices resulting from the tariffs imposed by the U.S. government on steel imports in 2002. Gross profit percentages are exclusive of distribution costs of $85 million, up from $84 million in the prior year period, but approximately 13.5 percent of revenues in each year. Such costs are included in Other operating expenses for all periods.
Funeral Services operating profit of $182 million in 2003 increased 7.8 percent as a result of favorable price realization, continued efficiencies in manufacturing and production costs and savings on purchased materials related to strategic sourcing efforts. These benefits were partially offset by lower volumes of nearly 5 percent across essentially all product lines, expected inefficiencies due to the introduction of a new product line at one of our plants and increased steel prices resulting from the tariffs enacted in the prior year. Operating expenses increased $4 million from the prior year, resulting from an increase in uncollectible accounts, higher costs related to investments in new product development, increased distribution costs related to higher fuel costs and amortization expense resulting from the acquisition of the Marsellus intellectual property in 2003. Offsetting the increases in operating expenses were lower selling costs driven by the lower burial volumes. In 2002, Batesville Casket incurred special charges of $4 million, related to the closure of a wood casket manufacturing plant in Canada and an employee reduction action in the United States.

23


Table of Contents

Fiscal Year Ended September 30, 2003 Compared to Ten Months Ended September 30, 2002
                                 
    Fiscal Year Ended   Ten Months Ended
(Dollars in millions)   September 30, 2003   September 30, 2002
            % of           % of
            Revenues           Revenues
Net revenues
  $ 1,695       100.0     $ 1,393       100.0  
Gross profit
    885       52.2       706       50.7  
Operating expenses
    544       32.1       485       34.8  
Operating profit/(loss)
    332       19.6       (33 )     (2.3 )
Summary
Consolidated revenues for the fiscal year ended September 30, 2003 totaled $1,695 million compared to $1,393 million for the ten months ended September 30, 2002. Giving consideration to the different time periods, overall revenues were somewhat higher in 2003 as a result of stronger Health Care and Funeral Services sales. Benefiting overall Health Care sales were favorable movements in foreign currency exchange rates of approximately $24 million. Offsetting the Health Care sales improvement was nearly $17 million of additional revenue recorded in 2002 as a result of the inclusion of an additional month of sales for certain foreign operations as Hill-Rom discontinued consolidating such operations on a one-month lag basis in September 2002. 2003 revenues also benefited from the resolution of outstanding claims with the Center for Medicare and Medicaid Services (CMS) related to previously reserved past due receivables in the amount of approximately $3 million.
Consolidated gross profit increased to $885 million in 2003. As a percentage of total revenues, consolidated gross profit margins of 52.2 percent in 2003 increased from 50.7 percent in the ten months ended September 30, 2002, resulting primarily from favorable price realization in Funeral Services, lower costs resulting from continued quality initiatives and improved manufacturing efficiencies.
Other operating expenses decreased to 32.1 percent of revenues for fiscal year 2003 compared to 34.8 percent of revenues for the ten months ended September 30, 2002. In the fourth quarter of 2003, a pension curtailment charge of approximately $3.5 million was recognized related to a previously announced pension choice program. Other operating expenses consist of selling, marketing, distribution and general administrative costs. The decrease in operating expenses as a percentage of revenues is consistent with the explanation previously provided in the comparison of twelve-month results for September 30, 2003 and 2002. Operating results for the fiscal year ended September 30, 2003 included net capital losses and impairment charges of $17 million generated by the private equity limited partnerships retained upon the sale of Forethought compared to $11 million in 2002. Operating results in 2002 were negatively impacted by a $5 million operating expense charge related to the write-off of a separate technology asset with no continuing value at Hill-Rom.
Operating results in 2003 also included a special charge of $9 million related to severance and benefit-related costs associated with the new business structure at Hill-Rom. Operating results in 2002 included the $250 million KCI antitrust litigation charge and a net special charge of $4 million. The net special charge was associated primarily with a realignment action by Hill-Rom in Germany and the closure of a wood casket manufacturing plant in Canada and other employee reduction actions in the United States by Batesville Casket. These charges were partially offset by the reversal of prior special charge provisions in excess of actual requirements at Hill-Rom.
An operating profit of $332 million, or 19.6 percent of revenues, was recognized for the 2003 fiscal year, compared to an operating loss of $33 million for the ten months ended September

24


Table of Contents

30, 2002. The 2002 operating loss was primarily attributable to the $250 million KCI antitrust litigation charge previously discussed. The improvement in operating profit as a percentage of revenues over 2002, in addition to the impact of the KCI litigation charge, related to both higher gross profit margins, which increased 153 basis points, and lower operating expenses as a percentage of revenues. The improved gross profit margins resulted from improved product mix, primarily in Health Care rentals, price realization in Funeral Services sales and the benefits of cost reduction and realignment efforts throughout the Company. Lower operating expenses as a percentage of revenues resulted predominantly from lower incentive compensation, legal and selling-related expenses. The inclusion of an additional month of activity for certain foreign operations of Hill-Rom had a minimal impact on 2002 operating income.
Other Income and Expense
                                 
    Fiscal Year           Ten Months    
    Ended           Ended    
    September 30,   % of   September 30,   % of
(Dollars in millions)   2003   Revenues   2002   Revenues
 
Interest expense
  $ (19 )     (1.1 )   $ (14 )     (1.0 )
Investment income
    9       0.5       9       0.6  
Loss on extinguishment of debt
    (16 )     (1.0 )            
Other
    (26 )     (1.5 )     (17 )     (1.2 )
 
Other Income (Expense), Net
  $ (52 )     (3.1 )   $ (22 )     (1.6 )
 
Interest expense increased in fiscal year 2003 compared to the ten months ended September 30, 2002 as a result of the amortization of debt issuance costs and other expenses associated with our revolving credit facilities and related amendments and the additional two months in 2003. Investment income in 2003 was essentially unchanged compared to the ten months ended September 30, 2002, as the additional two months of income were offset by the effects of lower cash and cash equivalents and the lower interest rate environment. We also recognized a $16 million charge in Other expense related to the completion of a bond tender offer in the fourth quarter of 2003 as previously discussed. Other expenses increased year-over-year, primarily as a result of other investment write-downs in 2003 and the investment losses generated by the private equity limited partnerships retained upon the sale of Forethought.
The effective income tax rate on income from continuing operations for fiscal year 2003 was approximately 35.4 percent compared to 68.6 percent for the ten months ended September 30, 2002. The effective tax rate for 2003 included the effect of a valuation allowance of approximately $4 million provided in the fourth quarter. The allowance was provided in response to concerns regarding the utilization of certain foreign deferred tax assets resulting from continued deterioration in operating results and generally weak economic conditions in certain foreign tax jurisdictions. Excluding the effect of this valuation allowance, the effective tax rate for 2003 would have approximated 34 percent. Income taxes in 2002 were favorably impacted by the release of previously provided tax reserves associated with the resolution of certain domestic and foreign tax matters. The release of these reserves benefited income taxes by $6 million in 2002. Excluding the impact of the KCI antitrust litigation charge and the release of these reserves, the effective tax rate in 2002 would have approximated 31.5 percent.
Income from continuing operations of $181 million was recognized in 2003 compared to a net loss of $17 million in 2002. The increase in income was related primarily to the KCI antitrust litigation charge of $250 million, $158 million net-of-tax, along with the 2002 period including only ten months.
The results from discontinued operations reflected net income of $8 million in 2003 compared to $7 million for the ten months ended September 30, 2002. Results in 2003 were favorably

25


Table of Contents

impacted by the additional two months of earnings included in 2003 compared to the prior year period when we changed our year-end to September 30, along with improved operating results at Forethought related to higher underwriting and investment income. This favorability of $12 million was offset by the negative effects of the higher net capital losses and impairments of $21 million recognized in 2003 compared to $11 in the 2002 period, both on a net-of-tax basis. The reported income for 2002 also included a favorable patent litigation settlement in the amount of approximately $6 million, net-of-tax, offset by a provision of approximately $5 million for deferred taxes associated with Forethought’s decision to surrender company-owned life insurance policies. (See Note 3 to Consolidated Financial Statement for further details).
Operating Company Results of Operations
Health Care
                         
    Fiscal   Ten    
    Year Ended   Months Ended    
    September 30,   September 30,    
(Dollars in millions)   2003   2002   % Change
 
Revenues:
                       
Health Care sales
  $ 749     $ 615       21.8  
Health Care rentals
  $ 318     $ 268       18.7  
 
                       
Cost of revenues:
                       
Health Care sales
  $ 370     $ 311       19.0  
Health Care rentals
  $ 161     $ 141       14.2  
 
                       
Gross profit:
                       
Health Care sales
  $ 379     $ 304       24.7  
% of revenues
    50.6 %     49.4 %        
Health Care rentals
  $ 157     $ 127       23.6  
% of revenues
    49.4 %     47.4 %        
Health Care Sales
Health Care sales for the fiscal year ended September 30, 2003 were $749 million compared to $615 million for the ten months ended September 30, 2002. This increase in revenue resulted primarily from the different time periods and the favorable impacts of foreign currency movements. Negatively impacting the revenue comparison was the inclusion of an extra month of sales in 2002 for certain foreign operations, with an estimated impact of $15 million on capital sales. North American sales volumes in the comparable portion of each reporting period demonstrated some improvement, but this was generally offset by declines in European volumes. Downward pricing pressure on low- to mid-range product offerings also negatively impacted Health Care sales.
Gross profit for Health Care sales increased to 50.6 percent of revenues for fiscal year 2003 compared to 49.4 percent of revenues for the ten months ended September 30, 2002. The increase in gross profit percentage was due primarily to lower costs resulting from continuing quality initiatives and improved manufacturing efficiencies.
Health Care Rentals
Health Care rental revenues were $318 million for fiscal year 2003 compared to $268 million for the ten months ended September 30, 2002. The additional two months of rental revenue combined with favorable foreign currency movements and favorable product mix drove the increase. This was offset by generally lower units in use and lower rate realization for most

26


Table of Contents

product lines, which put added pressure on rental revenues. The extra month of sales in 2002 for certain foreign operations previously mentioned increased 2002 Health Care rental revenues by approximately $2 million.
Health Care rental gross profit increased to 49.4 percent of revenues for fiscal year 2003 compared to 47.4 percent of revenues for the ten months ended September 30, 2002. The improvement in gross profit percentage was attributable to continued improvements in overall field service and selling costs and the fiscal fourth quarter resolution of approximately $3 million of past due and fully reserved receivables with CMS previously discussed, partially offset by the negative effect of higher product warranties in 2003. Lower realized rate, most notably in home care, where the prior year included collections on receivables previously written off, along with lower volumes partially offset the gross profit improvement.
Health Care Operating Profit
Health Care operating profit of $195 million in 2003 increased from an operating loss of $136 million for the ten months ended September 30, 2002 primarily as a result of the $250 million KCI antitrust litigation charge included in 2002 and the difference in the length of the time periods under comparison. The improvement in operating profit was also favorably impacted by the increased gross profit margins for both Health Care sales and Health Care rentals and the decline in operating expenses as a percentage of revenues, as previously discussed.
Health Care operating results for fiscal year 2003 included a $9 million special charge related to severance and benefit-related costs associated with the new business structure at Hill-Rom. This was partially offset by the resolution of outstanding claims with CMS of approximately $3 million. For the ten months ended September 30, 2002, operating results included the $250 million KCI antitrust litigation charge and a net special charge of $1 million as a small realignment action in Germany was partially offset by the reversal of prior special charge provisions in excess of actual requirements. Operating results in 2002 also included an operating expense charge of $5 million related to the write-off of a technology asset with no continuing value.
Funeral Services
                         
    Fiscal   Ten    
    Year Ended   Months Ended    
    September 30,   September 30,    
(Dollars in millions)   2003   2002   % Change
 
Funeral Services
                       
Revenues
  $ 628     $ 510       23.1  
 
                       
Cost of Revenues
  $ 279     $ 235       18.7  
 
                       
Gross profit
  $ 349     $ 275       26.9  
% of revenues
    55.6 %     53.9 %        
Funeral Services product sales for fiscal year 2003 were $628 million compared to $510 million for the ten months ended September 30, 2002. Overall, excluding the impact of different time periods, volume declines across virtually all product lines were more than offset by improved price realization and increased revenue from cremation products and other miscellaneous product accessory revenues over the prior year. The decline in volume was attributable to lower death rates, an estimated one-percentage point increase in cremation rates and management’s decision to exit some unprofitable product lines in Canada.
Funeral Services gross profit increased to 55.6 percent of revenues for fiscal year 2003 compared to 53.9 percent of revenues for the ten months ended September 30, 2002. This increase is due to favorable price realization, continued efficiencies in manufacturing and

27


Table of Contents

production costs, savings on purchased materials resulting from strategic sourcing efforts and lower inventory provisions than in the prior year. These benefits were partially offset by expected inefficiencies due to the introduction of a new product line at one of the Company’s plants and increased steel prices resulting from the tariffs enacted in the prior year. Gross profit percentages are exclusive of distribution costs of 13.5 percent and 13.8 percent of revenues for 2003 and 2002, respectively, which are included in Other operating expenses.
Funeral Services operating profit as a percentage of revenue improved nearly 175 basis points in 2003 compared to 2002, primarily as a result of the increased gross profit margins discussed above. Operating expenses as a percentage of revenue increased slightly, resulting from the same factors cited in the comparison of twelve months results for September 30, 2003 and 2002. In 2002 Batesville Casket incurred a special charge of $3 million for the closure of a wood casket manufacturing plant in Canada along with other employee reduction actions in the United States.
LIQUIDITY AND CAPITAL RESOURCES
                         
    Fiscal Year   Fiscal Year   Ten Months
    Ended   Ended   Ended
    September 30,   September 30,   September 30,
  2004   2003   2002
(Dollars in millions)   (As Restated)                
 
Cash Flows Provided By (Used In):
                       
Operating activities
  $ 348     $ 366     $ 318  
Investing activities
    (511 )     (164 )     (300 )
Financing activities
    135       (155 )     (15 )
Effect of exchange rate changes on cash
    1       2       1  
 
(Decrease) Increase in Cash and Cash Equivalents
  $ (27 )   $ 49     $ 4  
 
Net cash flows from operating activities and selected borrowings have represented our primary sources of funds for growth of the business, including capital expenditures and acquisitions. We have not used any off-balance sheet arrangements, other than routine operating leases. Our financing agreements contain no restrictive provisions or conditions relating to dividend payments, working capital or additional unsecured indebtedness (except to the extent that a dividend payment or incurrence of additional unsecured indebtedness would result in a default under our financing agreements), but there are limitations with respect to secured indebtedness. Our debt agreements also contain no credit rating triggers. Credit rating changes can, however, impact the cost of borrowings under our financing agreements.
Operating Activities
For the fiscal year ended September 30, 2004, net cash provided by operating activities totaled $348 million compared to $366 million for the prior year. The operating cash flow was heavily influenced by the 2004 loss on impairment of discontinued operations of $71 million, net-of-tax, and the timing of payments made to KCI under the antitrust litigation settlement reached in 2002. Payments of $175 million ($111 million net-of-tax) and $75 million ($47 million net-of-tax) were made in January 2003 and December 2003, respectively.
Depreciation, amortization and the write-down of intangibles increased to $108 million in 2004 from $75 million in 2003. The increase in depreciation and amortization in 2004 related primarily to the acquisitions of ARI, Mediq and NaviCare during the current year. Amortization expense also increased as a result of the continued rollout of our enterprise-wide technology platform.

28


Table of Contents

Changes in working capital decreased cash from operations. The KCI antitrust litigation payment referred to above was the primary driver of the decline. Accounts receivable increased over the prior year, resulting from businesses acquired during the year and an increase in overall days revenues outstanding. Our Hill-Rom collection operations were recently brought in-house, after previous management by an outside vendor, in an effort to improve collections activity. Inventories increased from the prior year-end as a result of increased raw material costs at Hill-Rom and Batesville Casket, lower volumes and inventory build in response to labor negotiations with the Steelworkers Union at Batesville Casket’s Batesville location, which were successfully concluded late in the fourth quarter, and inventory build for new product roll-outs and lower volumes at Hill-Rom. Also contributing to the decline in working capital was a decrease in accrued incentive compensation driven by results falling short of our targeted incentive levels, partially offset by year-over-year salary increases. Although accounts payable increased slightly over the prior year-end, we experienced an overall decline in the management of accounts payable, as we acquired approximately $18 million of accounts payable in the ARI, Mediq and NaviCare transactions. A reduction of deferred taxes, influenced by the timing of payments related to the KCI antitrust litigation referred to above, provided a partial offset to the decline.
Investing Activities
Net cash used in investing activities for the fiscal year ended September 30, 2004 totaled $511 million compared to $164 million for the fiscal year ended September 30, 2003. Capital expenditures in both periods included expenditures associated with our continuing efforts to move to a single information technology platform, expenditures related to the introduction of new products and the replacement of therapy units in the rental fleet. Fiscal year 2004 capital expenditures also included capital expenditures at ARI, Mediq and NaviCare. Capital expenditures in 2003 included the purchase by Batesville Casket of certain intellectual property related to the former Marsellus Casket Company. The year-over-year increase in capital expenditures related primarily to incremental requirements for the Mediq rental business. Investing activities in 2003 also included $14 million of minority investments made throughout the Company.
Investment activity in fiscal 2004 included $85 million of purchases and capital calls and $85 million provided from sales and maturities. We invest a portion of our excess cash from operations into highly liquid auction rate municipal bonds. These liquid, current investments accounted for $81 million of the purchases and $62 million of the sales for fiscal 2004, as they were utilized as a treasury management strategy to earn better rates of return on available cash. In fiscal 2003, current investment purchases were $110 million, with sales of $280 million.
On October 17, 2003, we completed our acquisition of ARI. The purchase price was $83 million, plus an additional $2 million of acquisition costs incurred in relation to the transaction. This purchase price was subject to certain working capital adjustments at the date of close not to exceed $12 million, plus additional contingent payments not to exceed $20 million based on ARI achieving certain net revenue targets. Upon closing, $73.3 million of the purchase price was paid to the shareholders of ARI, with an additional $9.7 million deferred until a later date. Upon final determination of the working capital adjustment in January 2004, an additional $11.8 million was paid to the shareholders of ARI, along with $4 million of the originally deferred payments. The remaining deferral of $5.7 million is outstanding and accrued in the Consolidated Balance Sheet as of September 30, 2004. This acquisition was funded directly out of our cash on hand. The additional payments, including the contingency payments, if any, will be payable no later than the end of calendar 2005.
We completed our acquisition of Mediq on January 30, 2004. The purchase price and related acquisition costs for Mediq were approximately $335 million, subject to certain adjustments based upon the Mediq balance sheet at the date of close. The amount of the working capital adjustments and all deferred payments were accrued in the Consolidated Balance Sheet as of

29


Table of Contents

September 30, 2004. The purchase was initially funded from cash on hand and from our revolving credit facilities. The additional payments, including the contingency payments, if any, will be payable no later than the end of calendar 2005.
In addition, on January 30, 2004, we completed the acquisition of the remaining 84 percent of the equity of NaviCare that we did not own for approximately $14 million, including deferred payments of approximately $2 million payable within one year. The purchase was funded from cash on hand.
We received total cash of approximately $8 million in the acquisitions of ARI, Mediq and NaviCare during 2004, which were reflected as a decrease in the acquisition price on the Statements of Consolidated Cash Flows.
The divestiture of the piped-medical gas business was completed in October 2003 with the receipt of gross proceeds of approximately $13 million. The divestiture of the infant care business was completed in August 2004 with the receipt of gross proceeds of $31 million.
We also received approximately $105 million of cash proceeds from the disposition of Forethought, which closed on July 1, 2004. Other consideration from the sale of Forethought included a $92 million seller note receivable, $20 million of FFS preferred stock, $1 million of FFS stock warrants, $11 million debt service account, $6 million receivable due at the closing of Forethought Federal Savings Bank, and the transfer of $31 million of private equity limited partnerships. See Note 3 to the Consolidated Financial Statements for more detail on the Forethought divestiture.
On June 29, 2004, Forethought sold specific real estate partnerships that were part of their investment portfolio and were originally expected to be retained by Hillenbrand at closing. Forethought received $104 million in cash proceeds on the sale and recorded a capital loss on the transaction of approximately $7 million. The loss realized as a result of this transaction is included in discontinued operations for the year ended September 30, 2004. Included in the sale were mortgage loans of $54 million related to two of the real estate properties. Accordingly, the net impact of selling these partnerships resulted in Hillenbrand receiving an additional $50 million in cash proceeds from Forethought’s sale.
Financing Activities
Net cash provided by financing activities totaled $135 million for the fiscal year ended September 30, 2004 compared to net cash used in financing activities of $155 million for the fiscal year ended September 30, 2003. Cash provided by financing activities in 2004 related to borrowings on our revolver to initially finance the Mediq acquisition, and the subsequent issuance of $250 million of 4.5 percent coupon senior notes in June 2004, utilized to permanently finance the Mediq acquisition described above. This increase in cash from financing activities was partially offset by the open market repurchase of $47 million principal amount of longer maturity, high coupon debt in June 2004 for approximately $55 million. During the fourth quarter of 2003, we completed a tender offer to repurchase our outstanding long-term debt, resulting in the repurchase of $157 million of our debentures for $185 million. Partially offsetting the cash paid for the bond tender was $27 million of proceeds received on the termination of interest rate swap agreements, which were completed in the second half of 2003.
Cash dividends paid increased to $67 million in 2004, compared to $62 million in 2003. Quarterly cash dividends per share were $0.27 in 2004, $0.25 in 2003 and $0.23 in 2002. With our change in fiscal year-end to September 30 beginning in 2002, our Board of Directors approved a one-month dividend of $0.0767 per share, which was paid in March 2002.
Our long-term debt-to-capital ratio was 23.4 percent at September 30, 2004 compared to 11.4 percent at September 30, 2003. This increase was primarily due to the $250 million debt

30


Table of Contents

issuance described above. This increase was partially offset by the repurchase of $47 million of our debt in the third quarter of fiscal 2004 and $157 million of our debt during the fourth quarter of fiscal 2003.
Other Liquidity Matters
As of September 30, 2004, cash and cash equivalents (excluding investments in insurance operations) had decreased $27 million to $128 million from $155 million at September 30, 2003. Current investments, which are highly liquid securities, increased $19 million to $52 million at September 30, 2004 from $33 million at September 30, 2003.
As outlined above, the primary reason for the decrease related to the acquisitions of ARI, Mediq and NaviCare during the first six months of 2004, combined with the $75 million payment made in December 2003 as part of the December 2002 settlement of the antitrust litigation with KCI and the June 2004 repurchase of $47 million of debt. The impact of these payments was partially offset by net borrowings from our credit facilities, the June 2004 issuance of $250 million of 4.5 percent coupon senior notes, net cash flows generated from operations and proceeds received from divestitures.
On July 28, 2004, we replaced our previously existing senior credit facilities with a $400 million five-year senior revolving credit facility with a syndicate of banks led by Bank of America, N.A. and Citigroup North America, Inc. The term of the five-year facility expires on June 1, 2009. Borrowings under the credit facility bear interest at variable rates, as defined therein. The availability of borrowings under the five-year facility is subject to our ability at the time of borrowing to meet certain specified conditions. These conditions are similar to those under the prior credit facilities, and include, without limitation, a maximum debt to capital ratio of 55 percent. The proceeds of the five-year facility shall be used: (i) for working capital, capital expenditures, and other lawful corporate purposes; and (ii) to finance acquisitions.
As of September 30, 2004, we: (i) had $15 million of outstanding, undrawn letters of credit under the five-year facility, (ii) were in compliance with all conditions set forth under the facility and (iii) had complete access to the remaining $385 million of borrowing capacity available under that facility.
We have additional uncommitted credit lines totaling $15 million that have no commitment fees, compensating balance requirements or fixed expiration dates. As of September 30, 2004, we had $13 million of outstanding, undrawn letters of credit under these facilities.
We intend to continue to pursue acquisition candidates, but the timing, size or success of any acquisition effort and the related potential capital commitments cannot be predicted. We expect to fund future acquisitions primarily with cash on hand, cash flow from operations and borrowings, including the unborrowed portion of the five-year credit facility, but we may also issue additional debt and/or equity in connection with acquisitions.
In this regard, on July 14, 2003, we filed a universal shelf registration statement with the U.S. Securities and Exchange Commission on Form S-3 for the potential sale of up to $1 billion in debt and/or equity securities. The registration statement was declared effective and should provide us with significant flexibility with respect to our access to the public markets. There can be no assurance that additional financing under the universal shelf registration statement or elsewhere will be available at terms acceptable to us. On June 7, 2004, we issued $250 million of senior notes from this universal shelf registration statement, leaving $750 million of available capacity under the universal registration statement.
During 2004, we repurchased 475,200 shares of our common stock in the open market. As of September 30, 2004, we had Board of Directors’ approval to repurchase 2,840,000 additional shares. We may consider additional repurchases of shares if justified by the stock price or other considerations. Repurchased shares are to be used for general business purposes.

31


Table of Contents

We believe that cash on hand, marketable securities, cash generated from operations and amounts available under our five-year credit facility along with amounts available from the capital markets, will be sufficient to fund operations, working capital needs, capital expenditure requirements and financing obligations. However, in connection with the Spartanburg antitrust litigation, if a class is certified and the plaintiffs prevail at trial, potential damages awarded the plaintiffs could have a material adverse effect on our financial condition and liquidity.
Contractual Obligations and Contingent Liabilities and Commitments
To give a clear picture of matters potentially impacting our liquidity position, following are tables of contractual obligations and commercial commitments as of September 30, 2004 (all amounts in millions):
                                         
    Payments Due by Period
Contractual           Less than   1 - 3   4 - 5   After 5
Obligations   Total   1 year   years   years   years
 
Long-Term Debt
  $ 360     $     $     $ 256     $ 104  
Interest Payments Relating to Long- Term Debt (1)
  $ 161     $ 19     $ 37     $ 37     $ 68  
Information Technology Infrastructure (2)
  $ 159     $ 27     $ 54     $ 52     $ 26  
Capital Lease Obligations
  $ 2     $ 1     $ 1     $     $  
Operating Lease Obligations
  $ 75     $ 22     $ 30     $ 20     $ 3  
Investment Commitments (3)
  $ 19     $ 17     $ 2     $     $  
Minimum Pension Funding (4)
  $ 27     $ 9     $ 18     $     $  
Purchase Obligations (5)
  $ 17     $ 17     $     $     $  
Total Contractual Cash Obligations
  $ 820     $ 112     $ 142     $ 365     $ 201  
 
(1)   Interest payments on our long-term debt is projected based on the contractual rates of those debt securities including the $250 million 4.5 percent debt securities dated June 7, 2004. However, $200 million of our 4.5 percent debt securities are subject to interest rate swap agreements, effectively converting the securities from 4.5 percent fixed rate interest to variable rate interest, calculated at LIBOR plus 0.15 percent. For the 2004 period in which the interest rate swap agreements were outstanding, the average variable interest rate on debt covered by the swaps approximated 1.7 percent. Since we are unable to project future LIBOR rates we have opted to project interest payments based on the contractual rates of our debt.
 
(2)   We are in year two of an agreement with IBM to manage our global information structure environment, which was announced near the end of the third quarter of fiscal 2003. The original seven-year agreement had a cumulative estimated cost of $187 million, with a remaining cumulative estimated cost of $153 million, which will continue to be incurred in nearly equal amounts over the remaining term of the agreement. During the first year, we

32


Table of Contents

    have on occasion, solicited IBM to perform services that are outside the scope of the original base agreement. These services can result in a one-time fee or can result in additional services received and costs incurred over the remaining term of the agreement. Currently, fees related to out-of-scope services have a cumulative estimated cost of $6 million and are primarily related to new projects and acquisition activities. These fees have been included and will be incurred in nearly equal amounts over the remaining term of the agreement. In conjunction with the recent divestiture of Forethought, the IBM agreement will be renegotiated during fiscal 2005. We believe that our contractual obligation to IBM can be reduced based upon the elimination of specific services related to Forethought.
 
(3)   The investment commitment amounts represent additional commitments to private equity limited partnerships. The timing of these commitment calls has been estimated based on the current status of each partnership. These commitments will be funded with existing cash and cash flow from operations.
 
(4)   The minimum pension funding represents payments to comply with funding requirements. The projected payments beyond fiscal 2007 are not currently determinable.
 
(5)   Purchase obligations represent contractual obligations under various take-or-pay arrangements entered into as part of the normal course of business. These commitments represent future purchases in line with expected usage to obtain favorable pricing. The amounts do not include obligations related to other purchase obligations that are not take-or-pay arrangements. Such purchase obligations are primarily reflected in purchase orders at fair value that are part of normal operations, which we do not believe represent firm purchase commitments. We expect to fund these commitments with operating cash flows.
Unless a range of amounts is disclosed in the following table, the amounts disclosed represent the total expected commitment.
                                         
            Amount of Commitment Expiration Per
            Period
    Total                
Other Commercial   Amounts   Less than   1 - 3   4 - 5   Over 5
Commitments   Committed   1 year   years   years   years
 
Standby Letters of Credit
  $ 28     $ 28     $     $     $  
In addition to the contractual obligations and commitments disclosed above, we also have a variety of other agreements related to the procurement of materials and services and other commitments. We are not subject to any contracts that commit us to material non-cancelable commitments. While many of these agreements are long-term supply agreements, some of which are exclusive supply or complete requirements-based contracts, we are not committed under these agreements to accept or pay for requirements which are not needed to meet production needs.
In conjunction with the recent acquisition and divestiture activities, we have entered into certain guarantees and indemnifications of performance with respect to the fulfillment of our commitments under the respective purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. Those representations and warranties which survive closing generally survive for periods up to five years or the expiration of the applicable statutes of limitations. Potential losses under the indemnifications are generally limited to a portion of the original transaction price, or to other lesser specific dollar amounts for certain provisions. With respect to sale transactions, we also routinely enter into non-

33


Table of Contents

competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities would not materially affect our financial condition or results of operations.
With respect to capital expenditures, we expect capital spending in 2005 to approximate $160 million before consideration of additional capital requirements for new business acquisitions.
Shareholders’ Equity
Cumulative treasury stock acquired in open market and private transactions increased in 2004 to 21,449,067 shares. As of September 30, 2004, we had Board of Directors’ authorization to repurchase up to a total of 2,840,000 additional shares of our common stock. Repurchased shares are to be used for general business purposes. From the cumulative shares acquired, 620,619 shares, net of shares converted to cash to pay withholding taxes, were reissued during fiscal 2004 under provisions of our various stock-based compensation plans.
OTHER ISSUES
Special Charges
2004 Actions
During the fourth fiscal quarter of 2004, we announced a restructuring intended to better align Hill-Rom’s financial and personnel resources to fully support its growth initiatives, decrease overall costs, and improve performance in Europe. The plan includes the elimination of approximately 130 salaried positions in the U.S. and approximately 100 positions in Europe and resulted in a fourth quarter charge of approximately $7 million, associated with severance and benefit-related costs. All obligations associated with this action will be settled in cash. Upon completion, this action is expected to reduce net-operating costs by approximately $16 million annually. We expect the restructuring to be completed during our 2005 fiscal year.
2003 Actions
During the third fiscal quarter of 2003, we announced a new business structure at Hill-Rom to accelerate the execution of its strategy and strengthen its core businesses. As a result of this action, Hill-Rom announced it expected to eliminate approximately 300 salaried positions globally. Hill-Rom also announced it expected to hire approximately 100 new personnel with the skills and experience necessary to execute its business strategy. A fiscal 2003 third quarter charge of $9 million was recognized with respect to this action, essentially all related to severance and benefit-related costs. As of September 30, 2004 this action is essentially complete, with less than $1 million remaining in the reserve. During fiscal 2004 approximately $1 million of the originally recorded reserve was also reversed. In excess of 280 salaried positions were eliminated under the action, with over 60 of the original list of terminees being transferred to other positions in line with Hill-Rom’s strategy. As of this same date, approximately 90 new positions had been hired under the new business structure. This action is expected to be fully completed in the second quarter of fiscal 2005, in combination with the completion of the enterprise-wide technology platform integration.
2002 Actions
During the fourth quarter of 2002, we announced realignment actions at Batesville Casket and Hill-Rom. The actions at Batesville Casket included the closure of a wood casket plant in Canada along with other employee reduction actions in the United States. These combined actions resulted in the reduction of approximately 100 employees. A charge of $3 million was recorded in relation to these actions for severance and other facility closing costs. In addition, during the fourth quarter of fiscal 2002 Hill-Rom announced an action in Germany to downsize its field service operations and to relocate its sales and other administrative functions. A

34


Table of Contents

charge of $2 million was recorded for severance and other facility costs associated with this action, which resulted in the termination of 25 employees. Of the total charge recorded for the above actions, $4 million was associated with severance and other costs to be settled in cash while $1 million related to asset impairments. All activities associated with these charges are now complete.
Other
In addition to the reserve balances outlined above, approximately $3 million of accrued liabilities were outstanding at September 30, 2004 related to retirement obligations of W August Hillenbrand, a former Chief Executive Officer of the Company. Mr. Hillenbrand retired in the fourth calendar quarter of 2000.
CRITICAL ACCOUNTING POLICIES
Our accounting policies, including those described below, require management to make significant estimates and assumptions using information available at the time the estimates are made. Such estimates and assumptions significantly affect various reported amounts of assets, liabilities, revenues and expenses. If future experience differs materially from these estimates and assumptions, results of operations and financial condition could be affected. A more detailed description of our accounting policies is included in the Notes to our Consolidated Financial Statements included in this Form 10-K/A.
Revenue Recognition
Net revenues reflect gross revenues less sales discounts and allowances and customer returns for product sales and a provision for uncollectible receivables for rentals. Revenue recognition for product sales and rentals is evaluated under the following criteria:
  Evidence of an arrangement: Revenue is recognized when there is evidence of an agreement with the customer reflecting the terms and conditions to deliver products or services.
  Delivery: For products, delivery is considered to occur upon receipt by the customer and the transfer of title and risk of loss. For rental services, delivery is considered to occur when the services are rendered.
  Fixed or determinable price: The sales price is considered fixed or determinable if it is not subject to refund or adjustment.
  Collection is deemed probable: At or prior to the time of a transaction, credit reviews of each customer are performed to determine the creditworthiness of the customer. Collection is deemed probable if the customer is expected to be able to pay amounts under the arrangement as those amounts become due. If collection is not probable, revenue is recognized when collection becomes probable, generally upon cash collection.
As a general interpretation of the above guidelines, revenues for health care products in the patient care environment and for casket and cremation products in the funeral services portion of our business are generally recognized upon delivery of the products to the customer and their assumption of risk of loss and other risks and rewards of ownership. Local business customs and non-standard sales terms can sometimes result in deviations to this normal practice in certain instances.
For non-invasive therapy products within our health care business, the majority of product offerings are rental products for which revenues are recognized consistent with the rendering of the service and use of products. These revenues are recorded net of a provision for uncollectible receivables based upon historic payment and coverage patterns for the various products and paying entities. For The VestÔ product, which was acquired in 2004 with the

35


Table of Contents

acquisition of ARI, revenue is generally recognized at the time of receipt of authorization for billing from the applicable paying entity based on the specifics of the authorization and the period of product usage by the patient.
For health care products and services aimed at improving operational efficiency and asset utilization, various revenue recognition techniques are used, depending on the offering. Service contract revenue is generally recognized ratably over the contract period, if applicable, or as services are rendered. Product-related goods are generally recognized upon delivery to the customer, similar to products in the patient care environment.
Based on estimated product returns and price concessions, a reserve for returns and allowances is recorded at the time of the sale, resulting in a reduction of revenue. An allowance for doubtful accounts is recorded based upon the estimated collectibility of receivables, and results in an increase in operating expenses.
Liabilities for Loss Contingencies Related to Lawsuits
We are involved on an ongoing basis in claims and lawsuits relating to our operations, including environmental, antitrust, patent infringement, business practices, commercial transactions and other matters. The ultimate outcome of these lawsuits cannot be predicted with certainty. An estimated loss from these contingencies is recognized when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. However, it is difficult to measure the actual loss that might be incurred related to litigation. The ultimate outcome of these lawsuits could have a material adverse effect on our financial condition, results of operations and cash flow.
We are also involved in other possible claims, including product liability, workers compensation, auto liability and employment related matters. These have deductibles and self-insured retentions ranging from $150 thousand to $1.5 million per occurrence or per claim, depending upon the type of coverage and policy period.
Since December 1999, we have purchased deductible reimbursement policies from our wholly-owned insurance company, Sycamore Insurance Company, Ltd., for the deductibles and self-insured retentions associated with our product liability, workers compensation and auto liability programs. Outside insurance company and third-party claims administrators establish individual claim reserves and an independent outside actuary provides estimates of ultimate projected losses, including incurred but not reported claims. The actuary also provides estimates for accruals for losses incurred prior to December 1999.
Claim reserves for employment related matters are established based upon advice from internal and external counsel and historical settlement information for claims and related fees.
The recorded amounts represent our best estimate of the costs we will incur in relation to such exposures, but it is possible that actual costs could differ from those estimates.
Goodwill and Intangible Assets
We adopted the provisions of SFAS No. 142, “Goodwill and Other Intangible Assets”, as of December 2, 2001. Under this Standard, goodwill and certain other indefinite-lived intangible assets are no longer amortized, but instead are subject to periodic impairment evaluations. We made our initial transition impairment assessment in 2002 and determined that there was no impairment with respect to recorded intangible assets. The most recent update completed during the third quarter of 2004 reconfirmed the lack of any impairment. With the exception of goodwill, all of our intangible assets are subject to amortization. The majority of our goodwill resides at Hill-Rom. If we had adopted this Standard as of October 1, 2001, the effect on net income would not have been material as outlined at Note 1 to the Consolidated Financial Statements.

36


Table of Contents

In performing periodic impairment tests, the fair value of the reporting unit is compared to the carrying value, including goodwill and intangible assets. If the fair value exceeds the carrying value, there is no impairment. If the carrying value exceeds the fair value, however, an impairment condition exists. The impairment loss is determined based on the excess of the carrying value of the goodwill or intangible asset to their respective implied or assigned fair values. Impairment tests are required to be conducted at least annually, or when events or conditions occur that might suggest a possible impairment. These events or conditions include, but are not limited to, a change in the business environment, legal factors, regulatory changes, loss of key personnel, sale or disposition of a significant portion of a reporting unit or a change in reporting structure. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge and adversely affecting our results of operations.
Stock-Based Compensation
We apply the provisions of APB Opinion No. 25, “Accounting for Stock Issued to Employees,” in accounting for stock-based compensation. As a result, no compensation expense is recognized for stock options granted with exercise prices equivalent to the fair market value of the stock on date of grant. SFAS No. 123, “Accounting for Stock-Based Compensation” provides an alternative method of accounting for stock options based on fair value concepts and the use of an option-pricing model. Accounting for stock options in accordance with SFAS No. 123 would have reduced our earnings as outlined in Note 1 to the Consolidated Financial Statements. The Financial Accounting Standards Board (FASB) currently has a project underway to reconsider the accounting model for stock-based compensation plans. In October 2004, the FASB deferred the effective date for public companies of the proposed statement from fiscal years beginning after December 15, 2004 to interim and annual periods beginning after June 15, 2005. The FASB expects to issue a final standard by December 31, 2004. The new effective date will require us to make the required changes in our fourth fiscal quarter of 2005. We will monitor the progress of this project, assess the impact and make the required changes upon finalization of the FASB project.
Retirement Plans
We sponsor retirement plans covering a majority of employees. Expense recognized in relation to defined benefit retirement plans is based upon actuarial valuations and inherent in those valuations are key assumptions including discount rates, expected returns on assets and projected future salary rates. We are required to consider current market conditions, including changes in interest rates, in setting these assumptions. Changes in retirement benefit expense and the recognized obligation may occur in the future as a result of a number of factors, including changes to these assumptions. Our expected rate of return on plan assets was 7.75 percent for fiscal years 2004 and 2003. The discount rate was reduced from 6.25 percent in 2003 to 6.00 percent in 2004 and this 25 basis point change in the discount rate impacted pension expense by approximately $0.5 million. This impact could be positive or negative depending on the direction of the change in rates. See Note 2 to the Consolidated Financial Statements, which statements are included under Item 8, for key assumptions and other information regarding recent changes to our retirement plans.
Valuation Allowances Recorded Against Deferred Tax Assets and Allocated Tax Reserves
We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. We have recorded valuation allowances against certain of our deferred tax assets, primarily those related to foreign tax attributes in countries with poor operating results and capital loss carryforwards in the United States where future capital gains may not be available to realize the benefit. In evaluating whether it is more likely than not that we would recover these

37


Table of Contents

deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.
We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances. We currently have $86 million of valuation allowances on deferred tax assets, on a tax-effected basis, principally related to foreign operating loss carryforwards and capital loss carryforwards.
Investments
The majority of investments previously reported were held at Forethought and are therefore no longer part of the current year Consolidated Balance Sheet. In accordance with the provisions of SFAS No. 115, “Accounting for Certain Investments in Debt and Equity Securities,” we have classified our investments in debt and equity securities as “available for sale” and reported them at fair value on the Consolidated Balance Sheets. Unrealized gains and losses are charged or credited to accumulated other comprehensive income (loss) in shareholders’ equity and deferred taxes are recorded for the income tax effect of such unrealized gains and losses. The fair value of investments is predominantly based on market values provided by brokers/dealers or other external investment advisors.
Upon the sale of Forethought, certain private equity limited partnerships previously held in the insurance investment portfolio were retained. We continue to use the equity method of accounting, with earnings or losses reported within Other income in the Statements of Consolidated Income (Loss). Earnings and values for investments accounted for under the equity method are determined based on audited financial statements provided by the investment companies. Other minority investments made outside of the insurance business are accounted for on either a cost or equity basis, dependent upon our level of influence over the investee.
We regularly evaluate all investments for possible impairment based on current economic conditions, credit loss experience and other criteria. If there is a decline in a security’s net realizable value that is other than temporary, the decline is recognized as a realized loss and the cost basis of the security is reduced to its estimated fair value. Select criteria utilized in analyzing individual securities for impairment include:
    The extent and duration to which the market value of a security was below its cost;
 
    Downgrades in debt ratings;
 
    Significant declines in value, regardless of the length of time the market value was below cost;
 
    The status of principal and interest payments on debt securities;
 
    Financial condition and recent events impacting companies underlying the securities; and
 
    General economic and industry conditions.
The evaluation of investments for impairment requires significant judgments to be made including (i) the identification of potentially impaired securities; (ii) the determination of their estimated fair value; and (iii) assessment of whether any decline in estimated fair value was other than temporary. If new information becomes available or the financial condition of the investee changes, our judgment may change resulting in the recognition of an investment loss at that time. At September 30, 2004 accumulated other comprehensive income included net unrealized gains on investments of $12 million, which included unrealized losses of less than $1 million. These unrealized losses are considered to be temporary.
Environmental Matters
We are committed to operating all of our businesses in a manner that protects the environment. In the past year, we have been issued Notices of Violation alleging violation of certain

38


Table of Contents

environmental permit conditions. The Notices of Violation involved no fines or penalties. We, however, have successfully implemented measures to abate such conditions in compliance with the underlying agreements and/or regulations. In the past, we have voluntarily entered into remediation agreements with various environmental authorities to address onsite and offsite environmental impacts. The remaining voluntary remediation activities are nearing completion. We have also been notified as a potentially responsible party in investigations of certain offsite disposal facilities. Based on the nature and volume of materials involved, the cost of such onsite and offsite remediation activities to be incurred by us in which we are currently involved is not expected to exceed $1 million. We believe we have provided adequate reserves in our financial statements for all of these matters, which have been determined without consideration of possible loss recoveries from third parties. Future events or changes in existing laws and regulations or their interpretation may require us to make additional expenditures in the future. The cost or need for any such additional expenditures is not known.
Accounting Standards
In January 2003, the FASB issued FASB Interpretation No. 46 (“FIN 46”), “Consolidation of Variable Interest Entities”. FIN 46 addresses the requirements for business enterprises to consolidate related entities in which they are determined to be the primary economic beneficiary as a result of their variable economic interests. In December 2003, the FASB released FIN 46R, that provided a partial deferral of FIN 46 along with various other amendments. FIN 46R provides guidance related to evaluating, identifying and reporting of variable interest entities (VIEs). We adopted the new deferral provisions and amendments of FIN 46R as of the second quarter of fiscal 2004. The adoption of FIN 46R required the consolidation of four real estate partnerships that were previously not consolidated. On June 29, 2004, we sold the four real estate partnerships. Therefore, the amounts previously reported in continuing operations for these four VIEs were reclassed to discontinued operations for the year ended September 30, 2004. As of September 30, 2004, we no longer hold any investments that would be considered VIEs and require consolidation under FIN 46R.
In December 2003, the FASB issued SFAS No. 132R, “Employers’ Disclosures about Pensions and Other Postretirement Benefits.” This Statement retains the disclosure requirements contained in SFAS No. 132, which it replaces. SFAS No. 132R also requires additional disclosures about the assets, obligations, cash flows and net periodic benefit cost of defined benefit pension plans and other defined benefit postretirement plans. Those disclosures include information describing the types of plan assets, investment strategy, measurement dates, plan obligations, cash flows, and components of net periodic benefit cost recognized during interim periods. This Statement is effective for financial statements with fiscal years ending after December 15, 2003. We adopted this Statement as of the second quarter of fiscal 2004.
In March 2004, the FASB ratified the Emerging Issues Task Force (EITF) Issue No. 03-1, “The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments” (EITF 03-1). EITF 03-1 provides guidelines on the meaning of other-than-temporary impairment and its application to investments, in addition to requiring quantitative and qualitative disclosures in the financial statements. The disclosure provisions of EITF 03-1 are effective for fiscal years ending after December 15, 2003. The implementation of the disclosure provisions of EITF 03-1 did not have a material impact on our Consolidated Financial Statements or results of operations. On September 30, 2004, FASB Staff Position EITF 03-1-1 was issued, which deferred the application of the measurement provisions of EITF 03-1. The FASB determined that a delay in the effective date of those provisions was necessary until it can issue additional guidance on the application of EITF 03-1.

39


Table of Contents

RISK FACTORS
Our business involves risks. The following information about these risks should be considered carefully together with the other information contained herein. The risks described below are not the only risks we face. Additional risks not currently known or deemed immaterial also may result in adverse effects on our business.
Failure to comply with the Food and Drug Administration (FDA) regulations and similar foreign regulations applicable to our medical device products could expose us to enforcement actions or other adverse consequences.
Our health care businesses design, manufacture, install and distribute medical devices that are regulated by the FDA in the United States and similar agencies in other countries. Failure to comply with applicable regulations could result in future product recalls, injunctions preventing shipment of products or other enforcement actions that could have a material adverse effect on the revenues and profitability of our health care businesses.
Capital equipment sales and rental revenues may be adversely affected by Medicare and state government Medicaid funding cuts that could affect customers in every segment of our health care business. We could be subject to substantial fines and possible exclusion from participation in federal health care programs if we fail to comply with the laws and regulations applicable to our business.
Medicare, Medicaid and managed care organizations, such as health maintenance organizations and preferred provider organizations, traditional indemnity insurers and third-party administrators are increasing pressure to both control health care utilization and to limit reimbursement. Historical changes to Medicare payment programs from traditional “cost-plus” reimbursement to a prospective payment system resulted in a significant change in how our health care customers acquire and utilize our products. This has resulted in reduced utilization and downward pressure on prices. Similarly, future revenues and profitability will be subject to the effect of possible changes in the mix of our patients among Medicare, Medicaid and third-party payor categories, increases in case management and review of services or reductions in coverage or reimbursement rates by such payors. A rising uninsured population (estimated by the U.S. Census Bureau to be 45 million) further exacerbates a challenging reimbursement environment for us. We are subject to stringent laws and regulations at both the federal and state levels, requiring compliance with extensive and complex billing, substantiation and record-keeping requirements. If we are deemed to have violated these laws and regulations, we could be subject to substantial fines and possible exclusion from participation in federal health care programs such as Medicare and Medicaid.
Continued declines and fluctuations in mortality rates and increased cremations may adversely affect, as they have in recent years, the volume of Batesville Casket’s sales of burial caskets.
As the population of the United States continues to age, the number of deaths in the United States is expected to continue to increase slightly each year for at least the next couple of decades, although all factors indicate we experienced a slight decline in fiscal 2004. The aging of the baby boomer generation will not significantly impact the number of U.S. deaths for some years, as the oldest of the boomers is currently 57 years of age. Offsetting the aging of the population is the long-term trend of a decreasing age-adjusted death rate. The life expectancy of U.S. citizens has increased steadily since the 1950s and is expected to continue to do so for the foreseeable future.
Cremations as a percentage of total U.S. deaths have increased steadily since the 1960s, and are also expected to continue to increase for the foreseeable future. The number of U.S. cremations is currently growing faster than the increase in the number of U.S. deaths, resulting in a contraction in the demand for burial caskets, which contributed to lower burial

40


Table of Contents

casket sales volumes for Batesville Casket in the ten-month transition period ended September 30, 2002, fiscal year 2003 and fiscal year 2004.
Batesville Casket expects these trends to continue into the foreseeable future and Batesville Casket’s burial casket volumes will likely continue to be negatively impacted by these market conditions. Finally, death rates can vary over short periods of time and among different geographical areas. Such variations could cause Batesville Casket’s sales of burial caskets to fluctuate from quarter to quarter.
Future financial performance will depend in part on the successful introduction of new products into the marketplace on a cost-effective basis. The financial success of new products could be adversely impacted by competitors’ products, customer acceptance, difficulties in product development and manufacturing, certain regulatory approvals and other factors.
Future financial performance will depend in part on our ability to influence, anticipate, identify and respond to changing consumer preferences and needs. We cannot assure that our new products will achieve the same degree of success that have been achieved historically by our products. We may not correctly anticipate or identify trends in consumer preferences or needs, or may identify them later than competitors do. Any strategies we may implement to address these trends may prove incorrect or ineffective. In addition, difficulties in manufacturing or in obtaining regulatory approvals may delay or prohibit introduction of new products into the marketplace. Further, we may not be able to develop and produce new products at a cost that allows us to meet our goals for profitability, particularly since downward pressure on health care product prices is expected to continue. Failure to successfully introduce new products on a cost-effective basis, or delays in customer purchasing decisions related to evaluation of new products, could cause us to lose market share and could materially adversely affect our business, financial condition, results of operations and cash flow.
Our health care and funeral services businesses are significantly dependent on several major contracts with large national providers and group purchasing organizations. Our relationships with these customers and organizations pose several risks.
In our health care and funeral services businesses, we have several large contracts with national providers and group purchasing organizations that have varying degrees of purchasing leverage. A significant portion of our sales in our health care and funeral services products businesses are made under these contracts. If one or more of these national providers or group purchasing organizations enters into an exclusive arrangement with another provider or if we otherwise lose one or more of these contracts or customers for other reasons, this loss could have an adverse effect on our business, financial condition, results of operations and cash flow.
The hospital group purchasing organization industry is rapidly changing and facing significant challenges as individual group purchasing organizations begin to modify their membership requirements and contracting practices, including conversion of sole sourced agreements to agreements with multiple suppliers, in response to recent Congressional hearings and public criticism.
Over the past several years, there has been some industry concern regarding the overall financial condition of several of the national funeral service providers, and one such customer of Batesville filed for bankruptcy during the 2003 fiscal year. Although the bankruptcy of this customer did not by itself materially adversely affect our results of operations should one or more additional national funeral service providers that are customers of Batesville file for bankruptcy, become insolvent or otherwise be unable to pay for Batesville’s products, our results of operations could be materially adversely affected.
Additionally, while our contracts with large health care and funeral services providers and group purchasing organizations provide important access to several of the largest purchasers of

41


Table of Contents

health care and funeral services products, they generally obligate us to sell our products within certain price parameters, therefore limiting our ability, in the short-term, to raise prices in response to significant increases in raw material prices or other factors.
Increased prices for or unavailability of raw materials or finished goods used in our products could adversely affect our profitability or revenues.
Our profitability is affected by the prices of the raw materials and finished goods used in the manufacture of our products. These prices may fluctuate based on a number of factors beyond our control, including changes in supply and demand, general economic conditions, labor costs, competition, import duties, tariffs, currency exchange rates and, in some cases, government regulation. Significant increases in the prices of raw materials or finished goods that could not be recovered through increases in the prices of our products could adversely affect our results of operations. For example, we experienced significantly higher prices in fiscal 2003 and 2004 than we had in prior periods for steel, a principal raw material used in our funeral services products business and, to a lesser degree, our health care products business. In addition to steel, we have also experienced large price increases on other commodities used in the manufacture of our products, including red metals, solid wood and fuel. Although Batesville has historically been able to offset such price increases with increases in the prices of its products, there can be no assurance that our customers will be willing to pay the higher prices or that such prices will fully offset such price increases in the future. Any further increases in prices resulting from a tightening supply of steel, and/or other materials could adversely affect our profitability. We generally do not engage in hedging transactions with respect to raw material purchases, but do enter into fixed price supply contracts at times. Our decision not to engage in hedging transactions may result in increased price volatility, with resulting adverse effects on profitability.
Our dependency upon regular deliveries of supplies from particular suppliers means that interruptions or stoppages in such deliveries could adversely affect our operations until arrangements with alternate suppliers could be made. Several of the raw materials and finished goods used in the manufacture of our products currently are available only from a single source. If any of these sole source suppliers were unable to deliver these materials for an extended period of time as a result of financial difficulties, catastrophic events affecting their facilities or other factors, or if we were unable to negotiate acceptable terms for the supply of materials with these sole source suppliers, our business could suffer. We may not be able to find acceptable alternatives, and any such alternatives could result in increased costs. Extended unavailability of a necessary raw material or finished good could cause us to cease manufacturing one or more products for a period of time.
We may not be successful in achieving expected operating efficiencies and operating cost reductions associated with announced restructuring, realignment and cost reduction activities.
In recent periods, we have announced a number of restructuring, realignment and cost reduction measures, including the significant reorganization of the Hill-Rom business structure announced in the third quarter of fiscal 2003 followed by the recent fourth quarter 2004 restructuring. These activities may not provide the full efficiency and cost reduction benefits we expected from these activities. Further, such benefits may be realized later than expected, and the costs of implementing these measures may be greater than anticipated. If these measures are not successful, we may undertake additional realignment and cost reduction efforts, which could result in future charges. Moreover, our ability to achieve our other strategic goals and business plans may be adversely affected if our restructuring and realignment efforts prove ineffective.

42


Table of Contents

Implementation of our Enterprise Resource Planning system could cause us to make unplanned expenditures or could cause disruptions in our business.
We currently are in the process of implementing a comprehensive Enterprise Resource Planning (ERP) business system at Hill-Rom. Although this effort, expected to be completed by mid-2005, was on schedule and on budget as of September 30, 2004, there can be no assurance that the rollout of the ERP system will be completed on time and without unplanned expenditures, or that it will not cause significant disruptions of our business.
Product liability or other liability claims could expose us to adverse judgments or could affect the sales of our products.
We are involved in the design, manufacture and sale of health care products, which face an inherent risk of exposure to product liability claims if our products are alleged to have caused injury or are found to be unsuitable for their intended use. Any such claims could negatively impact the sales of products that are the subject of such claims or other products. We from time to time, and currently, are a party to claims and lawsuits alleging that our products have caused injury or death or are otherwise unsuitable. It is possible that we will receive adverse judgments in such lawsuits, and any such adverse judgments could be material.
We are involved on an ongoing basis in claims and lawsuits relating to our operations, including environmental, antitrust, patent infringement, business practices, commercial transactions, and other matters.
The ultimate outcome of these lawsuits cannot be predicted with certainty but could have a material adverse effect on our financial condition, results of operations and cash flow. We are also involved in other possible claims, including product liability, workers compensation, employment-related matters and auto liability. While insurance is maintained for such exposures, the policies in place are high-deductible policies resulting in our assuming exposure for a layer of coverage with respect to such claims.
Our funeral services business is facing increasing competition from a number of non-traditional sources, including internet casket retailers, large retail discount stores, and caskets manufactured abroad.
Non-traditional funeral services retailers could present more of a competitive threat to Batesville than is currently anticipated. While some of these, like internet casket retailers and third-party casket stores, have competed against Batesville for a number of years, large discount retailers such as Costco, which has recently begun selling caskets, represent a more recent competitive development. Also, we have learned that several manufacturers located in China are currently manufacturing caskets with the intent to market those caskets in the United States. It is not possible to quantify the financial impact that these competitors will have on Batesville’s business, but these competitors will continue to place additional pricing and other competitive pressures on Batesville that could have a negative impact on Batesville’s results of operations.
We may not be able to execute our growth strategy if we are unable to successfully acquire and integrate other companies in the health care industry.
Our announced growth plans include acquiring other companies in the health care industry. We may not be able to identify suitable acquisition candidates, negotiate acceptable terms for such acquisitions or receive necessary financing for such acquisitions on acceptable terms. Moreover, once an acquisition agreement is signed, various events or circumstances may either prevent the successful consummation of the contemplated acquisition, or make it unadvisable. In addition, we expect to compete against other companies for acquisitions. If we are able to consummate acquisitions, such acquisitions could be dilutive to earnings, and we could overpay for such acquisitions. Additionally, we may not be successful in our efforts to integrate

43


Table of Contents

acquired companies. Integration of acquired companies will divert management and other resources from other important matters, and we could experience delays or unusual expenses in the integration process. Further, we may become responsible for liabilities associated with businesses that we acquire to the extent they are not covered by indemnification from the sellers or by insurance.
Our success depends on our ability to retain our executive officers and other key personnel.
Our future performance depends in significant part upon the continued service of our executive officers and other key personnel, many of whom we have hired recently as part of our strategic initiative to ensure leadership excellence. The loss of the services of one or more of our executive officers or other key employees could have a material adverse effect on our business, prospects, financial condition and results of operations. This effect could be exacerbated if any officers or other key personnel left as a group. Our success also depends on our continuing ability to attract and retain highly qualified personnel. Competition for such personnel is intense, and there can be no assurance that we can retain our key employees or attract, assimilate and retain other highly qualified personnel in the future.
A substantial portion of our workforce is unionized, and we could face labor disruptions that would interfere with our operations.
As of September 30, 2004, approximately 2,800, or 27 percent, of our employees were covered by collective bargaining agreements. In the United States and Canada, the collective bargaining agreements have expiration dates ranging from January 2005 to August 2010. In 2004, four contracts were renewed including the Batesville Casket steelworkers contract in Batesville that became effective in October 2004. We have four additional collective bargaining agreements in the United States and Canada that will expire during the next twelve months. These agreements include three at Batesville Casket and one at Hill-Rom. Outside of the United States and Canada negotiations take place as determined by country level requirements, with some elements of employment being negotiated annually. Although we have not experienced any significant work stoppages in the past 20 years as a result of labor disagreements, we cannot ensure that such a stoppage will not occur in the future. Inability to negotiate satisfactory new agreements or a labor disturbance at one of our principal facilities could have a material adverse effect on our operations.
Volatility of our investment portfolio could negatively impact earnings.
Volatility of our investment portfolio with a book value of approximately $79 million could negatively impact earnings. The investment portfolio, which includes equity partnerships among other investments, could be adversely affected by general economic conditions, changes in interest rates, default on debt instruments and other factors, resulting in an adverse impact on financial condition.

44


Table of Contents

Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
         
    Page  
Financial Statements:
       
    46  
    48  
    49  
    50  
    52  
    53  
    54  
Financial Statement Schedule for the fiscal years ended September 30, 2004 and September 30, 2003 and the ten months ended September 30, 2002:
       
    103  
All other schedules are omitted because they are not applicable or the required information is shown in the financial statements or the notes thereto.

45


Table of Contents

REPORT OF MANAGEMENT
(AS RESTATED)
Management of Hillenbrand Industries is responsible for the preparation, fairness and integrity of our financial statements and other information included in this Form 10-K/A. The financial statements have been prepared in accordance with generally accepted accounting principles applied on a materially consistent basis. Where necessary, management has made informed judgments and estimates as to the outcome of events and transactions, with due consideration given to materiality.
Management is also responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended, is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.
Management has revised its Report of Management as originally included in our Annual Report on Form 10-K filed on December 7, 2004. In that report, management concluded that our policies, procedures and internal control systems provided reasonable assurance that assets were safeguarded and transactions were properly recorded and executed in accordance with its authorization. Subsequent to the filing of the Annual Report on Form 10-K, we identified errors in the 2004 and 2003 financial statements and have restated those annual financial statements in this filing on Form 10-K/A. With the identification of these errors, management concluded that the errors resulted from control deficiencies that represented material weaknesses in internal control over financial reporting in the areas of accounting for goodwill and income taxes, as further described below. These errors, as outlined in Note 17 to the Consolidated Financial Statements, related to the allocation of goodwill to businesses to be disposed of and the accounting for income taxes related to such dispositions.
A material weakness is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected. As of September 30, 2004, the Company did not maintain effective controls over (i) the accuracy of its accounting for goodwill or (ii) the accuracy of its accounting for income taxes, including the determination of income taxes payable, deferred income tax assets and liabilities and the related income tax provision. Specifically, the Company did not have effective controls to properly allocate goodwill to the carrying value of businesses to be disposed of or effective review controls over the differences between the income tax basis and the financial reporting basis associated with the tax losses incurred on the disposition of discontinued operations. Each of these control deficiencies resulted in the restatement of the Company’s 2004 and 2003 annual consolidated financial statements. Additionally, each of these control deficiencies could result in a misstatement of the aforementioned accounts and disclosures that would result in a material misstatement to annual or interim financial statements that would not be prevented or detected. Accordingly, management determined that each of these control deficiencies constituted a material weakness.

46


Table of Contents

(-s- Rolf A. Classon)
Rolf A. Classon
Interim President and Chief Executive Officer
(-s- Gregory N. Miller)
Gregory N. Miller
Senior Vice President and Chief Financial Officer
(-s- Richard G. Keller)
Richard G. Keller
Vice President — Controller and Chief Accounting Officer

47


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and
Board of Directors of
Hillenbrand Industries, Inc.
In our opinion, the consolidated financial statements listed in the accompanying index present fairly, in all material respects, the financial position of Hillenbrand Industries, Inc. and its subsidiaries at September 30, 2004 and 2003, and the results of their operations and their cash flows for the fiscal years ended September 30, 2004 and 2003 and the ten months ended September 30, 2002 in conformity with accounting principles generally accepted in the United States of America. In addition, in our opinion, the financial statement schedule listed in the accompanying index presents fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements. These financial statements and financial statement schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and financial statement schedule based on our audits. We conducted our audits of these statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
As discussed in Note 17 to the consolidated financial statements, the Company has restated its 2004 and 2003 consolidated financial statements and financial statement schedule.
     
/s/ PricewaterhouseCoopers LLP
   
 
   
PricewaterhouseCoopers LLP
   
Cincinnati, Ohio
   
December 3, 2004, except for the restatement discussed in
Note 17, as to which the date is December 16, 2005

48


Table of Contents

Hillenbrand Industries, Inc. and Subsidiaries
STATEMENTS OF CONSOLIDATED INCOME (LOSS)
(Dollars in millions except per share data)
                         
    (As Restated   (As Restated    
    See Note 17)   See Note 17)    
    Fiscal Year   Fiscal Year   Ten Months
    Ended   Ended   Ended
    September 30,   September 30,   September 30,
    2004   2003   2002
 
Net Revenues
                       
Health Care sales
  $ 737     $ 749     $ 615  
Health Care rentals
    452       318       268  
Funeral Services sales
    640       628       510  
 
Total revenues
    1,829       1,695       1,393  
 
Cost of Revenues
                       
Health Care cost of goods sold
    382       370       311  
Health Care rental expenses
    249       161       141  
Funeral Services cost of goods sold
    290       279       235  
 
Total cost of revenues
    921       810       687  
 
Gross Profit
    908       885       706  
Other operating expenses
    582       544       485  
Litigation charge (Note 16)
                250  
Special charges (Note 5)
    6       9       4  
 
Operating Profit (Loss)
    320       332       (33 )
Other income (expense), net:
                       
Interest expense
    (15 )     (19 )     (14 )
Investment income
    9       9       9  
Loss on extinguishment of debt (Note 7)
    (6 )     (16 )      
Other
          (26 )     (17 )
 
Income (Loss) from Continuing Operations Before Income Taxes
    308       280       (55 )
Income tax expense (benefit)
    120       99       (38 )
 
Income (Loss) from Continuing Operations
    188       181       (17 )
Discontinued Operations (Note 3):
                       
(Loss) income from discontinued operations (including loss on impairment of discontinued operations of $107, $0 and $0)
    (71 )     13       20  
Income tax (benefit) expense
    (26 )     5       13  
 
(Loss) income from discontinued operations
    (45 )     8       7  
 
Net Income (Loss)
  $ 143     $ 189     $ (10 )
 
Income (loss) per common share from continuing operations — Basic
  $ 3.02     $ 2.91     $ (0.28 )
(Loss) income per common share from discontinued operations — Basic
    (0.72 )     0.14       0.12  
 
Net Income (Loss) per Common Share — Basic
  $ 2.30     $ 3.05     $ (0.16 )
 
Income (loss) per common share from continuing operations — Diluted
  $ 3.00     $ 2.90     $ (0.28 )
(Loss) income per common share from discontinued operations — Diluted
    (0.72 )     0.14       0.12  
 
Net Income (Loss) per Common Share — Diluted
  $ 2.28     $ 3.04     $ (0.16 )
 
 
                       
 
Dividends per Common Share
  $ 1.08     $ 1.00     $ 0.77  
 
 
                       
 
Average Common Shares Outstanding — Basic
    62,237,404       62,032,768       62,653,922  
 
Average Common Shares Outstanding — Diluted
    62,725,372       62,184,537       62,653,922  
 
Note: Certain per share amounts may not accurately add due to rounding.
See Notes to Consolidated Financial Statements.

49


Table of Contents

Hillenbrand Industries, Inc. and Subsidiaries
CONSOLIDATED BALANCE SHEETS
(Dollars in millions)
                 
    (As Restated   (As Restated
    See Note 17)   See Note 17)
    September 30,   September 30,
    2004   2003
 
ASSETS
               
 
Current Assets
               
Cash and cash equivalents
  $ 128     $ 155  
Current investments
    52       33  
Trade accounts receivable, less allowances of $31 in 2004 and $26 in 2003 (Note 1)
    417       361  
Inventories (Note 1)
    122       92  
Deferred income taxes (Notes 1 and 12)
    12       63  
Other
    16       17  
 
Total current assets
    747       721  
 
 
               
Equipment Leased to Others (Note 1)
    325       200  
Less accumulated depreciation
    174       143  
 
Equipment leased to others, net
    151       57  
 
 
               
Property (Note 1)
    679       655  
Less accumulated depreciation
    458       448  
 
Property, net
    221       207  
 
 
               
Investments (Note 1)
    79       68  
 
               
Other Assets
               
Intangible assets:
               
Goodwill (Notes 1 and 4)
    429       146  
Software and other (Note 1)
    190       106  
Notes receivable, net of discount (Note 6)
    105        
Deferred charges and other assets
    49       41  
 
Total other assets
    773       293  
 
 
               
Assets of Discontinued Operations (Note 3)
    98       30  
 
 
               
Insurance Assets (Note 14)
               
Investments
          3,334  
Deferred acquisition costs
          695  
Deferred income taxes
          6  
Other
          64  
 
Total insurance assets
          4,099  
 
Total Assets
  $ 2,069     $ 5,475  
 

50


Table of Contents

                 
    September 30,   September 30,
    2004   2003
 
LIABILITIES
               
 
Current Liabilities
               
Trade accounts payable
  $ 93     $ 87  
Short-term borrowings
    11       5  
Income taxes payable (Note 12)
          13  
Accrued compensation
    87       104  
Accrued litigation charge (Note 16)
          75  
Accrued product warranties (Note 1)
    19       21  
Accrued customer rebates
    22       22  
Other
    76       52  
 
Total current liabilities
    308       379  
 
Long-Term Debt (Notes 7 and 10)
    360       155  
 
Other Long-Term Liabilities
    124       116  
 
Deferred Income Taxes (Notes 1 and 12)
    5       6  
 
 
               
Insurance Liabilities (Note 14)
               
Benefit reserves
          2,728  
Unearned revenue
          806  
General liabilities
          68  
 
Total insurance liabilities
          3,602  
 
 
               
Liabilities of Discontinued Operations (Note 3)
    92       7  
 
               
 
Total Liabilities
    889       4,265  
 
               
 
Commitments and Contingencies (Note 16)
               
 
 
               
 
SHAREHOLDERS’ EQUITY (Notes 8 and 9)
               
 
Common stock — without par value:
               
Authorized — 199,000,000 shares
               
Issued — 80,323,912 shares in 2004 and 2003
    4       4  
Additional paid-in capital
    62       47  
Retained earnings
    1,659       1,583  
Accumulated other comprehensive income (Note 1)
    6       118  
Treasury stock, at cost: 2004 — 18,363,520 shares 2003 — 18,508,939 shares
    (551 )     (542 )
 
Total Shareholders’ Equity
    1,180       1,210  
 
Total Liabilities and Shareholders’ Equity
  $ 2,069     $ 5,475  
 
See Notes to Consolidated Financial Statements.

51


Table of Contents

Hillenbrand Industries, Inc. and Subsidiaries
STATEMENTS OF CONSOLIDATED CASH FLOWS
(Dollars in millions)
                         
    (As Restated   (As Restated    
    See Note 17)   See Note 17)    
    Fiscal Year   Fiscal Year   Ten Months
    Ended   Ended   Ended
    September 30,   September 30,   September 30,
    2004   2003   2002
 
Operating Activities
                       
Net income (loss)
  $ 143     $ 189     $ (10 )
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
                       
Depreciation, amortization and write-down of intangibles
    108       75       71  
Accretion and capitalized interest on financing provided on divestiture
    (4 )            
Net capital (gains) losses — Insurance
    (4 )     49       27  
Litigation charge
                250  
Provision for deferred income taxes from continuing operations
    37       71       (85 )
Loss on divestiture of discontinued operations, net-of-tax
    71              
Loss on disposal of fixed assets
    11       5       4  
Loss on extinguishment of debt
    6       16        
Change in working capital excluding cash, current debt, acquisitions and dispositions:
                       
Trade accounts receivable
    (14 )     (5 )     34  
Inventories
    (23 )     (5 )      
Other current assets
    73       118       (20 )
Trade accounts payable
    (12 )     3       3  
Accrued expenses and other liabilities
    (113 )     (187 )     (33 )
Change in insurance deferred policy acquisition costs
    (1 )     2       (24 )
Change in insurance unearned revenue
    5       11       2  
Increase in benefit reserves
    57       80       70  
Change in other insurance items, net
    31       8       9  
Other, net
    (23 )     (64 )     20  
 
Net cash provided by operating activities
    348       366       318  
 
Investing Activities
                       
Capital expenditures and purchase of intangibles
    (125 )     (115 )     (96 )
Proceeds on disposal of property and equipment leased to others
          1       2  
Other investments
          (14 )      
Proceeds on sales of businesses
    149              
Payment for acquisitions of businesses, net of cash acquired
    (430 )            
Investment purchases and capital calls
    (85 )     (110 )     (89 )
Proceeds on investment sales
    85       280       91  
Insurance investments:
                       
Purchases
    (616 )     (1,558 )     (1,457 )
Proceeds on maturities
    94       356       380  
Proceeds on sales
    417       996       869  
 
Net cash used in investing activities
    (511 )     (164 )     (300 )
 
Financing Activities
                       
Proceeds from interest rate swap terminations
          27        
Additions to short-term debt
    6       5        
Borrowings of long-term debt
    541              
Repayments of long-term debt
    (346 )     (185 )      
Debt issuance costs
    (3 )            
Payment of cash dividends
    (67 )     (62 )     (48 )
Proceeds on exercise of options
    25       3       11  
Treasury stock acquired
    (28 )           (62 )
Insurance deposits received
    228       329       314  
Insurance benefits paid
    (221 )     (272 )     (230 )
 
Net cash provided by (used in) financing activities
    135       (155 )     (15 )
 
Effect of Exchange Rate Changes on Cash
    1       2       1  
 
Total Cash Flows
    (27 )     49       4  
Cash and Cash Equivalents
                       
At beginning of period
    155       106       102  
 
At end of period
  $ 128     $ 155     $ 106  
 
See Notes to Consolidated Financial Statements.

52


Table of Contents

Hillenbrand Industries, Inc. and Subsidiaries
STATEMENTS OF CONSOLIDATED SHAREHOLDERS’ EQUITY AND COMPREHENSIVE INCOME
(Dollars in millions)
                                                                 
                                    Accumulated            
    Common Stock                   Other   Common Stock    
    Shares           Additional   Retained   Comprehensive   in Treasury    
    Outstanding   Amount   Paid-in-Capital   Earnings   Income (Loss)   Shares   Amount   Total
 
Balance at December 1, 2001
    62,466,722     $ 4     $ 34     $ 1,514     $ (34 )     17,857,190     $ (492 )   $ 1,026  
Comprehensive Income:
                                                               
Net loss
                      (10 )                       (10 )
Foreign currency translation adjustment
                            9                   9  
Net change in unrealized gain (loss) on available for sale securities
                            66                   66  
Minimum pension liability
                            (1 )                 (1 )
 
                                                               
Total comprehensive income
                                                            64  
Dividends
                      (48 )                       (48 )
Treasury shares acquired
    (1,141,900 )                             1,141,900       (62 )     (62 )
Stock awards and option exercises
    377,588             10                   (377,588 )     9       19  
 
Balance at September 30, 2002
    61,702,410       4       44       1,456       40       18,621,502       (545 )     999  
Comprehensive Income:
                                                               
Net income (As restated)
                      189                         189  
Foreign currency translation adjustment
                            5                   5  
Net change in unrealized gain (loss) on available for sale securities
                            73                   73  
 
                                                               
Total comprehensive income
                                                            267  
Dividends
                      (62 )                       (62 )
Stock awards and option exercises
    112,563             3                   (112,563 )     3       6  
 
Balance at September 30, 2003 (As Restated, See Note 17)
    61,814,973       4       47       1,583       118       18,508,939       (542 )     1,210  
Comprehensive Income:
                                                               
Net income (As restated)
                      143                         143  
Foreign currency translation adjustment
                            3                   3  
Net change in unrealized gain (loss) on available for sale securities
                            (114 )                 (114 )
Minimum pension liability
                            (1 )                 (1 )
 
                                                               
Total comprehensive income
                                                            31  
Dividends
                      (67 )                       (67 )
Treasury shares acquired
    (475,200 )                             475,200       (28 )     (28 )
Stock awards and option exercises
    620,619             15                   (620,619 )     19       34  
 
Balance at September 30, 2004 (As Restated, See Note 17)
    61,960,392     $ 4     $ 62     $ 1,659     $ 6       18,363,520     $ (551 )   $ 1,180  
 
See Notes to Consolidated Financial Statements.

53


Table of Contents

Hillenbrand Industries, Inc. and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions except per share data)
1. Summary of Significant Accounting Policies
Principles of Consolidation
The Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. Material intercompany accounts and transactions have been eliminated in consolidation.
Change in Fiscal Year
Effective for fiscal year 2002, we changed our fiscal year-end to September 30 from the Saturday nearest November 30 of each year. As a result of this change, the Statements of Consolidated Income (Loss), Statements of Consolidated Cash Flows and Statements of Consolidated Shareholders’ Equity and Comprehensive Income are presented for the fiscal years ended September 30, 2004 and 2003, and the ten-month period ended September 30, 2002.
Nature of Operations
Hillenbrand Industries is organized into two major operating companies serving the health care and funeral services industries. Hill-Rom is a manufacturer of equipment for the health care industry, a provider of associated systems for wound, pulmonary and circulatory care and provides biomedical equipment rentals and other services to enhance the operational efficiency and asset utilization of health care facilities. Its products and services are marketed to acute and long-term health care facilities and home care patients primarily in North America and Europe. Hill-Rom generated 65 percent of Hillenbrand’s revenues from continuing operations for the fiscal year ended September 30, 2004. Batesville Casket serves the funeral services industry and produces metal and hardwood burial caskets, cremation urns and caskets and marketing support services. Its products are marketed to licensed funeral directors operating licensed funeral homes primarily in North America. Batesville Casket generated 35 percent of Hillenbrand’s revenues from continuing operations for the fiscal year ended September 30, 2004. Prior to July 1, 2004, Forethought was our third operating company, and it marketed funeral plans funded by life insurance policies and trust products.
We announced the planned divestitures of the infant care and piped-medical gas businesses of Hill-Rom in the fourth quarter of fiscal 2003 and Forethought in the second quarter of 2004 and closed the sale of each of those businesses in the first, third and fourth quarters, respectively, of fiscal 2004, as further described in Note 3 below. These operations are presented as discontinued operations within our Statements of Consolidated Income (Loss) for all periods presented. Under this presentation, the revenues and variable costs associated with the businesses have been removed from the individual line items comprising the Statements of Consolidated Income (Loss) and presented in a separate section entitled, “Discontinued Operations”. In addition, fixed costs related to the businesses eliminated with the divestitures have also been included as a component of discontinued operations. The results of discontinued operations are not necessarily indicative of the results of the businesses if they had been operated on a stand-alone basis. On the Consolidated Balance Sheets, the assets and liabilities of the discontinued operations are also presented separately beginning in the period in which the businesses were discontinued. On the Statements of Consolidated Cash Flows, proceeds from the sale of discontinued operations are classified as an investing cash inflow and any losses are presented as a reconciling item in the reconciliation of net income and net cash provided from operations. Year-to-date operating, investing and financing activities of the discontinued operations are reflected within the respective captions of the Statements of Consolidated Cash Flows up to the disposal date and consistent with previous periods. The remaining assets of Discontinued operations on the 2004 Consolidated Balance

54


Table of Contents

Sheets relate to Forethought Federal Savings Bank, for which the sale is expected to close during the first half of our 2005 fiscal year.
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
We consider investments in marketable securities and other highly liquid instruments with a maturity of three months or less at date of purchase to be cash equivalents. Investments which have no stated maturity are also considered cash equivalents. All of our marketable securities may be freely traded.
Current Investments
At September 30, 2004 and 2003, we held $52 million and $33 million, respectively, of current investments, which consist of auction rate municipal bonds classified as available-for-sale securities. Our investments in these securities are recorded at cost, which approximates fair market value due to their variable interest rates, which typically reset every 7 to 35 days, and, despite the long-term nature of their stated contractual maturities, we have the ability to quickly liquidate these securities. As a result, we had no cumulative gross unrealized holding gains (losses) or gross realized gains (losses) from our current investments. All income generated from these current investments was recorded as Investment income.
Trade Accounts Receivable
Trade accounts receivable are recorded at the invoiced amount and do not bear interest, unless the transaction is an installment sale with payment terms exceeding one year. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on historical write-off experience by industry and the reimbursement platform. We review our allowance for doubtful accounts monthly. Past due balances in our Health Care and Funeral Services sales categories are reviewed individually for collectibility. Health Care rental receivables are reviewed on a pooled basis based on historical collection experience for each reimbursement type. Account balances are charged against the allowance when we feel it is probable the receivable will not be recovered. We do not have any off-balance-sheet credit exposure related to our customers.
We generally hold our trade accounts receivable until they are paid. Certain long-term receivables are occasionally sold to third parties, however, any recognized gain or loss on such sales has historically not been material.
As of September 30, 2004 and 2003 we had $31 million and $26 million in the allowance for doubtful accounts.
Inventories
Inventories are valued at the lower of cost or market. Inventory costs are determined by the last-in, first-out (LIFO) method for approximately 63 percent and 54 percent of our inventories at September 30, 2004 and 2003, respectively. Costs for other inventories have been determined principally by the first-in, first-out (FIFO) method. Inventories at the end of each period consist of the following:

55


Table of Contents

                 
    2004   2003
 
Finished products
  $ 88     $ 66  
Work in process
    10       12  
Raw materials
    24       14  
 
Total
  $ 122     $ 92  
 
If the FIFO method of inventory accounting, which approximates current cost, had been used for all inventories, they would have been approximately $10 million and $8 million higher than reported at September 30, 2004 and 2003, respectively.
Equipment Leased to Others
Equipment leased to others represents primarily rental units, which are recorded at cost and depreciated on a straight-line basis over their estimated economic life, ranging from 2 to 7 years. Total depreciation expense for fiscal years 2004 and 2003 and the ten months ended September 30, 2002 was $42 million, $21 million and $22 million, respectively. The majority of these units are leased on a day-to-day basis.
Property
Property is recorded at cost and depreciated over the estimated useful life of the assets using principally the straight-line method. Ranges of estimated useful lives are as follows:
     
Land improvements   15 — 25 years
Buildings and building equipment   20 — 40 years
Machinery and equipment   3 — 10 years
Generally, when property is retired from service or otherwise disposed of, the cost and related amount of depreciation or amortization are eliminated from the asset and accumulated depreciation accounts, respectively. The difference, if any, between the net asset value and the proceeds on sale are charged or credited to income. Total depreciation expense for fiscal years 2004 and 2003 and the ten months ended September 30, 2002 was $42 million, $39 million and $31 million, respectively. The major components of property and the related accumulated depreciation at September 30, were as follows:
                                 
    2004   2003
 
            Accumulated           Accumulated
    Cost   Depreciation   Cost   Depreciation
 
Land and land improvements
  $ 15     $ 6     $ 15     $ 5  
Buildings and building equipment
    164       100       160       100  
Machinery and equipment
    500       352       480       343  
 
Total
  $ 679     $ 458     $ 655     $ 448  
 
Goodwill and Intangible Assets
Intangible assets, consisting predominantly of patents, trademarks and software, are stated at cost and amortized on a straight-line basis over periods generally ranging from 3 to 20 years. We review intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable or as required by professional standards. If an intangible asset is considered impaired and the carrying value exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess.
As of December 2, 2001, we adopted Statement of Financial Accounting Standards (SFAS) No. 142, “Goodwill and Other Intangible Assets.” This Standard addresses financial accounting and reporting for acquired goodwill and other intangible assets upon their acquisition and after

56


Table of Contents

they have been initially recognized in the financial statements. Under this Standard, existing intangible assets were evaluated for possible impairment at the date of transition, and then periodically thereafter when conditions warrant, but at least annually. In addition, goodwill and certain other indefinite-lived intangible assets are no longer amortized. We made our initial transition impairment assessment in 2002 and determined that there was no impairment with respect to recorded goodwill. The most recent annual test completed during the third quarter of 2004 reconfirmed the lack of any impairment.
With the exception of goodwill, all of our intangible assets are subject to amortization. Essentially all of our goodwill resides in the Hill-Rom Americas/Asia Pacific segment. A summary of intangible assets and the related accumulated amortization as of September 30 was as follows:
                                 
    2004   2003
 
            Accumulated           Accumulated
(As Restated)   Cost   Amortization   Cost   Amortization
 
Goodwill
  $ 467     $ 38     $ 184     $ 38  
Software
    140       40       126       35  
Other
    168       78       85       70  
 
Total
  $ 775     $ 156     $ 395     $ 143  
 
Amortization expense for fiscal years 2004 and 2003 and the ten months ended September 30, 2002 was $22 million, $13 million and $11 million, respectively. Intangible asset write-offs approximated $5 million for the ten months ended September 30, 2002. Amortization expense for all intangibles is expected to approximate the following for each of the next five fiscal years and thereafter: $24 million in 2005, $22 million in 2006, $20 million in 2007, $20 million in 2008, $18 million in 2009 and $81 million thereafter.
Goodwill increased $283 million during 2004, resulting from the acquisitions of ARI, Mediq and NaviCare, all within the Hill-Rom segment. This included $73 million and $197 million from the acquisitions of ARI and Mediq, respectively. The $13 million of goodwill resulting from the NaviCare acquisition included approximately $2 million representing the initial investment in NaviCare made during 2003.
Internal Use Software
Costs associated with internal use software are recorded in accordance with American Institute of Certified Public Accountants Statement of Position 98-1, “Accounting for Costs of Computer Software Developed or Obtained for Internal Use.” Certain expenditures relating to the development of software for internal use are capitalized in accordance with this Statement, including applicable costs associated with our implementation of an Enterprise Resource Planning system. Unamortized computer software costs, included within Intangible assets, were $100 million and $91 million at September 30, 2004 and 2003, respectively. Capitalized software costs are amortized on a straight-line basis over periods ranging from five to ten years once the software is ready for its intended use. Amortization expense approximated $13 million for fiscal year 2004, $11 million for fiscal year 2003 and $8 million for the ten months ended September 30, 2002.
Investments
The majority of investments previously reported were held at Forethought and are therefore no longer part of the current year Consolidated Balance Sheet. In accordance with the provisions of SFAS No. 115, “Accounting for Certain Investments in Debt and Equity Securities,” we have classified our investments in debt and equity securities as “available for sale” and reported them at fair value on the Consolidated Balance Sheets. Unrealized gains and losses are charged or credited to accumulated other comprehensive income (loss) in shareholders’ equity and deferred taxes are

57


Table of Contents

recorded for the income tax effect of such unrealized gains and losses. The fair value of investments is predominantly based on market values provided by brokers/dealers or other external investment advisors.
Upon the sale of Forethought, certain private equity limited partnerships previously held in the insurance investment portfolio were retained. We continue to use the equity method of accounting for these investments, with earnings or losses reported within Other income in the Statements of Consolidated Income (Loss). Earnings and values for investments accounted for under the equity method are determined based on audited financial statements provided by the investment companies. Other minority investments made outside of the insurance business are accounted for on either a cost or equity basis, dependent upon our level of influence over the investee.
We regularly evaluate all investments for possible impairment based on current economic conditions, credit loss experience and other criteria. If there is a decline in a security’s net realizable value that is other-than-temporary, the decline is recognized as a realized loss and the cost basis of the security is reduced to its estimated fair value.
The evaluation of investments for impairment requires significant judgments to be made including (i) the identification of potentially impaired securities; (ii) the determination of their estimated fair value; and (iii) the assessment of whether any decline in estimated fair value is other-than-temporary.
Guarantees
We routinely grant limited warranties on our products with respect to defects in material and workmanship. The terms of these warranties are generally one year, however, certain components and products have longer warranty periods. We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve. The amount of the warranty reserve is determined based on historical trend experience for the covered products. For more significant warranty-related matters which might require a broad-based correction, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated. A reconciliation of changes in our warranty reserve for the fiscal years 2004 and 2003 and the ten months ended September 30, 2002 is as follows:
                         
    2004   2003   2002
 
Balance at beginning of period
  $ 21     $ 23     $ 22  
 
Provision for warranties during the period
    14       23       20  
 
Warranty reserves acquired
    2              
 
Warranty claims during the period
    (18 )     (25 )     (19 )
 
 
Balance at September 30
  $ 19     $ 21     $ 23  
 
In the normal course of business we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners and others. Examples of these arrangements would include guarantees of product performance, indemnifications to service providers and indemnifications of our actions to business partners. These guarantees and indemnifications would not materially impact our financial condition or results of operations, although indemnifications associated with our actions generally have no dollar limitations.

58


Table of Contents

In conjunction with our acquisition and divestiture activities, we have entered into select guarantees and indemnifications of performance with respect to the fulfillment of our commitments under the respective purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. For those representations and warranties which survive closing, they generally survive for periods up to five years or the expiration of the applicable statutes of limitations. Potential losses under the indemnifications are generally limited to a portion of the original transaction price, or to other lesser specific dollar amounts for select provisions. With respect to sale transactions, we also routinely enter into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities would not materially impact our financial condition or results of operations.
Environmental Liabilities
Expenditures that relate to an existing condition caused by past operations, and which do not contribute to current or future revenue generation, are expensed. A reserve is established when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These reserves are determined without consideration of possible loss recoveries from third parties. More specifically, financial management, in consultation with its environmental engineer, estimates the range of liability based on current interpretation of environmental laws and regulations. For each site in which a Company unit is involved, a determination is made of the specific measures that are believed to be required to remediate the site, the estimated total cost to carry out the remediation plan and the periods in which we will make payments toward the remediation plan. We do not make an estimate of general or specific inflation for environmental matters since the number of sites is small, the magnitude of costs to execute remediation plans is not significant and the estimated time frames to remediate sites are not believed to be lengthy.
Specific costs included in environmental expense include site assessment, development of a remediation plan, clean-up costs, post-remediation expenditures, monitoring, fines, penalties and legal fees. The reserve represents the expected undiscounted future cash outflows.
Expenditures that relate to current operations are charged to expense.
Self Insurance
We are self-insured up to certain limits for auto and general liability, workers’ compensation, general product liability and certain employee health benefits including medical, drug and dental with the related liabilities included in the accompanying financial statements. Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and actuarial analysis, which are based on historical information along with certain assumptions about future events. The estimated reserves for self insurance are classified as Other current liabilities and Other Long-Term Liabilities within the Consolidated Balance Sheets.
We carry external medical and disability insurance coverage for the remainder of our eligible workforce not covered by self-insured plans. We also carry stop-loss insurance coverage to mitigate severe losses under external and self-insured plans. Insurance benefits are not provided to retired employees.
Revenue Recognition — Sales and Rentals
Net revenues reflect gross revenues less sales discounts and allowances and customer returns for product sales and a provision for uncollectible receivables for rentals. Revenue recognition for product sales and rentals is evaluated under the following criteria:

59


Table of Contents

  Evidence of an arrangement: Revenue is recognized when there is evidence of an agreement with the customer reflecting the terms and conditions to deliver products or services.
 
  Delivery: For products, delivery is considered to occur upon receipt by the customer and the transfer of title and risk of loss. For rental services, delivery is considered to occur when the services are rendered.
 
  Fixed or determinable price: The sales price is considered fixed or determinable if it is not subject to refund or adjustment.
 
  Collection is deemed probable: At or prior to the time of a transaction, credit reviews of each customer are performed to determine the creditworthiness of the customer. Collection is deemed probable if the customer is expected to be able to pay amounts under the arrangement as those amounts become due. If collection is not probable, revenue is recognized when collection becomes probable, generally upon cash collection.
As a general interpretation of the above guidelines, revenues for health care products in the patient care environment and for casket and cremation products in the funeral services portion of our business are generally recognized upon delivery of the products to the customer and their assumption of risk of loss and other risks and rewards of ownership. Local business customs and non-standard sales terms can sometimes result in deviations to this normal practice in certain instances.
For non-invasive therapy products within our health care business, the majority of product offerings are rental products for which revenues are recognized consistent with the rendering of the service and use of products. These revenues are recorded net of a provision for uncollectible receivables based upon historic payment and coverage patterns for the various products and paying entities. For The VestÔ product, which was acquired in 2004 with the acquisition of ARI, revenue is generally recognized at the time of receipt of authorization for billing from the applicable paying entity based on the specifics of the authorization and the period of product usage by the patient.
For health care products and services aimed at improving operational efficiency and asset utilization, various revenue recognition techniques are used, depending on the offering. Service contract revenue is generally recognized ratably over the contract period, if applicable, or as services are rendered. Product-related goods are generally recognized upon delivery to the customer, similar to products in the patient care environment.
Based on estimated product returns and price concessions, a reserve for returns and allowances is recorded at the time of the sale, resulting in a reduction of revenue. An allowance for doubtful accounts is recorded based upon the estimated collectibility of receivables, and results in an increase in operating expenses.
Cost of Revenues
Cost of goods sold for product sales consist primarily of purchased material costs, fixed manufacturing expense, and variable direct labor and overhead costs. Health Care rental expenses are those costs associated directly with rental revenue, including depreciation and service of our rental units, service center facility and personnel costs, and regional sales expenses.
Research and Development Costs
Research and development costs are expensed as incurred and were $56 million and $59 million for fiscal years 2004 and 2003, respectively, and $42 million for the ten months ended September 30, 2002.

60


Table of Contents

Distribution Costs
Distribution costs consist of shipping and handling costs and are included in Other operating costs in the Statements of Consolidated Income (Loss). Distribution costs were $110 million, $107 million and $90 million for fiscal year 2004, fiscal year 2003 and the ten months ended September 30, 2002, respectively.
Advertising Costs
Advertising costs are expensed as incurred and were $7 million, $6 million and $5 million for fiscal year 2004, fiscal year 2003 and the ten months ended September 30, 2002, respectively.
Earnings Per Common Share
Basic earnings per share is calculated based upon the weighted average number of outstanding common shares for the period, plus the effect of deferred vested shares. Diluted earnings per share is calculated consistent with the basic earnings per share calculation including the effect of dilutive unissued common shares related to stock-based employee compensation programs. For all years presented, anti-dilutive stock options were excluded from the calculation of dilutive earnings per share. Excluded shares were 198,190, 734,432 and 407,887 for fiscal year 2004, fiscal year 2003 and the ten months ended September 30, 2002, respectively. Cumulative treasury stock acquired, less cumulative shares reissued, have been excluded in determining the average number of shares outstanding.
Comprehensive Income
SFAS No. 130, “Reporting Comprehensive Income,” requires the net-of-tax effect of unrealized gains or losses on our available-for-sale securities, foreign currency translation adjustments and minimum pension liability adjustments, which prior to adoption were reported separately in the Statements of Consolidated Shareholders’ Equity, to be included in Comprehensive Income.
The composition of Accumulated other comprehensive income at September 30, 2004 and 2003 is the net unrealized gains or losses on available-for-sale securities, which in 2003 mainly related to the insurance portfolio, of $10 million and $124 million, foreign currency translation adjustments of ($2) million and ($5) million, and a minimum pension liability of ($2) million and ($1) million, respectively.
Stock-Based Compensation
We apply the provisions of Accounting Principles Board (APB) Opinion No. 25, “Accounting for Stock Issued to Employees”, in accounting for stock-based compensation. As a result, no compensation expense is recognized for stock options granted with exercise prices equivalent to the fair market value of stock on date of grant. Compensation expense is recognized on other forms of stock-based compensation, including stock and performance-based awards and units.
The following table illustrates the effect on net income and earnings per share if we had applied the fair value recognition provisions of SFAS No. 123, “Accounting for Stock-Based Compensation”, to all stock-based employee compensation for fiscal years 2004 and 2003 and the ten months ended September 30, 2002. The fair value of stock option grants are estimated on the date of grant using the Black-Scholes option-pricing model (See Note 8 for more details).

61


Table of Contents

                         
    2004   2003   2002
    (As Restated)   (As Restated)        
 
Net income (loss), as reported
  $ 143     $ 189     $ (10 )
Add:
                       
Total stock-based employee compensation, net of related tax effects, included in net income (loss), as reported
    3       1       1  
Deduct:
                       
Total stock-based employee compensation, net of related tax effects, assuming fair value based method of accounting
    (8 )     (6 )     (4 )
 
Pro forma net income (loss)
  $ 138     $ 184     $ (13 )
 
 
                       
Earnings per share:
                       
Basic — as reported
  $ 2.30     $ 3.05     $ (0.16 )
Basic — pro forma
  $ 2.22     $ 2.97     $ (0.21 )
 
                       
Diluted — as reported
  $ 2.28     $ 3.04     $ (0.16 )
Diluted — pro forma
  $ 2.20     $ 2.96     $ (0.21 )
 
Income Taxes
The Company and its eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions. Deferred income taxes are computed in accordance with SFAS No. 109, “Accounting for Income Taxes” and reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts.
Derivative Instruments and Hedging Activity
Derivative financial instruments are recognized on the Consolidated Balance Sheets as either assets or liabilities and are measured at fair value. Changes in the fair value of derivatives are recorded each period in earnings or Accumulated other comprehensive income, depending on whether a derivative is designated and effective as part of a hedge transaction, and if it is, the type of hedge transaction. Gains and losses on derivative instruments reported in Accumulated other comprehensive income are subsequently included in earnings in the periods in which earnings are affected by the hedged item. Our use of derivatives is generally limited to interest rate swaps, which did not have a material effect on our financial position or results of operations.
Foreign Currency Translation
The functional currency of foreign operations is generally the local currency in the country of domicile. Assets and liabilities of foreign operations are primarily translated into U.S. dollars at year-end rates of exchange and the income statements are translated at the average rates of exchange prevailing during the year. Adjustments resulting from translation of the financial statements of foreign operations into U.S. dollars are excluded from the determination of net income, but included as a component of other comprehensive income. Foreign currency gains and losses resulting from foreign currency transactions are included in results of operations and are not material.
Insurance Liabilities, Recognition of Insurance Policy Income, and Related Benefits and Expenses
Forethought’s life insurance subsidiaries sold long-duration insurance contracts. Revenue was recognized on amounts charged to the insurance liabilities for current benefits and expenses.

62


Table of Contents

Premiums received in excess of the portion required to provide future benefits and current expenses were deferred and also recognized as revenue over the actuarially determined life of the contract. Benefit reserves equaled the cash surrender values provided in the contracts. Expenses were recorded for interest credited to the benefit reserve, death benefits in excess of the benefit reserve and amortization of deferred acquisition costs.
Deferred Acquisition Costs
Policy acquisition costs consisting of commissions, certain policy issue expenses and premium taxes, varied with, and were primarily related to, the production of new business. These deferred acquisition costs were being amortized consistently with unearned revenues. Amortization charged to expense for fiscal years 2004 and 2003 and the ten months ended September 30, 2002 was $46 million, $61 million and $44 million, respectively.
Reclassification
Certain prior year amounts have been reclassified to conform to the current year’s presentation. See Note 17 for further discussion.
Accounting Standards
In January 2003, the Financial Accounting Standards Board (FASB) issued FASB Interpretation No. 46 (“FIN 46”), “Consolidation of Variable Interest Entities”. FIN 46 addresses the requirements for business enterprises to consolidate related entities in which they are determined to be the primary economic beneficiary as a result of their variable economic interests. In December 2003, the FASB released FIN 46R, that provided a partial deferral of FIN 46 along with various other amendments. FIN 46R provides guidance related to evaluating, identifying and reporting of variable interest entities (VIEs). We adopted the new deferral provisions and amendments of FIN 46R as of the second quarter of fiscal 2004. The adoption of FIN 46R required the consolidation of four real estate partnerships that were previously not consolidated. On June 29, 2004, we sold the four real estate partnerships (see Note 3). Therefore, the amounts previously reported in continuing operations for these four VIEs were reclassed to discontinued operations for the year ended September 30, 2004. As of September 30, 2004, we no longer hold any investments that would be considered VIEs and require consolidation under FIN 46R.
In December 2003, the FASB issued SFAS No. 132R, “Employers’ Disclosures about Pensions and Other Postretirement Benefits.” This Statement retains the disclosure requirements contained in SFAS No. 132, which it replaces. SFAS No. 132R also requires additional disclosures about the assets, obligations, cash flows and net periodic benefit cost of defined benefit pension plans and other defined benefit postretirement plans. Those disclosures include information describing the types of plan assets, investment strategy, measurement dates, plan obligations, cash flows, and components of net periodic benefit cost recognized during interim periods. This Statement is effective for financial statements with fiscal years ending after December 15, 2003. We adopted this Statement as of the second quarter of fiscal 2004.
In March 2004, the FASB ratified the Emerging Issues Task Force (EITF) Issue No. 03-1, “The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments” (EITF 03-1). EITF 03-1 provides guidelines on the meaning of other-than-temporary impairment and its application to investments, in addition to requiring quantitative and qualitative disclosures in the financial statements. The disclosure provisions of EITF 03-1 are effective for fiscal years ending after December 15, 2003. The implementation of the disclosure provisions of EITF 03-1 did not have a material impact on our Consolidated Financial Statements or results of operations. On September 30, 2004, FASB Staff Position EITF 03-1-1 was issued, which deferred the application of the measurement provisions of EITF 03-1. The FASB determined that a delay in the effective date of those provisions was necessary until it can issue additional guidance on the application of EITF 03-1.

63


Table of Contents

2. Retirement Plans
Hillenbrand and its subsidiaries have several defined benefit retirement plans covering the majority of employees, including certain employees in foreign countries. We contribute funds to trusts as necessary to provide for current service and for any unfunded projected future benefit obligation over a reasonable period. The benefits for these plans are based primarily on years of service and the employee’s level of compensation during specific periods of employment. We acquired Mediq on January 30, 2004, including its retirement plans. All of our plans have a September 30 measurement date.
Effect on Operations
The components of net pension expense for defined benefit retirement plans in the United States for fiscal year 2004 and 2003 and the ten months ended September 30, 2002 were as follows (in millions):
                         
    2004   2003   2002
 
Service cost
  $ 10     $ 10     $ 9  
 
                       
Interest cost
    16       14       11  
 
                       
Expected return on plan assets
    (16 )     (14 )     (12 )
 
Amortization of unrecognized prior service cost, net
    1       1       1  
 
Net periodic benefit cost
    11       11       9  
 
 
Curtailment (gain) loss
    (2 )     3        
 
Net pension expense
  $ 9     $ 14     $ 9  
 
Obligations and Funded Status
The change in benefit obligations, plan assets and funded status, along with amounts recognized in the Consolidated Balance Sheets for our domestic defined benefit retirement plans at September 30 were as follows (in millions):

64


Table of Contents

                 
    September 30,   September 30,
    2004   2003
 
Change in benefit obligation:
               
Benefit obligation at beginning of year
  $ 230     $ 205  
Acquisition
    34        
Service cost
    10       10  
Interest cost
    16       14  
Amendments
    1        
Actuarial loss
    9       11  
Curtailment
    (2 )     (5 )
Benefits paid
    (8 )     (5 )
 
Benefit obligation at end of year
    290       230  
 
Change in plan assets:
               
Fair value of plan assets at beginning of year
    180       163  
Acquisition
    23        
Actual return on plan assets
    13       13  
Employer contributions
    8       9  
Benefits paid
    (8 )     (5 )
 
Fair value of plan assets at end of year
    216       180  
 
Funded status:
               
Plan assets less than benefit obligations
    (74 )     (50 )
Unrecognized net actuarial loss
    21       8  
Unrecognized prior service cost
    12       13  
 
Net amount recognized
    (41 )     (29 )
 
Amounts recorded in the Consolidated Balance Sheets:
               
Accrued benefit costs
    (42 )     (30 )
Accumulated other comprehensive income
    1       1  
 
Net amount recognized
  $ (41 )   $ (29 )
 
For all of our defined benefit retirement plans, the fair value of plan assets was less than the accumulated benefit obligation as of September 30, 2004 and 2003, resulting in the recognition of minimum pension liabilities of $2 million and $1 million, respectively.
Accumulated Benefit Obligation
The accumulated benefit obligation for all defined benefit pension plans was $255 million and $195 million at September 30, 2004 and 2003, respectively.
Selected information for our plans with accumulated benefit obligation in excess of plan assets at September 30, 2004 and 2003, was as follows (in millions):
                 
    September 30,   September 30,
    2004   2003
 
Projected benefit obligation
  $ 290     $ 230  
Accumulated benefit obligation
    255       195  
Fair value of plan assets
    216       180  

65


Table of Contents

Actuarial Assumptions
The weighted average assumptions used in accounting for our domestic pension plans were as follows:
                         
    2004   2003   2002
 
Discount rate for obligation
    6.00 %     6.25 %     6.75 %
Discount rate for expense
    6.25 %     6.75 %     7.25 %
Expected rate of return on plan assets
    7.75 %     7.75 %     8.00 %
Rate of compensation increase
    4.00 %     4.00 %     4.00 %
Plan Assets
The weighted-average asset allocations of our domestic defined benefit plans at September 30, 2004 and 2003, by asset category are as follows:
                         
    2004   2003
    Target   Actual   Actual
    Allocation   Allocation   Allocation
 
Equity securities
    49-62 %     57 %     56 %
Fixed income securities
    38-48       42       43  
Real estate
    1-2       1       1  
Other
    0-1              
 
Total
            100 %     100 %
 
The investment strategies and policies are set by the plans’ fiduciaries. Long-term strategic investment objectives utilize a diversified mix of equity and fixed income securities to preserve the funded status of the trusts and balance risk and return. The plan fiduciaries oversee the investment allocation process, which includes selecting investment managers, setting long-term strategic targets and monitoring asset allocations. Target allocation ranges are guidelines, not limitations, and plan fiduciaries may occasionally approve allocations above or below a target range.
Trust assets are invested subject to the following policy restrictions: short-term securities must be rated A2/P2 or higher; all fixed-income securities shall have a credit quality rating “BBB” or higher; investments in equities in any one company may not exceed 10 percent of the equity portfolio. Hillenbrand common stock represented 6 percent and 7 percent of trust assets at year-end 2004 and 2003, respectively and is subject to a statutory limit when it reaches 10 percent of total trust assets. The overall expected long-term rate of return is based primarily on historical returns, which are inflation adjusted and weighted for the expected return for each component of the investment mix.
Cash Flows
We expect to contribute approximately $8 million to our domestic defined benefit plans in fiscal year 2005.

66


Table of Contents

Estimated Future Benefit Payments
The benefit payments, which reflect expected future service, are expected to be paid as follows (in millions):
         
    Pension Benefits
 
2005
  $ 8  
2006
    9  
2007
    10  
2008
    11  
2009
    12  
2010-2014
    83  
Other
Subsequent to the January 30, 2004 acquisition of Mediq, we amended the Mediq pension plan to freeze all benefits effective April 30, 2004.
During fiscal year 2003, we amended the terms of one of our defined benefit pension plans for most non-bargained employees. Under the amended plan, employees hired after June 30, 2003 are no longer eligible for participation in the defined benefit plan, but participate in a new 401(k) retirement program that began January 1, 2004. Current employees and those hired up to July 1, 2003 were given the opportunity to choose to continue participating in the defined benefit pension plan and the existing 401(k) plan or to participate in the new 401(k) retirement program. Elections were completed as of September 30, 2003, and became effective January 1, 2004.
For those employees that elected to continue participation in the defined benefit pension plan, there were no changes in benefits and all service is recognized as credited service under the plan. For those who elected the new 401(k) retirement program, benefits under the defined benefit pension plan were frozen and will be paid out in accordance with the plan provisions with future service considered only under the new 401(k) retirement program. We recognized a curtailment loss of approximately $3.5 million during the fourth fiscal quarter of 2003 as a result of this amendment and the related reduction in future service under the defined benefit pension plan. This loss was recognized as a component of Other operating expense in the Statement of Consolidated Income (Loss).
In addition to the above plans, we have an unfunded liability for a defined benefit pension plan in Germany. The unfunded benefit obligation of this plan, included in Other long-term liabilities, was $12 million and $11 million at September 30, 2004 and 2003, respectively. Pension expense was negligible in all reporting periods.
We also sponsor several defined contribution plans covering certain of our employees. Employer contributions are made to these plans based on a percentage of employee compensation. The cost of these defined contribution plans was $13 million for fiscal year 2004, $10 million for fiscal year 2003 and $8 million for the ten months ended September 30, 2002.
3. Discontinued Operations
On July 1, 2004, we closed the sale of Forethought Financial Services, Inc. to FFS Holdings, Inc., an acquisition vehicle formed by the Devlin Group, LLC., which acquired all the common stock of Forethought and its subsidiaries for a combination of cash, seller financing, certain retained assets of Forethought and stock warrants. Total nominal consideration for the transaction was approximately $295 million, including the value of the partnership assets transferred to us and excluding a dividend received by us in December 2003 from Forethought in the amount of approximately $29 million made in anticipation of the transaction. Hillenbrand received cash proceeds in the transaction of approximately $105 million, provided seller financing in various forms with an estimated face value of $151 million, retained specific

67


Table of Contents

investments in limited equity partnership assets of Forethought with a book value of $31 million and received warrants to acquire up to 5 percent of the common stock of FFS Holdings, Inc. An additional cash payment of approximately $6 million is due upon the regulatory approval of the sale of Forethought Federal Savings Bank, which is expected in the first half of fiscal 2005. The final consideration was subject to adjustment based upon results through the close of the transaction. The seller financing is subject to a discount of approximately $29 million to reflect a market rate of return on the financing, which is expected to be recognized in future periods as accretion on the underlying financial instruments.
The seller financing is in the form of a seller note with a face value of approximately $107 million. This note carries an increasing rate of interest over its ten-year term, with interest accruing at 6 percent for the first five years. No payments are due under the note until year six at which time annual payments of $10 million are required, with all remaining amounts, including unpaid interest, due at maturity. The seller financing also includes preferred stock in the amount of $29 million, which accrues cumulative dividends at the rate of 5 percent per annum. The preferred stock is redeemable at any time at the option of FFS Holdings and must be redeemed by FFS Holdings under specified circumstances. Additional financing was also provided in the form of a $15 million debt service account associated with third party secured financing obtained by FFS Holdings under the transaction. We are scheduled to receive payments from this account beginning in year three with final repayment due in year eight. This account is not subject to interest until year three.
The divestiture of Forethought resulted in an impairment loss. While this loss will generate significant tax benefits, as a result of limitations on our ability to utilize capital losses related to the transaction it is more likely than not that we will not realize these benefits and a full valuation allowance has been provided. Therefore, tax benefits recognized in conjunction with the sale will be generally limited to ordinary losses. Additional tax benefits may be recognized in the future should we generate capital gains sufficient to utilize the resulting losses. In conjunction with this divestiture, in the three months ended March 31, 2004 we realized a loss on the impairment of the discontinued net assets of Forethought of $96 million, net-of-tax, consisting of a $129 million pre-tax loss and a $33 million income tax benefit. In the fourth quarter of 2004, this loss was adjusted to $89 million, net-of-tax, as a result of the book value at the date of close.
On June 29, 2004, Forethought sold specific real estate partnerships that were part of their investment portfolio and were originally expected to be retained by Hillenbrand at closing. Forethought received $104 million in cash proceeds on the sale and recorded a capital loss on the transaction of approximately $7 million. The loss realized as a result of this transaction is included in discontinued operations for the year ended September 30, 2004. Included in the sale were mortgage loans of $54 million related to two of the real estate properties. Accordingly, the net impact of selling these partnerships resulted in Hillenbrand receiving an additional $50 million in cash proceeds from Forethought’s sale. Our estimated maximum exposure to loss as a result of continuing involvement with these real estate partnerships was approximately $88 million. The maximum exposure to loss represented the sum of the carrying value of our investment balances, the estimated amounts that we were committed to fund in the future for each of these potential variable interest entities and the maximum amount of debt guaranteed under which we could have been required to perform. In addition, we had other funding commitments with these real estate partnerships, which were dependent upon the operating performance of the respective partnerships. As a result of the sale of these real estate partnerships, the exposure to loss and funding commitments have been eliminated.
In October 2003, Hill-Rom sold its piped-medical gas business to Beacon Medical Products LLC, for $13 million, after final purchase price adjustments, resulting in a net gain of $5 million. The piped-medical gas business provided medical gas delivery and management systems in acute care facilities. Hill-Rom retained approximately $4 million of outstanding receivables and the land and building upon close.

68


Table of Contents

In the third fiscal quarter of 2004, Hill-Rom closed on the sale of its Air-Shields infant care business to a subsidiary of Dräger Medical AG & Co. KGaA for approximately $26 million. Additional proceeds of $5 million were received in the fourth quarter upon the final transfer of an investment, bringing the total proceeds to $31 million and the net gain realized on the disposal to $13 million. Air-Shields provides infant care warming therapy, incubators and other infant care products. Hill-Rom retained approximately $9 million of outstanding receivables of the infant care business at the date of close.
Upon approval of the Board of Directors and the signing of the definitive sale agreements, the Hill-Rom infant care and piped-medical gas businesses and Forethought, a provider of pre-need insurance to fund funeral and cemetery costs, were all treated as discontinued operations for all periods presented within the Statements of Consolidated Income (Loss) in accordance with the provisions of SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets”.
Operating results for the discontinued operations were as follows for fiscal years 2004 and 2003 and the ten months ended September 30, 2002:
                         
    Fiscal Year   Fiscal Year   Ten Months
    Ended   Ended   Ended
    September 30,   September 30,   September 30,
    2004   2003   2002
(Dollars in millions)   (As Restated)   (As Restated)        
 
Investment income
  $ 133     $ 178     $ 138  
Earned revenue
    162       216       177  
Net capital gains (losses)
    4       (32 )     (16 )
Other revenues
    47       102       75  
 
Net revenues from discontinued operations
    346       464       374  
Benefits paid
    66       84       71  
Credited interest
    134       183       148  
Other costs of revenue
    77       132       103  
Other operating expenses
    33       52       32  
Loss on impairment of discontinued operations
    107              
 
Pre-tax (loss) income from discontinued operations
    (71 )     13       20  
Income tax (benefit) expense
    (26 )     5       13  
 
(Loss) income from discontinued operations
  $ (45 )   $ 8     $ 7  
 
The assets and liabilities of Forethought Federal Savings Bank are included in the assets and liabilities of discontinued operations, which are presented in separate line items within the Consolidated Balance Sheet as of September 30, 2004. The assets and the liabilities of the piped-medical gas and infant care businesses, as applicable, are included in the assets and liabilities of discontinued operations as of September 30, 2003. Components of assets and liabilities of discontinued operations were as follows (Dollars in millions):

69


Table of Contents

                 
    September 30,   September 30,
    2004   2003
            (As Restated)
 
Current assets
  $     $ 21  
Property, plant and equipment, net
          6  
Goodwill
          3  
Insurance assets
    98        
 
Assets of discontinued operations
    98       30  
 
               
Insurance liabilities
    92        
Other liabilities
          7  
 
Liabilities of discontinued operations
    92       7  
 
Net assets of discontinued operations
  $ 6     $ 23  
 
In terms of operating cash flows, because Forethought operates in a regulated environment its cash flows are generally neutral to Hillenbrand. Hillenbrand has also in the past made capital contributions to and received dividends from Forethought, thereby impacting our overall cash position. In the first quarter of fiscal 2004, we received a dividend of $29 million from Forethought. Cash flows from the piped-medical gas and infant care businesses generally approximate net income.
4. Acquisitions
During fiscal 2004, Hill-Rom completed the acquisitions of ARI, Mediq and NaviCare. The results of these businesses have been included in the Consolidated Financial Statements since each acquisition’s date of close.
On October 17, 2003, Hill-Rom acquired 100 percent of the outstanding common shares of ARI, a manufacturer and distributor of non-invasive airway clearance products and systems. The acquisition of ARI complements Hill-Rom’s existing pulmonary expertise, expands its home-care product line, offers growth potential and is aimed at allowing Hill-Rom to leverage its clinical sales force. These benefits along with management’s belief in the growth potential for the business were key determinants in the valuation of the business.
The purchase price for the ARI acquisition was $83 million, plus an additional $2 million of acquisition costs incurred in relation to the transaction. This purchase price was subject to certain working capital adjustments at the date of close not to exceed $12 million, plus additional contingent payments not to exceed $20 million based on ARI achieving certain net revenue targets. Upon closing, $73.3 million of the purchase price was paid to the shareholders of ARI, with an additional $9.7 million deferred until a later date. Upon final determination of the working capital adjustment in January 2004, an additional $11.8 million was paid to the shareholders of ARI, along with $4 million of the originally deferred payments. The remaining deferral of $5.7 million is outstanding and payable no later than the end of calendar 2005 and is accrued in the Consolidated Balance Sheets as of September 30, 2004. Based on net revenues achieved in fiscal 2004, an additional purchase price of $9 million was accrued in September 2004, which is expected to be paid before the end of calendar 2004. Any additional contingent purchase price is dependent upon ARI achieving certain net revenue targets over the next year. All required contingency payments, including the $9 million recorded in September 2004, will increase goodwill associated with the acquisition.
On January 30, 2004, Hill-Rom acquired Mediq, a company in the medical equipment outsourcing and asset management business. This acquisition expands Hill-Rom’s product and service offerings, strengthens after-sales service capabilities and allows increased leverage of Hill-Rom’s global rental service center network.

70


Table of Contents

The purchase price for Mediq was approximately $329 million, plus an additional $6 million of acquisition costs incurred in relation to the transaction. This purchase price was subject to certain adjustments based upon the Mediq balance sheet at the date of close. Subsequent to year-end, we reached a final agreement with the representative of the former Mediq shareholders as to the purchase price based upon reported assets and liabilities of Mediq as of the closing date, resulting in the release of the $3 million deposited into an escrow account at the time of purchase. In addition, there may be other potential adjustments to the purchase price, which should be agreed upon by the end of the first quarter of fiscal 2006. This adjustment relates primarily to the funded status of Mediq’s defined benefit pension plan as of the end of the first quarter of 2006, along with the occurrence of any issues associated with seller representations, warranties and other matters. We deposited $20 million into an escrow account at the time of purchase in connection with these possible adjustments, which will be held until final resolution in fiscal 2006. The escrow amounts are included in the reported purchase price of Mediq. If any adjustment differs in amount from the current escrow balances, the reported purchase price would be increased or decreased by the amount of any valid claims against the escrow amounts, and the reported amount of goodwill associated with the Mediq acquisition would be adjusted accordingly.
On January 30, 2004, we completed the acquisition of the remaining 84 percent of the equity of NaviCare that we did not already own for approximately $14 million, including deferred payments of approximately $2 million payable within one year. NaviCare provides operations management, resource optimization and dynamic workflow solutions to health care enterprises. NaviCare’s portfolio of communications and workflow products will become a key component of Hill-Rom’s workflow solutions offerings.
The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at their dates of acquisition. We are still in the process of finalizing the valuation of certain of the assets and liabilities acquired and the purchase prices remain subject to adjustment for the contingency payments outlined above; thus, the allocation of the purchase prices is subject to refinement.
                         
    ARI   Mediq   NaviCare
 
Current assets
  $ 25     $ 44     $ 2  
Property, plant and equipment
    6       99        
Intangible assets
    9       69       4  
Goodwill
    73       197       11  
Other long-term assets
    1       1        
 
Total assets acquired
    114       410       17  
Current liabilities
    (5 )     (36 )     (2 )
Long-term liabilities
    (3 )     (39 )     (1 )
 
Total liabilities assumed
    (8 )     (75 )     (3 )
 
Net assets acquired
  $ 106     $ 335     $ 14  
 
The $9 million of acquired intangibles at ARI were assigned to technology assets, a five-year non-compete agreement and a trademark, all of which will reside within the Clinical Division of Hill-Rom. The $69 million of acquired intangibles at Mediq were assigned primarily to customer relationship assets, which will reside predominantly within the Services Division of Hill-Rom, with lesser amounts residing in the Clinical Division. The $4 million of acquired intangibles at NaviCare were assigned to non-compete agreements, technology assets, customer relationship assets and a trademark. These intangible assets, with the exception of the trademarks, are generally subject to amortization over varied periods of time and none will be deductible for income tax purposes.
If these acquisitions had been completed as of the beginning of each period presented, reported results for the fiscal years ended September 30, 2004 and 2003 would have increased as follows (Dollars in millions, except per share data, unaudited):

71


Table of Contents

                                                 
    Year Ended September 30, 2004   Year Ended September 30, 2003
    ARI   Mediq   Total   ARI   Mediq   Total
 
Revenues
  $     $ 49     $ 49     $ 48     $ 157     $ 205  
 
Net income
          3       3       3       16       19  
Diluted earnings per share
  $     $ 0.05     $ 0.05     $ 0.05     $ 0.25     $ 0.30  
The net income and diluted earnings per share amounts in all periods presented above include the additional depreciation and amortization expense resulting from the purchase of property and intangibles at fair value, but exclude the impact of financing costs associated with the Mediq acquisition.
Based on the acquisition date of ARI and the timing of its inclusion in our Consolidated Financial Statements, the acquisition of ARI as of the beginning of the 2004 fiscal year would not have materially impacted our financial results for the year ended September 30, 2004. If the acquisition of NaviCare had been completed as of the beginning of fiscal 2004 or 2003, the impact to our revenues or results of operations would not have been material.
5. Special Charges
2004 Actions
During the fourth fiscal quarter of 2004, we announced a restructuring intended to better align Hill-Rom’s financial and personnel resources to fully support its growth initiatives, decrease overall costs, and improve performance in Europe. The plan includes the elimination of approximately 130 salaried positions in the U.S. and approximately 100 positions in Europe and resulted in a fourth quarter charge of approximately $7 million, associated with severance and benefit-related costs. All obligations associated with this action will be settled in cash. We expect the restructuring to be completed during our 2005 fiscal year.
2003 Actions
During the third fiscal quarter of 2003, we announced a new business structure at Hill-Rom to accelerate the execution of its strategy and strengthen its core businesses. As a result of this action, Hill-Rom announced it expected to eliminate approximately 300 salaried positions globally. Hill-Rom also announced it expected to hire approximately 100 new personnel with the skills and experience necessary to execute its business strategy. A fiscal 2003 third quarter charge of $9 million was recognized with respect to this action, essentially all related to severance and benefit-related costs. As of September 30, 2004 this action is essentially complete, with less than $1 million remaining in the reserve. During fiscal 2004 approximately $1 million of the originally recorded reserve was also reversed. In excess of 280 salaried positions were eliminated under the action, with over 60 of the original list of terminees being transferred to other positions in line with Hill-Rom’s strategy. As of this same date, approximately 90 new positions had been hired under the new business structure. This action is expected to be fully completed in the second quarter of fiscal 2005, in combination with the completion of the enterprise-wide technology platform integration.
2002 Actions
During the fourth quarter of 2002, we announced realignment actions at Batesville Casket and Hill-Rom. The actions at Batesville Casket included the closure of a wood casket plant in Canada along with other employee reduction actions in the United States. These combined actions resulted in the reduction of approximately 100 employees. A charge of $3 million was recorded in relation to these actions for severance and other facility closing costs. In addition, during the fourth quarter of fiscal 2002 Hill-Rom announced an action in Germany to downsize its field service operations and to relocate its sales and other administrative functions. A charge of $2 million was recorded for severance and other facility costs associated with this

72


Table of Contents

action, which resulted in the termination of 25 employees. Of the total charge recorded for the above actions, $4 million was associated with severance and other costs to be settled in cash while $1 million related to asset impairments. All activities associated with these charges are now complete.
Other
In addition to the reserve balances outlined above, approximately $3 million of accrued liabilities were outstanding at September 30, 2004 related to retirement obligations of W August Hillenbrand, a former Chief Executive Officer of the Company. Mr. Hillenbrand retired in the fourth calendar quarter of 2000.
6. Notes Receivable
Notes receivable as of September 30, 2004 and 2003 consist of the following:
                 
    September 30,   September 30,
    2004   2003
 
Notes receivable — gross
  $ 109     $  
Discount on note
    (15 )      
 
Net receivable
    94        
 
 
               
Debt service account
    15        
Discount on service account
    (4 )      
 
Net debt service account
    11        
 
 
               
Total notes receivable
  $ 105     $  
 
 
               
Maturities at September 30
               
 
2005
  $          
2006
  $          
2007
  $ 7          
2008
  $ 2          
2009
  $ 2          
2010 and beyond
  $ 94          
On July 1, 2004 we closed the sale of Forethought to FFS Holdings. As part of the consideration received in the transaction, we provided seller financing in the form of a note receivable with a face value of approximately $107 million. This note carries an increasing rate of interest over its ten-year term, with interest accruing at 6 percent for the first five years. Interest compounds semi-annually, and the note receivable balance above includes $2 million of interest accrued as of September 30, 2004. No payments are due under the note until year six at which time annual payments of $10 million are required, with all remaining amounts, including unpaid interest, due at maturity.
Additional financing was also provided in the form of a $15 million debt service account associated with third party secured financing obtained by FFS Holdings under the transaction. We are scheduled to receive payments from this account beginning in year three with final repayment due in year eight. This account is not subject to interest until year three.

73


Table of Contents

7. Financing Agreements
Long-term debt consists of the following (Dollars in millions):
                 
    September 30,   September 30,
    2004   2003
 
Unsecured 8 1/2% debentures due on December 1, 2011
  $ 54     $ 55  
 
               
Unsecured 7% debentures due on February 15, 2024
    20       50  
 
               
Unsecured 6 3/4% debentures due on December 15, 2027
    30       50  
 
               
Unsecured 4 1/2% debentures due on July 15, 2009
    256        
 
 
               
Total long-term debt
  $ 360     $ 155  
 
On July 14, 2003, we filed a universal shelf registration statement with the U.S. Securities and Exchange Commission on Form S-3 for the potential future sale of up to $1 billion in debt and/or equity securities. The registration statement was declared effective and should provide us with significant flexibility with respect to our access to the public markets. There can be no assurance that additional financing under the universal shelf registration statement or elsewhere will be available at terms acceptable to us.
On June 7, 2004, we issued $250 million of 4.5 percent coupon senior notes due 2009 from this universal shelf registration statement, leaving $750 million of available capacity under the universal registration statement. The net proceeds from this borrowing were utilized to permanently finance the Mediq acquisition.
Also in June 2004, we completed the open market repurchase of approximately $47 million principal amount of longer maturity coupon debt for approximately $55 million.
Beginning in June 2004, $200 million of our debt securities were subject to interest rate swap agreements. The interest rate swaps covered part of these debt securities maturing on June 15, 2009, effectively converting the securities from fixed to variable interest rates. For the 2004 period in which the interest rate swap agreements were outstanding, the average variable interest rate on debt covered by the swaps approximated 1.7 percent.
Beginning in August 2001 and continuing through essentially the third quarter of 2003, $150 million of our debt securities were subject to interest rate swap agreements. The interest rate swaps covered all or part of the securities maturing on December 1, 2011 and February 15, 2024, effectively converting the securities from fixed to variable interest rates.
Near the end of the third quarter of fiscal year 2003, we terminated our then outstanding interest rate swap agreements, realizing cash proceeds and deferred gains of approximately $27 million. The deferred gains on the termination of the swaps will be amortized and recognized as a reduction in interest expense over the remaining term of the related debt. With the gains from the swap agreements, the prospective effective interest rates will be lower than the stated interest rates, but higher than the variable rates we had been subject to during the period the swap agreements were in place. For the periods in which the interest rate swap agreements were outstanding, the average variable interest rate on debt covered by the swaps approximated 3.3 percent and 4.2 percent, respectively, for fiscal year 2003 and the ten months ended September 30, 2002.
Upon completion of the open market debt repurchase previously discussed, approximately $2 million of the deferred gains related to the termination of the interest rate swap agreements were recognized, reducing the loss on repurchase of the debt to approximately $6 million,

74


Table of Contents

including the write-off of approximately $1 million of debt issuance costs associated with the original debt placement.
On July 28, 2004, we entered into a $400 million five-year senior revolving credit facility with a syndicate of banks led by Bank of America, N.A. and Citigroup North America, Inc. The term of the five-year facility expires on June 1, 2009. Borrowings under the credit facility bear interest at variable rates, as defined therein. The availability of borrowing under the five-year facility is subject to our ability at the time of borrowing to meet certain specified conditions. These conditions include a maximum debt to capital ratio of 55 percent, absence of default under the facility and continued accuracy of certain representations and warranties contained in the credit facility. The proceeds of the five-year facility may be used: (i) for working capital, capital expenditures, and other lawful corporate purposes; (ii) to finance acquisitions.
As of September 30, 2004, we: (i) had $15 million of outstanding, undrawn letters of credit, (ii) were in compliance with all conditions set forth under the credit facility, and (iii) had complete access to the remaining $385 million of borrowing capacity available under the credit facility.
We have additional uncommitted credit lines totaling $15 million that have no commitment fees, compensating balance requirements or fixed expiration dates. As of September 30, 2004, we had $13 million of outstanding, undrawn letters of credit under these facilities.
8. Stock-Based Compensation
Over time, we have had various stock-based compensation programs, the key components of which are further described below. Our primary active stock-based compensation program is the Stock Incentive Plan. All stock-based compensation programs are administered by the full Board of Directors or its Compensation and Management Development Committee.
The Stock Incentive Plan, which was approved at the 2002 annual meeting of shareholders, replaced the 1996 Stock Option Plan. Common shares reserved for issuance under the Stock Incentive Plan total 5 million, plus 294,611 shares previously authorized but unissued under the 1996 Stock Option Plan. The Stock Incentive Plan provides for long-term performance compensation for key employees and members of the Board of Directors. A variety of discretionary awards for employees and non-employee directors are authorized under the plan, including incentive or non-qualified stock options, stock appreciation rights, restricted stock, deferred stock and bonus stock. The vesting of such awards may be conditioned upon either a specified period of time or the attainment of specific performance goals as determined by the administrator of the plan. The option price and term are also subject to determination by the administrator with respect to each grant. Option prices are generally expected to be set at the average fair market price at date of grant and option terms are not expected to exceed ten years.
Under the terms of the plan, each non-employee director was automatically granted an option to purchase 4,000 shares of common stock each year on the first day following our annual meeting, vesting on the first anniversary of the date of grant and exercisable over a ten year term. Beginning in fiscal 2004, instead of options, each non-employee member of the Board of Directors was granted restricted stock units (or deferred stock awards), which will vest on the later to occur of the first anniversary of the date of grant or the six-month anniversary of the date that a director ceases to be a member of our Board of Directors. In 2004, the annual grant consisted of 1,400 restricted stock units, to be increased to 1,800 in 2005, for each non-employee director. The annual grant for the Chairman of the Board is 3,500 restricted stock units.
As of September 30, 2004, 1,461,250 option shares have been granted and 157,030 shares have been cancelled under the Stock Incentive Plan. In addition, a total of 241,782 restricted stock units have been granted under the Stock Incentive Plan, all of which are contingent upon continued employment and vest over periods ranging from one to five years. The shares had a

75


Table of Contents

fair value at the date of grant ranging between $47.49 and $69.25 per share. Dividends, payable in stock, accrue on the grants and are subject to the same specified terms as the original grants. As of September 30, 2004, a total of 186,860 restricted stock units, net of cancellations and dividends earned, remain outstanding. A total of 3,757,359 shares remain available for future grants under all aspects of the Stock Incentive Plan.
The fair value of option grants under our Stock Incentive Plan and the predecessor 1996 Stock Option Plan are estimated on the date of grant using the Black-Scholes option-pricing model. The weighted average fair value of options granted under each of these plans was $15.55, $12.74 and $17.65 per share for fiscal years 2004 and 2003 and the ten months ended September 30, 2002, respectively. The following assumptions were used in the determination of fair value in each period:
                         
    2004   2003   2002
Risk-free interest rate
    3.73 %     3.52 %     4.70 %
Dividend yield
    1.76 %     1.60 %     1.55 %
Volatility factor
    .2634       .2629       .2637  
Weighted average expected life
  6.00 years   5.97 years   5.92 years
The following table summarizes transactions under our current and predecessor stock option plans for fiscal years 2004 and 2003 and the ten months ended September 30, 2002:
                                                 
    2004   2003   2002
 
            Weighted           Weighted           Weighted
            Average           Average           Average
    Number of   Exercise   Number of   Exercise   Number of   Exercise
    Shares   Price   Shares   Price   Shares   Price
 
Unexercised options outstanding — beginning of year
    2,688,079     $ 47.77       2,247,572     $ 47.69       2,309,166     $ 45.78  
Options granted
    637,650     $ 58.18       590,100     $ 47.58       263,500     $ 60.09  
Options exercised
    (543,219 )   $ 46.54       (62,933 )   $ 39.86       (253,019 )   $ 43.49  
Options canceled
    (93,859 )   $ 54.86       (86,660 )   $ 50.33       (72,075 )   $ 46.95  
 
Unexercised options outstanding — end of year
    2,688,651     $ 50.24       2,688,079     $ 47.77       2,247,572     $ 47.69  
 
Exercisable options — end of year
    1,655,687     $ 47.61       1,606,408     $ 46.53       1,188,640     $ 45.27  
 
The following table summarizes information about stock options outstanding at September 30, 2004:
                                         
    Options Outstanding   Options Exercisable
 
            Weighted                
            Average   Weighted           Weighted
Range of   Number   Remaining   Average   Number   Average
Exercise Prices   Outstanding   Contractual Life   Exercise Price   Exercisable   Exercise Price
 
$29.97-$45.34
    591,411       5.14     $ 39.81       591,411     $ 39.81  
$46.44-$48.64
    594,998       7.57     $ 47.65       312,905     $ 47.78  
$50.11-$52.16
    683,661       5.53     $ 51.06       560,360     $ 51.26  
$52.42-$57.44
    69,666       6.56     $ 56.04       41,667     $ 56.56  
$58.24-$69.25
    748,915       8.57     $ 59.23       149,344     $ 61.93  
 
$29.97-$69.25
    2,688,651       6.77     $ 50.24       1,655,687     $ 47.61  
 
Members of the Board of Directors may elect to defer fees earned and invest them in common stock of the Company under the Hillenbrand Industries Directors’ Deferred Compensation Plan. A total of 1,092 deferred shares are payable as of September 30, 2004 under this program.
We have historically had various other stock-based compensation programs, including a long-term performance based plan. Shares granted under these predecessor programs were contingent upon continued employment over specified terms, generally not exceeding three years,

76


Table of Contents

and some required the achievement of pre-established and approved financial objectives. As of September 30, 2004, there are 249,567 shares which are deferred, but fully vested and payable.
9. Shareholders’ Equity
One million shares of preferred stock, without par value, have been authorized and none have been issued.
As of September 30, 2004, the Board of Directors had authorized the repurchase, from time to time, of up to 24,289,067 shares of the Company’s stock. The purchased shares will be used for general corporate purposes. As of September 30, 2004, a total of 21,449,067 shares had been purchased at market trading prices, of which 18,363,520 shares remain in treasury.
10. Financial Instruments
The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value.
The carrying amounts of current assets and liabilities approximate fair value because of the short maturity of those instruments.
The carrying amounts of the private equity limited partnerships retained in the sale of Forethought and the other minority investments were $79 million and $68 million at September 30, 2004 and 2003. The fair value of equity method investments is not readily available and disclosure is not required.
The fair value of notes receivable is estimated by using a discount rate that approximates the current rate for comparable notes. At September 30, 2004, the aggregate fair value approximated the carrying value of the notes.
The fair value of our debt is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt of the same remaining maturities. The carrying value and estimated fair values of our long-term debt instruments were $360 million and $369 million at September 30, 2004 and $155 million and $166 million at September 30, 2003, respectively.
We have limited involvement with derivative financial instruments and do not use them for trading purposes. They are used to manage well-defined interest rate and foreign currency risks. With respect to foreign currency risks, forward contracts are sometimes utilized to hedge exposure to adverse exchange risk related to specific assets and obligations denominated in foreign currencies. As of September 30, 2004 and 2003, we had no outstanding forward contracts. During 2004, we entered into interest rate swap agreements to effectively convert a portion of our fixed interest rate long-term debt to variable rates. The notional amount of the interest rate swaps was $200 million. There is no hedge ineffectiveness as each swap meets the short-cut method requirements under SFAS No. 133, “Accounting for Derivatives and Hedging Activities”. As a result, changes in the fair value of the interest rate swap agreements during their term offset changes in the fair value of the underlying debt, with no net gain or loss recognized in earnings. As of September 30, 2004, the interest rate swap agreements reflected a cumulative gain of $7 million. During 2003, we terminated interest rate swap agreements covering a notional amount of $150 million of long-term debt that were entered into in 2001. During the term of these swap agreements, there was no hedge ineffectiveness as each swap met the short-cut method requirements under SFAS No. 133. With the termination of the swap agreements and the completion of debt repurchases in the fourth quarter of fiscal year 2003 and the third quarter of 2004, the remaining unrecognized deferred gains remain classified as debt and will be amortized and recognized as a reduction of interest expense over the remaining term of the debt securities.

77


Table of Contents

11. Segment Reporting
SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information” requires reporting of segment information that is consistent with the way in which management operates and views the Company.
We are organized into two major operating companies serving the health care and funeral services industries. Hill-Rom is a manufacturer of equipment for the health care industry, a provider of associated systems for wound, pulmonary and circulatory care and a provider of biomedical equipment rentals and other services to enhance the operational efficiency and asset utilization of health care facilities. Batesville Casket serves the funeral services industry and manufactures and sells a variety of metal and hardwood caskets and a line of urns and caskets used in cremation. Batesville’s products are sold to licensed funeral professionals operating licensed funeral homes.
With the continued evolution of the prior year realignment of the Hill-Rom business structure, changes were adopted in fiscal 2004 in terms of the way in which management views the business, including reporting to our executive management team. With these changes, the prior Hill-Rom reporting segment has now been split into Americas/Asia Pacific and EMEA (Europe, Middle East and Africa) reporting segments, with performance measured on a divisional income basis before special items. Intersegment sales between the Americas/Asia Pacific and EMEA are generally accounted for at current market value or cost plus markup. Divisional income represents the division’s gross profit less their direct operating costs. Functional costs and eliminations include common costs, such as administration, finance and non-divisional legal and human resource costs, intercompany eliminations and other charges not directly attributable to the segments. Functional costs and eliminations, while not considered a segment, will be presented separately to aid in the reconciliation of segment information to consolidated Hill-Rom financial information. Essentially all our goodwill resides in the Hill-Rom Americas/Asia Pacific segment.
The reporting segment of Batesville Casket is measured on the basis of income from continuing operations before income taxes. Intersegment sales do not occur between Hill-Rom and Batesville Casket. Forethought results, which were previously considered a reporting segment, are now being presented in the results from discontinued operations as further discussed in Note 3 to the Consolidated Financial Statements.
Corporate manages areas that affect all segments such as taxes, interest income and expense, debt, legal, treasury, and business development. Nearly all interest expense amounts relate to activities undertaken at Corporate to benefit the Company as a whole. Corporate, while not a segment, is presented separately to aid in the reconciliation of segment information to that reported in the Statements of Consolidated Income (Loss).
In analyzing segment performance, our management reviews income before income taxes and net income, both before the impact of the litigation charge and before special charges.

78


Table of Contents

Financial information regarding our reportable segments is presented below (Dollars in millions):
                                                         
                    Functional                
    Americas/           Costs and   Total   Batesville   Corporate    
    Asia Pacific   EMEA   Eliminations   Hill-Rom   Casket   and Other   Consolidated
 
2004 (As Restated)
                                                       
 
Net revenues
  $ 1,002     $ 187     $     $ 1,189     $ 640     $     $ 1,829  
Intersegment revenues
  $ 27     $ 8     $ (35 )   $                          
Divisional income (loss)
  $ 299     $ (1 )   $ (119 )   $ 179                          
Income (loss) from continuing operations before income taxes and special charges (a)
                          $ 179     $ 189     $ (54 )   $ 314  
Special charges (b)
                                                  $ 6  
 
                                                       
Income from continuing operations before income taxes
                                                  $ 308  
Income tax expense
                                                  $ 120  
 
                                                       
Income from continuing operations
                                                  $ 188  
Loss from discontinued operations (c)
                                                  $ (45 )
 
                                                       
Net income
                                                  $ 143  
Assets
                          $ 1,272     $ 279     $ 518     $ 2,069  
Capital expenditures and intangibles
                          $ 98     $ 17     $ 10     $ 125  
Depreciation and amortization
                          $ 81     $ 19     $ 8     $ 108  
 
 
                                                       
 
2003 (As Restated)
                                                       
 
Net revenues
  $ 898     $ 169     $     $ 1,067     $ 628     $     $ 1,695  
Intersegment revenues
  $ 49     $     $ (49 )   $                          
Divisional income
  $ 298     $     $ (94 )   $ 204                          
Income (loss) from continuing operations before income taxes and special charges (d)
                          $ 203     $ 185     $ (99 )   $ 289  
Special charges (e)
                                                  $ 9  
 
                                                       
Income from continuing operations before income taxes
                                                  $ 280  
Income tax expense
                                                  $ 99  
 
                                                       
Income from continuing operations
                                                  $ 181  
Loss from discontinued operations (c)
                                                  $ 8  
 
                                                       
Net income
                                                  $ 189  
Assets (f)
                          $ 751     $ 281     $ 4,443     $ 5,475  
Capital expenditures and intangibles
                          $ 92     $ 16     $ 7     $ 115  
Depreciation and amortization
                          $ 49     $ 18     $ 8     $ 75  
 
(a)   Corporate and Other includes $6 million on the extinguishment of debt ($4 million after tax)
 
(b)   Reflects a $6 million charge related to a realignment of financial and personnel resources at Hill-Rom.
 
(c)   Reflects results of Forethought and Hill-Rom’s piped-medical gas and infant care businesses classified as discontinued operations. Results for 2004 include the loss on disposal of Forethought of $89 million (after tax) and a net gain on the dispositions of the piped-medical gas and infant care businesses of a combined $18 million (after tax).
 
(d)   Corporate and Other includes a $16 million loss on the extinguishment of debt ($11 million after tax).
 
(e)   Reflects a $9 million charge related to a business structure realignment at Hill-Rom.
 
(f)   Corporate and Other includes $4 billion of the assets of Forethought classified as discontinued operations.

79


Table of Contents

Prior to the fiscal 2003 realignment of the Hill-Rom business structure, Americas/Asia Pacific and EMEA were combined in the Hill-Rom reporting segment.
                                 
        Batesville   Corporate    
    Hill-Rom   Casket   and Other   Consolidated
 
2002
                               
Net revenues
  $ 883     $ 510     $     $ 1,393  
Income (loss) from continuing operations before income taxes, litigation charge and special charges
  $ 116     $ 143     $ (60 )   $ 199  
Litigation charge (a)
                          $ 250  
Special charges (b)
                          $ 4  
 
                               
Loss from continuing operations before income taxes
                          $ (55 )
Income tax benefit
                          $ (38 )
 
                               
Loss from continuing operations
                          $ (17 )
Income from discontinued operations (c)
                          $ 7  
 
                               
Net loss (d)
                          $ (10 )
Assets (e)
  $ 700     $ 283     $ 4,472     $ 5,455  
Capital expenditures and intangibles
  $ 72     $ 12     $ 12     $ 96  
Depreciation and amortization (f)
  $ 50     $ 15     $ 6     $ 71  
 
(a)   Reflects antitrust litigation charge of $158 million (after tax) related to Hill-Rom.
 
(b)   Reflects $3 million (after tax) charge related to realignment of certain operations.
 
(c)   Reflects results of Forethought and the Hill-Rom piped-medical gas and infant care businesses classified as discontinued operations.
 
(d)   Includes the reversal of $6 million of previously provided tax reserves for potential disallowances and valuation allowances no longer considered necessary in 2002.
 
(e)   Corporate and Other includes $4 billion of the assets of Forethought classified as discontinued operations.
 
(f)   Hill-Rom reflects a $5 million operating expense charge related to the write-off of a technology asset with no continuing value.
Geographic Information
Most of our operations outside the United States are in Europe and consist of the manufacturing, selling and renting of health care products.
Geographic data for net revenues from continuing operations and long-lived assets (which consist mainly of property, equipment leased to others and intangibles) for fiscal years 2004 and 2003 and the ten months ended September 30, 2002 were as follows (Dollars in millions):
                         
    2004   2003   2002
    (As Restated)   (As Restated)        
 
Net revenues to unaffiliated customers: (a)
                       
United States
  $ 1,586     $ 1,472     $ 1,203  
Foreign
    243       223       190  
 
Total revenues
  $ 1,829     $ 1,695     $ 1,393  
 
Long-lived assets: (b)
                       
United States
  $ 917     $ 447     $ 428  
Foreign
    74       69       56  
 
Total long-lived assets
  $ 991     $ 516     $ 484  
 
 
(a)   Net revenues are attributed to geographic areas based on the location of the operation making the sale.
 
(b)   Includes property, equipment leased to others and intangibles, including goodwill.

80


Table of Contents

12. Income Taxes
Income taxes are computed in accordance with SFAS No. 109. The significant components of income (loss) from continuing operations before income taxes and the consolidated income tax provision from continuing operations for fiscal years 2004 and 2003 and the ten months ended September 30, 2002 were as follows (Dollars in millions):
                         
    2004   2003   2002
 
Income (loss) from continuing operations before income taxes:
                       
Domestic
  $ 323     $ 287     $ (53 )
Foreign
    (15 )     (7 )     (2 )
 
Total
  $ 308     $ 280     $ (55 )
 
Income tax expense (benefit) from continuing operations:
                       
Current provision:
                       
Federal
  $ 80     $ 22     $ 38  
State
          5       6  
Foreign
    3       1       3  
 
Total current provision
    83       28       47  
 
Deferred provision:
                       
Federal
    28       63       (76 )
State
    4       7       (7 )
Foreign
    5       1       (2 )
 
Total deferred provision
    37       71       (85 )
 
Income tax expense (benefit) from continuing operations
  $ 120     $ 99     $ (38 )
 
Differences between income tax expense (benefit) from continuing operations reported for financial reporting purposes and that computed based upon the application of the statutory U.S. Federal tax rate to the reported income (loss) from continuing operations before income taxes for fiscal years 2004 and 2003 and the ten months ended September 30, 2002 were as follows (Dollars in millions):
                                                 
    2004   2003   2002
 
            % of           % of           % of
            Pretax           Pretax           Pretax
    Amount   Income   Amount   Income   Amount   Loss
 
Federal income tax (a)
  $ 108       35.0     $ 98       35.0     $ (19 )     35.0  
State income tax (b)
    3       1.0       7       2.5       (1 )     1.2  
Foreign income tax (c)
                2       0.8              
Utilization of tax credits
    (3 )     (1.0 )     (10 )     (3.6 )     (4 )     7.2  
Adjustment of estimated income tax accruals
    11       3.5                   (4 )     7.2  
Valuation of foreign net operating losses and other tax attributes
    17       5.6       4       1.4       (2 )     3.5  
Impact from foreign restructuring
    (16 )     (5.2 )                        
Other, net
                (2 )     (0.7 )     (8 )     14.5  
 
Income tax expense (benefit) from continuing operations
  $ 120       38.9     $ 99       35.4     $ (38 )     68.6  
 
 
(a)   At statutory rate.
 
(b)   Net of Federal benefit.
 
(c)   Federal tax rate differential.

81


Table of Contents

The tax effects of temporary differences that gave rise to the deferred tax balance sheet accounts were as follows (Dollars in millions):
                                 
    September 30, 2004   September 30, 2003
    (As Restated)   (As Restated)
 
    Non-insurance   Insurance   Non-insurance   Insurance
 
Deferred tax assets:
                               
Current:
                               
Inventories
  $ 5     $     $ 3     $  
Employee benefit accruals
    6             4        
Self insurance accruals
    1             4        
Litigation accruals
    2             26        
Other, net
    22             21       1  
Long-term:
                               
Employee benefit accruals
    11             11        
Amortization
                      1  
Capital loss carryovers and impairments
    64             2       37  
Deferred policy revenues
                      282  
Net operating loss carryforwards
    7                    
Foreign restructuring
    16                    
Foreign loss carryforwards and other tax attributes
    27             16        
Other, net
    20             14        
 
Total assets
    181             101       321  
 
Deferred tax liabilities:
                               
Long-term:
                               
Depreciation
    40             29       1  
Amortization
    23             8        
Unrealized gain on investments
    5             2       65  
Benefit reserves
                      19  
Accrued market discount
                      7  
Deferred acquisition costs
                      218  
Other, net
    20                   5  
 
Total liabilities
    88             39       315  
 
Less valuation allowance for capital losses, foreign loss and other tax attributes
    (86 )           (5 )      
 
Net asset
  $ 7     $     $ 57     $ 6  
 
At September 30, 2004, we had $27 million of deferred tax assets related to operating loss carryforwards and other tax attributes in foreign jurisdictions. These tax attributes are subject to various carryforward periods ranging from 1 year to an unlimited period. We also had $64 million of deferred tax assets related to capital loss carryforwards, which expire between 2006 and 2009; and $7 million of deferred tax assets related to state operating loss carryforwards, which expire between 2008 and 2023.
The gross deferred tax assets as of September 30, 2004 were reduced by valuation allowances of $86 million, principally relating to foreign operating loss carryforwards and capital loss carryforwards as it is more likely than not that they will expire before being utilized. The valuation allowance was increased by $81 million during fiscal 2004 principally due to continued losses in France and capital losses realized from divestitures.
As of September 30, 2004, we have developed a strategy to restructure our French operations. The restructuring involves the creation of a new French entity and the conversion of the existing French entities into a new operating structure. This resulted in the recognition of a related deferred tax asset of $16 million.

82


Table of Contents

Our income tax return filings are subject to audit by various taxing authorities. In fiscal 2004, we recorded both benefits to income and additional accruals related to audit activity by the Internal Revenue Service and various states. The net effect of these adjustments was the recording of $11 million in expense for fiscal 2004.
In evaluating whether it is more likely than not that we would recover our deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies were considered. We believe that our estimate for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances.
13. Supplementary Information
The following amounts were (charged) or credited to income from continuing operations for fiscal year 2004, fiscal year 2003 and the ten months ended September 30, 2002 (Dollars in millions):
                         
    2004   2003   2002
 
Rental expense
  $ (25 )   $ (18 )   $ (14 )
Research and development costs
  $ (56 )   $ (59 )   $ (42 )
Investment income (a)
  $ 9     $ 9     $ 9  
 
(a)   Excludes insurance operations.
The table below indicates the minimum annual rental commitments (excluding renewable periods) aggregating $75 million, for manufacturing facilities, warehouse distribution centers, service centers and sales offices, under noncancelable operating leases.
         
2005
  $ 22  
2006
  $ 17  
2007
  $ 13  
2008
  $ 11  
2009
  $ 9  
2010 and beyond
  $ 3  
We are in year two of a seven-year agreement with IBM to manage our global information structure environment, which was announced near the end of the third quarter of fiscal 2003. The original seven-year agreement had a cumulative estimated cost of $187 million, with a remaining cumulative estimated cost of $153 million, which will continue to be incurred in nearly equal amounts over the remaining term of the agreement. During the first year, we have on occasion, solicited IBM to perform services that are outside the scope of the original base agreement. These services can result in a one-time fee or can result in costs which will be incurred over the remaining term of the agreement. Currently, fees related to out-of-scope services have a cumulative estimated cost of $6 million and are primarily related to new projects and acquisition activities. These fees have been included and will be incurred in nearly equal amounts over the remaining term of the agreement. In conjunction with the recent divestiture of Forethought, the IBM agreement will be renegotiated during fiscal 2005. We believe that our contractual obligation to IBM can be reduced based upon the elimination of specific services related to Forethought.
The table below provides supplemental information to the Statements of Consolidated Cash Flows for fiscal year 2004, fiscal year 2003 and the ten months ended September 30, 2002 (Dollars in millions):

83


Table of Contents

                         
    2004   2003   2002
 
Cash paid for:
                       
Income taxes
  $ 84     $ 7     $ 97  
Interest
  $ 10     $ 19     $ 20  
Non-cash financing activities:
                       
Treasury stock issued under stock compensation plans
  $ 17     $ 3     $ 8  
Gain on interest rate swaps
  $     $     $ 18  
14. Financial Services
Forethought and its subsidiaries served funeral and cemetery planning professionals with life insurance policies, trust products and marketing support for ForethoughtÒ funeral planning.
Investments were predominantly U.S. Treasuries and agencies, high-grade corporate and foreign bonds, with smaller investments in equities, commercial mortgage loans, high-yield corporate bonds and limited partnerships. Investments were carried on the Consolidated Balance Sheets at fair value. Forethought’s objective was to purchase investment securities with maturities that matched the expected cash outflows of policy benefit payments. The investment portfolio was constantly monitored to ensure assets matched the expected payment of the liabilities. Securities were also sold in other circumstances, including concern about the credit quality of the issuer. Cash (unrestricted as to use) was held for future investment.
The amortized cost and fair value of investment securities available for sale at September 30, 2003 were as follows (Dollars in millions):
                                 
            Gross   Gross    
    Amortized   Unrealized   Unrealized   Fair
    Cost   Gains   Losses   Value
 
U.S. Treasury securities and obligations of U.S. government corporations and agencies, Canada and other countries
  $ 1,444     $ 57     $ 5     $ 1,496  
Corporate securities and short-term investments
    1,434       133       5       1,562  
Mutual funds, short-term equities and cash
    56                   56  
Preferred and common stocks, limited partnerships, mortgage loans and other
    215       5             220  
 
Total
  $ 3,149     $ 195     $ 10     $ 3,334  
 
The cost used to compute realized gains and losses is determined by specific identification. Proceeds and realized gains and losses from the sale of investment securities available for sale and from write-downs associated with other-than-temporary declines in value (impairments) were as follows for fiscal years 2004 and 2003 and the ten months ended September 30, 2002 (Dollars in millions):
                         
    2004   2003   2002
 
Proceeds
  $ 417     $ 996     $ 869  
Realized gross gains
  $ 14     $ 68     $ 34  
Realized gross losses
  $ 10     $ 117     $ 61  

84


Table of Contents

Insurance liabilities consisted of the following at September 30, 2003 (Dollars in millions):
                     
        Mortality or   Interest    
    Withdrawal   Morbidity   Rate    
    Assumptions   Assumptions   Assumptions   2003
 
Life Insurance
Contracts
  Varies by age/plan/duration SP: up to 0.2% MP: up to 60%; avg. 5%-10% in duration 1   Varies by age/plan/duration using various percentages of the 1979-81 US Census Mortality Table   Varies by age and issue year
3% to 5.5%
  $ 2,683  
 
Annuity Contracts
  Varies by age/plan/duration SP: up to 0.2% MP: up to 60%; avg. 5%-10% in duration 1   Varies by age/plan/duration using various percentages of the 1979-81 US Census Mortality Table   Varies by age and issue year
2% to 5%
    45  
 
Total Benefit
Liabilities
              $ 2,728  
 
Statutory data at September 30, 2003 and 2002 (Dollars in millions):
                 
    2003   2002
 
Net income (loss)
  $ 22     $ (14 )
Capital and surplus
  $ 346     $ 263  
Forethought’s life insurance companies were restricted in the amount of dividends that they could distribute to their shareholders without approval of the department of insurance in their respective states of domicile. In December 2003, Forethought Life Insurance Company paid a dividend of $29 million to Hillenbrand Industries, Inc.
15. Unaudited Quarterly Financial Information
                                         
                                    Fiscal Year
                                    Ended
2004 Quarter Ended (a) (As Restated)   12/31/03   3/31/04   6/30/04   9/30/04   9/30/04
 
Net revenues
  $ 422     $ 472     $ 461     $ 474     $ 1,829  
Gross profit
    219       239       223       227       908  
Income from continuing operations (b)
    45       53       45       45       188  
Income (loss) from discontinued operations (c)
    17       (88 )     9       17       (45 )
     
Net income (loss)
    62       (35 )     54       62       143  
Basic net income (loss) per common share
  $ 1.00     $ (0.56 )   $ 0.87     $ 0.99     $ 2.30  
Diluted net income (loss) per common share
  $ 0.99     $ (0.55 )   $ 0.86     $ 0.99     $ 2.28  
                                         
                                    Fiscal Year
                                    Ended
2003 Quarter Ended (a) (As Restated)   12/31/02   3/31/03   6/30/03   9/30/03   9/30/03
 
Net revenues
  $ 405     $ 429     $ 426     $ 435     $ 1,695  
Gross profit
    207       222       227       229       885  
Income from continuing operations (b)
    36       51       52       42       181  
Income (loss) from discontinued operations
    (28 )     11       10       15       8  
     
Net income
    8       62       62       57       189  
Basic net income per common share
  $ 0.12     $ 1.01     $ 1.00     $ 0.92     $ 3.05  
Diluted net income per common share
  $ 0.12     $ 1.00     $ 1.00     $ 0.91     $ 3.04  

85


Table of Contents

 
(a)   Quarter results for 2004 and 2003 have been adjusted to reflect the piped-medical gas and infant care businesses of Hill-Rom and Forethought on a discontinued operations basis.
 
(b)   Reflects losses on the repurchases of debt of $4 million (after tax) and $11 million (after tax) in the third quarter of 2004 and the fourth quarter of 2003, respectively. Fourth quarter 2004 includes a special charge of $4 million (after tax) for the business realignment at Hill-Rom.
 
(c)   Reflects a first quarter gain on the divestiture of the Hill-Rom piped-medical gas business of $5 million (after tax) and a second quarter estimated loss on the divestiture of Forethought of $96 million (after tax), which was adjusted down to $89 million in the fourth quarter. Third quarter results included a gain on the divestiture of the Hill-Rom infant care business of $8 million (after tax). This gain was increased in the fourth quarter by $5 million (after tax) upon final transfer of an investment and collection of related proceeds.
16. Commitments and Contingencies
On June 30, 2003, Spartanburg Regional Healthcare System (the “plaintiff”) filed suit against Hillenbrand and its Hill-Rom subsidiary, in the United States District Court for the District of South Carolina. Plaintiff alleges violations of the federal antitrust laws, including attempted monopolization and tying claims. Discovery is underway. The trial is anticipated to occur on or after July 1, 2005.
Plaintiff is seeking certification of a class of all purchasers of Hill-Româ hospital beds and other in-room products between 1999 and 2003 where there have been contracts between Hill-Rom and such purchasers, either on behalf of themselves or through group purchasing organizations, where those contracts conditioned discounts on Hill-Româ hospital beds and other in-room products on commitments to rent or purchase specialty beds exclusively from Hill-Rom.
The hearing on class certification is anticipated to occur by mid to late January 2005. Plaintiff seeks actual monetary damages on behalf of the purported class in excess of $100 million, trebling of any such damages that may be awarded, recovery of attorney’s fees and injunctive relief. If a class is certified and if plaintiffs prevail at trial, potential trebled damages awarded the plaintiffs could be substantial in excess of $100 million and have a material adverse effect on our results of operations, financial condition, and liquidity. Therefore, we are aggressively defending against Plaintiff’s allegations and will assert what we believe to be meritorious defenses to class certification and plaintiff’s allegations and damage theories.
On August 16, 1995, Kinetic Concepts, Inc. (KCI), and one of its affiliates (collectively, the “plaintiffs”), filed suit against Hillenbrand and its Hill-Rom subsidiary in the United States District Court for the Western District of Texas, San Antonio Division (the Court). The plaintiffs alleged violation of various antitrust laws, including illegal bundling of products, predatory pricing, refusal to deal and attempting to monopolize the hospital bed industry. On December 31, 2002, we entered into a comprehensive settlement agreement relating to the longstanding antitrust litigation with the plaintiffs. At the request of the parties, on January 2, 2003, the Court dismissed the lawsuit with prejudice. Upon dismissal of the lawsuit, we took a litigation charge and established an accrual in the amount of $250 million in the fourth quarter of fiscal 2002. Hillenbrand paid KCI $175 million out of its cash on hand in January 2003 with the additional $75 million paid in December 2003. Neither party admitted any liability or fault in connection with the settlement.
In 2000, Hill-Rom, Inc. sued Ohmeda Medical and Datex-Ohmeda, Inc. (collectively, “Ohmeda”) in Federal Court in Indianapolis, Indiana alleging patent infringement. Hill-Rom succeeded in obtaining a preliminary injunction prohibiting Ohmeda from continuing efforts to make, import, sell, or offer for sale its combination incubator and infant warmer, the Giraffeä Omnibed, pending a jury trial on Hill-Rom’s patent infringement claim. A jury trial on this matter was held in May 2002 with the jury finding on behalf of Hill-Rom. Prior to the holding of a separate trial for determination of damages, the parties reached a settlement. While specific terms of the settlement are confidential, the settlement granted cross-licensing of certain patents and Hill-Rom also received a cash payment for past damages and a royalty on certain future product sales. The settlement amount has been recognized as a component of Discontinued operations within the Statements of Consolidated Income (Loss).

86


Table of Contents

We are committed to operating all of our businesses in a manner that protects the environment. In the past year, we have been issued Notices of Violation alleging violation of certain environmental permit conditions. The Notices of Violation involved no fines or penalties. We have, however, successfully implemented measures to abate such conditions in compliance with the underlying agreements and/or regulations. In the past, we have voluntarily entered into remediation agreements with various environmental authorities to address onsite and offsite environmental impacts. The remaining voluntary remediation activities are nearing completion. We have also been notified as a potentially responsible party in investigations of certain offsite disposal facilities. Based on the nature and volume of materials involved, the cost of such onsite and offsite remediation activities to be incurred by us in which we are currently involved is not expected to exceed $1 million. We believe we have provided adequate reserves in our financial statements for all of these matters, which have been determined without consideration of possible loss recoveries from third parties. Future events or changes in existing laws and regulations or their interpretation may require us to make additional expenditures in the future. The cost or need for any such additional expenditures is not known.
We are subject to various other claims and contingencies arising out of the normal course of business, including those relating to commercial transactions, patent infringement, business practices, antitrust, safety, health, taxes, environmental and other matters. Litigation is subject to many uncertainties, and the outcome of individual litigated matters is not predictable with assurance. It is possible that some litigation matters for which reserves have not been established could be decided unfavorably to us, and that any such unfavorable decision could have a material adverse effect on our financial condition, results of operations and liquidity.
We are also involved in other possible claims, including product liability, workers compensation, auto liability and employment related matters. These have deductibles and self-insured retentions ranging from $150 thousand to $1.5 million per occurrence or per claim, depending upon the type of coverage and policy period.
Since December 1999, we have purchased deductible reimbursement policies from our wholly-owned insurance company, Sycamore Insurance Company, Ltd., for the deductibles and self-insured retentions associated with our product liability, workers compensation and auto liability programs. Outside insurance company and third-party claims administrators establish individual claim reserves and an independent outside actuary provides estimates of ultimate projected losses, including incurred but not reported claims. The actuary also provides estimates for accruals for losses incurred prior to December 1999.
Claim reserves for employment related matters are established based upon advice from internal and external counsel and historical settlement information for claim and related fees.
The recorded amounts represent management’s best estimate of the costs it will incur in relation to such exposures, but it is possible that actual costs could differ from those estimates.
17. Restatement and Revised Classification of Consolidated Financial Statements
Restatement
During the fourth quarter of fiscal 2003, the Company entered into definitive agreements to sell Hill-Rom’s piped-medical gas and infant care businesses and in the second quarter of fiscal 2004, the Company entered into a definitive agreement to sell Forethought Financial Services, Inc. and its subsidiaries (“Forethought”). The divestitures of these businesses were all finalized in fiscal 2004 and all were accounted for as discontinued operations in the Company’s consolidated financial statements for all periods presented herein. While finalizing the fiscal 2004 U.S. federal and state income tax returns, and during preparation of the subsequent tax

87


Table of Contents

provision to income tax return reconciliations, management identified errors which understated the income tax benefits associated with these discontinued operations. Further, while assessing the implications of these errors, management determined that it had also made errors with respect to the Company’s allocation of goodwill to Hill-Rom’s piped-medical gas and infant care businesses for purposes of determining both the impairment loss recognized in the fourth fiscal quarter of 2003 and the effect of the dispositions recognized upon the closure of the transactions in fiscal 2004. As a result of the identification of these errors, the Audit Committee of the Board of Directors concluded, after consultation with management and a review of the pertinent facts, that it was necessary to restate the previously issued financial statements for the fiscal years ended September 30, 2003 and 2004.
As part of this restatement, income from discontinued operations and net income in fiscal 2003 increased $51 million, or $0.82 per fully diluted share, and income from discontinued operations and net income in fiscal 2004 increased $33 million, or $0.53 per fully diluted share. The effects of this restatement on the income statement impacted only discontinued operations and had no impact on income from continuing operations or cash flows. Hillenbrand’s balance sheets as of September 30, 2003 and all succeeding periods were also adjusted to reflect $69 million of additional goodwill as a result of the restatement.
Specifics related to the errors identified for fiscal 2003 and 2004 are further outlined below:
Impairment Loss and Gain Recognition on Disposal of Piped-Medical Gas and Infant Care Businesses
Statement of Financial Accounting Standards No. 142 (“SFAS 142”), Goodwill and Other Intangible Assets, requires that all goodwill acquired in a business combination be assigned to one or more reporting units. Upon adopting SFAS 142 in fiscal 2002, the net assets of Hill-Rom’s piped-medical gas and infant care businesses were included in the Hill-Rom reporting unit. When a portion of a reporting unit that constitutes a business is sold, SFAS 142 requires that the amount of goodwill associated with that business be determined based on the relative fair values of the business to be sold versus the portion of the reporting unit to be retained. SFAS 142 further provides, however, that if a business to be disposed of was never integrated into the reporting unit after its acquisition, the current carrying amount of acquired goodwill should be included in the carrying amount of the business to be disposed of.
When the Company reached definitive agreements in the fourth quarter of fiscal 2003 to sell Hill-Rom’s piped-medical gas and infant care businesses, the Company incorrectly conducted a SFAS 142 impairment assessment for these businesses as if they were non-integrated, separate, stand-alone entities for which it was concluded that the benefits of the acquired goodwill associated with these businesses had not been realized, and would not be realized in the future. This impairment assessment included all the original non-amortized goodwill associated with the acquisition of the businesses, other than a portion pertaining to a retained business, which led to the recognition of an impairment loss of $50 million ($51 million, net-of-tax) in the fourth quarter of fiscal 2003. No impairment loss should have been recorded based on the fair value of the entire reporting unit that included the disposed businesses.
Had the Company appropriately applied the provisions of SFAS 142 and allocated goodwill to the disposed businesses based on their relative fair values compared to the fair value of the reporting unit, the carrying amounts of the disposed businesses would have been lower and no impairment loss would have been recorded. Further, the Company would have recognized gains on the divestitures of both businesses in fiscal 2004 of a combined $18 million, net-of-tax.
Accounting for Income Taxes
With respect to the accounting for income taxes related to discontinued operations, including the dispositions of Hill-Rom’s piped-medical gas and infant care businesses and the pre-need

88


Table of Contents

insurance business of Forethought, the Company made certain errors with respect to the recognition of income tax benefits associated with these discontinued operations. These errors relate to the following:
  Improper recognition of book and tax differences associated with discounts applied to the seller financing provided by the Company in the disposition of Forethought. The errors also impacted the ordinary and capital loss components of the taxable gain/loss calculation as well as the amount of the valuation allowance required for capital loss carryforwards. The cumulative effect in 2004 was an understatement of net deferred tax assets and the tax benefit associated with the disposition of the business by approximately $8 million.
 
  Failure to identify necessary corrections to the recorded deferred tax balances of Forethought. Such adjustments should have been fully recorded with the disposition of Forethought, therefore resulting in an understatement in 2004 of net deferred tax assets and the recorded income tax benefit by approximately $1 million.
 
  Failure to fully consider the effects of certain K-1 partnership returns on investments held by Forethought in the determination of the income tax benefit associated with discontinued operations in fiscal 2004. This omission overstated income taxes payable by $2 million and understated the recorded income tax benefit related to discontinued operations by approximately $2 million.
 
  Improper calculation of the respective tax gain/loss associated with the Company’s dispositions of its piped-medical gas, infant care and Forethought businesses primarily associated with the improper treatment of certain disposition-related costs. The impact of these errors in 2004 resulted in an understatement of the recorded income tax benefit by approximately $4 million, along with an understatement of net deferred tax assets of $2 million and an overstatement of income taxes payable of $2 million.
The impact of all the above noted errors resulted in an overstatement of the recorded loss from discontinued operations of $51 million in the fourth quarter of fiscal 2003 and an overstatement of the recorded loss from discontinued operations in the first, second and third quarters of fiscal 2004 of $5 million, $13 million and $15 million, respectively. Further, in terms of a breakdown between divestiture transactions, $13 million of the errors related to the disposal of Forethought, while $5 million and $15 million related to the disposal of the Hill-Rom piped-medical gas and infant care businesses, respectively.
The consolidated financial statements included herein have been adjusted to give effect to these errors in fiscal 2004 and 2003, thus resulting in a restatement of our previously issued financial statements (the “Restatement”).
Other Items
During the first quarter of fiscal 2005, we concluded that it was appropriate to classify our auction rate municipal bonds as current investments. Previously, such investments had been classified as cash equivalents. Accordingly, we have revised our classification to report these securities as current investments in a separate line item on our Consolidated Balance Sheets for all periods presented herein. We have also made corresponding adjustments to our Statements of Consolidated Cash Flows for all periods presented to reflect the gross purchases and sales of these securities as investing activities rather than as a component of cash and cash equivalents. This change in classification does not affect previously reported cash flows from operations or from financing activities in our previously reported Statements of Consolidated Cash Flows, or our previously reported Statements of Consolidated Income (Loss) for any period.
As of September 30, 2004, 2003 and 2002, $52 million, $33 million and $203 million, respectively, of these current investments were previously classified as cash and cash

89


Table of Contents

equivalents on our Consolidated Balance Sheets. For the fiscal years ended September 30, 2004 and 2003 and for the ten months ended September 30, 2002, net cash provided (used in) investing activities related to these current investments of $(19) million, $170 million and $2 million, respectively, were previously included in cash and cash equivalents in our Statements of Consolidated Cash Flows.
We have also made certain other limited changes to the previously issued financial statements to reflect classification changes adopted in fiscal 2005 and to correct typographical errors made in the prior year.
The impacts of the Restatement and Other Items on our Consolidated Balance Sheets as of September 30, 2004 and 2003, and our Statements of Consolidated Income (Loss), of Cash Flows and of Shareholders’ Equity and Comprehensive Income (Loss) for the fiscal years ended September 30, 2004 and 2003, and on our Unaudited Quarterly Financial Information for fiscal 2004 and 2003, are shown in the accompanying tables below. We have also updated the disclosures in Notes 1, 3, 9, 11, 12 and 15 within these Consolidated Financial Statements to give effect to the Restatement and Other Items, as required.
The impact of the Restatement on our Schedule II Valuation and Qualifying Accounts was to reduce the additions charged to costs and expenses for the valuation allowance against deferred tax assets for the year ended September 30, 2003 by $10 million and to reduce the valuation allowance balance by $10 million at September 30, 2003. For the fiscal year ended September 30, 2004, the additions charged to costs and expenses for the valuation allowance against deferred tax assets increased by $9 million and the valuation allowance balance at September 30, 2004 was decreased by $1 million.

90


Table of Contents

The following table presents the effect of the Restatement on the Statements of Consolidated Income (Loss) for the fiscal years ended September 30, 2004 and 2003:
STATEMENTS OF CONSOLIDATED INCOME (LOSS)
(Dollars in millions except per share data)
                                 
    Fiscal Year Ended
    September 30, 2004   September 30, 2003
            (As Originally           (As Originally
    (As Restated)   Reported)   (As Restated)   Reported)
 
Net Revenues
                               
Health Care sales
  $ 737     $ 737     $ 749     $ 749  
Health Care rentals
    452       452       318       318  
Funeral Services sales
    640       640       628       628  
 
Total revenues
    1,829       1,829       1,695       1,695  
 
Cost of Revenues
                               
Health Care cost of goods sold
    382       382       370       370  
Health Care rental expenses
    249       249       161       161  
Funeral Services cost of goods sold
    290       290       279       279  
 
Total cost of revenues
    921       921       810       810  
 
Gross Profit
    908       908       885       885  
Other operating expenses
    582       582       544       544  
Litigation charge
                       
Special charges
    6       6       9       9  
 
Operating Profit
    320       320       332       332  
Other income (expense), net:
                               
Interest expense
    (15 )     (15 )     (19 )     (19 )
Investment income
    9       9       9       9  
Loss on extinguishment of debt
    (6 )     (6 )     (16 )     (16 )
Other
                (26 )     (26 )
 
Income from Continuing Operations Before Income Taxes
    308       308       280       280  
Income tax expense
    120       120       99       99  
 
Income from Continuing Operations
    188       188       181       181  
Discontinued Operations :
                               
(Loss) income from discontinued operations (including loss on impairment of discontinued operations of $107 and $0)
    (71 )     (90 )     13       (37 )
Income tax (benefit) expense
    (26 )     (12 )     5       6  
 
(Loss) income from discontinued operations
    (45 )     (78 )     8       (43 )
 
Net Income
  $ 143     $ 110     $ 189     $ 138  
 
Income per common share from continuing operations — Basic
  $ 3.02     $ 3.02     $ 2.91     $ 2.91  
(Loss) income per common share from discontinued operations — Basic
    (0.72 )     (1.26 )     0.14       (0.68 )
 
Net Income per Common Share — Basic
  $ 2.30     $ 1.76     $ 3.05     $ 2.23  
 
Income per common share from continuing operations — Diluted
  $ 3.00     $ 3.00     $ 2.90     $ 2.90  
(Loss) income per common share from discontinued operations — Diluted
    (0.72 )     (1.25 )     0.14       (0.68 )
 
Net Income per Common Share — Diluted
  $ 2.28     $ 1.75     $ 3.04     $ 2.22  
 
 
                               
 
Dividends per Common Share
  $ 1.08     $ 1.08     $ 1.00     $ 1.00  
 
 
                               
 
Average Common Shares Outstanding — Basic
    62,237,404       62,237,404       62,032,768       62,032,768  
 
Average Common Shares Outstanding — Diluted
    62,725,372       62,725,372       62,184,537       62,184,537  
 

91


Table of Contents

The following table presents the effect of the Restatement on the Consolidated Balance Sheets as of September 30, 2004 and 2003:
CONSOLIDATED BALANCE SHEETS
(Dollars in millions)
                                 
    September 30, 2004   September 30, 2003
            (As Originally           (As Originally
    (As Restated)   Reported)   (As Restated)   Reported)
 
ASSETS
                               
 
Current Assets
                               
Cash and cash equivalents
  $ 128     $ 180     $ 155     $ 188  
Current investments
    52             33        
Trade accounts receivable, less allowances of $31 in 2004 and $26 in 2003
    417       417       361       361  
Inventories
    122       122       92       92  
Deferred income taxes
    12       4       63       63  
Other
    16       16       17       17  
 
Total current assets
    747       739       721       721  
 
 
                               
Equipment Leased to Others
    325       325       200       200  
Less accumulated depreciation
    174       174       143       143  
 
Equipment leased to others, net
    151       151       57       57  
 
 
                               
Property
    679       679       655       655  
Less accumulated depreciation
    458       458       448       448  
 
Property, net
    221       221       207       207  
 
 
                               
Investments
    79       79       68       68  
 
                               
Other Assets
                               
Intangible assets:
                               
Goodwill
    429       360       146       77  
Software and other
    190       190       106       106  
Notes receivable, net of discount
    105       105              
Deferred charges and other assets
    49       49       41       41  
 
Total other assets
    773       704       293       224  
 
 
                               
Assets of Discontinued Operations
    98       98       30       49  
 
 
                               
Insurance Assets
                               
Investments
                3,334       3,334  
Deferred acquisition costs
                695       695  
Deferred income taxes
                6       6  
Other
                64       64  
 
Total insurance assets
                4,099       4,099  
 
Total Assets
  $ 2,069     $ 1,992     $ 5,475     $ 5,425  
 

92


Table of Contents

                                 
    September 30, 2004   September 30, 2003
            (As Originally           (As Originally
    (As Restated)   Reported)   (As Restated)   Reported)
 
LIABILITIES
                               
 
Current Liabilities
                               
Trade accounts payable
  $ 93     $ 93     $ 87     $ 87  
Short-term borrowings
    11       11       5       5  
Income taxes payable
          5       13       14  
Accrued compensation
    87       87       104       104  
Accrued litigation charge
                75       75  
Accrued product warranties
    19       19       21       21  
Accrued customer rebates
    22       17       22       22  
Other
    76       81       52       52  
 
Total current liabilities
    308       313       379       380  
 
Long-Term Debt
    360       360       155       155  
 
Other Long-Term Liabilities
    124       124       116       116  
 
Deferred Income Taxes
    5       7       6       6  
 
 
                               
Insurance Liabilities
                               
Benefit reserves
                2,728       2,728  
Unearned revenue
                806       806  
General liabilities
                68       68  
 
Total insurance liabilities
                3,602       3,602  
 
 
                               
Liabilities of Discontinued Operations
    92       92       7       7  
 
                               
 
Total Liabilities
    889       896       4,265       4,266  
 
                               
 
Commitments and Contingencies
                               
 
 
                               
 
SHAREHOLDERS’ EQUITY
                               
 
Common stock — without par value:
                               
Authorized — 199,000,000 shares
                               
Issued — 80,323,912 shares in 2004 and 2003
    4       4       4       4  
Additional paid-in capital
    62       62       47       47  
Retained earnings
    1,659       1,575       1,583       1,532  
Accumulated other comprehensive income
    6       6       118       118  
Treasury stock, at cost: 2004-18,363,520 shares 2003 — 18,508,939 shares
    (551 )     (551 )     (542 )     (542 )
 
Total Shareholders’ Equity
    1,180       1,096       1,210       1,159  
 
Total Liabilities and Shareholders’ Equity
  $ 2,069     $ 1,992     $ 5,475     $ 5,425  
 

93


Table of Contents

The following table presents the effect of the Restatement on the Statements of Consolidated Cash Flows for the fiscal years ended September 30, 2004 and 2003:
STATEMENT OF CONSOLIDATED CASH FLOWS
(Dollars in millions)
                                 
    Fiscal Year Ended
    September 30, 2004   September 30, 2003
            (As Originally           (As Originally
    (As Restated)   Reported)   (As Restated)   Reported)
 
Operating Activities
                               
Net income (loss)
  $ 143     $ 110     $ 189     $ 138  
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
                               
Depreciation, amortization and write-down of intangibles
    108       108       75       75  
Accretion and capitalized interest on financing provided on divestiture
    (4 )     (4 )            
Net capital (gains) losses — Insurance
    (4 )     (4 )     49       49  
Provision for deferred income taxes from continuing operations
    37       37       71       71  
Loss on divestiture of discontinued operations, net-of -tax
    71       105             51  
Loss on disposal of fixed assets
    11       11       5       5  
Loss on extinguishment of debt
    6       6       16       16  
Change in working capital excluding cash, current debt, acquisitions and dispositions:
                               
Trade accounts receivable
    (14 )     (14 )     (5 )     (5 )
Inventories
    (23 )     (23 )     (5 )     (5 )
Other current assets
    73       73       118       118  
Trade accounts payable
    (12 )     (12 )     3       3  
Accrued expenses and other liabilities
    (113 )     (113 )     (187 )     (187 )
Change in insurance deferred policy acquisition costs
    (1 )     (1 )     2       2  
Change in insurance unearned revenue
    5       5       11       11  
Increase in benefit reserves
    57       57       80       80  
Change in other insurance items, net
    31       31       8       8  
Other, net
    (23 )     (24 )     (64 )     (64 )
 
Net cash provided by operating activities
    348       348       366       366  
 
Investing Activities
                               
Capital expenditures and purchase of intangibles
    (125 )     (125 )     (115 )     (115 )
Proceeds on disposal of property and equipment leased to others
                1       1  
Other investments
                (14 )     (14 )
Proceeds on sales of businesses
    149       149              
Payment for acquisitions of businesses, net of cash acquired
    (430 )     (430 )            
Investment purchases and capital calls
    (85 )     (4 )     (110 )      
Proceeds on investment sales
    85       23       280        
Insurance investments:
                               
Purchases
    (616 )     (616 )     (1,558 )     (1,558 )
Proceeds on maturities
    94       94       356       356  
Proceeds on sales
    417       417       996       996  
 
Net cash used in investing activities
    (511 )     (492 )     (164 )     (334 )
 
Financing Activities
                               
Proceeds from interest rate swap terminations
                27       27  
Additions to short-term debt
    6       6       5       5  
Borrowings of long-term debt
    541       541              
Repayments of long-term debt
    (346 )     (346 )     (185 )     (185 )
Debt issuance costs
    (3 )     (3 )            
Payment of cash dividends
    (67 )     (67 )     (62 )     (62 )
Proceeds on exercise of options
    25       25       3       3  
Treasury stock acquired
    (28 )     (28 )            
Insurance deposits received
    228       228       329       329  
Insurance benefits paid
    (221 )     (221 )     (272 )     (272 )
 
Net cash provided by (used in) financing activities
    135       135       (155 )     (155 )
 
Effect of Exchange Rate Changes on Cash
    1       1       2       2  
 
Total Cash Flows
    (27 )     (8 )     49       (121 )
Cash and Cash Equivalents
                               
At beginning of period
    155       188       106       309  
At end of period
  $ 128     $ 180     $ 155     $ 188  
 

94


Table of Contents

The following table presents the effect of the Restatement on the Statements of Consolidated Shareholder’s Equity and Comprehensive Income (Loss) for the fiscal years ended September 30, 2004 and 2003:
STATEMENTS OF CONSOLIDATED SHAREHOLDERS’ EQUITY AND COMPREHENSIVE INCOME (LOSS)
(Dollars in millions)
                                                                 
                                    Accumulated              
    Common Stock                     Other     Common Stock        
    Shares             Additional     Retained     Comprehensive     in Treasury        
(As Restated)   Outstanding     Amount     Paid-in-Capital     Earnings     Income (Loss)     Shares     Amount     Total  
 
Balance at September 30, 2002
    61,702,410     $ 4     $ 44     $ 1,456     $ 40       18,621,502     $ (545 )   $ 999  
Comprehensive Income:
                                                               
Net income (As restated)
                      189                         189  
Foreign currency translation adjustment
                            5                   5  
Net change in unrealized gain (loss) on available for sale securities
                            73                   73  
 
                                                             
Total comprehensive income
                                                            267  
Dividends
                      (62 )                       (62 )
Stock awards and option exercises
    112,563             3                   (112,563 )     3       6  
 
Balance at September 30, 2003
    61,814,973       4       47       1,583       118       18,508,939       (542 )     1,210  
Comprehensive Income:
                                                               
Net income (As restated)
                      143                         143  
Foreign currency translation adjustment
                            3                   3  
Net change in unrealized gain (loss) on available for sale securities
                            (114 )                 (114 )
Minimum pension liability
                            (1 )                 (1 )
 
                                                             
Total comprehensive income
                                                            31  
Dividends
                      (67 )                       (67 )
Treasury shares acquired
    (475,200 )                             475,200       (28 )     (28 )
Stock awards and option exercises
    620,619             15                   (620,619 )     19       34  
 
Balance at September 30, 2004
    61,960,392     $ 4     $ 62     $ 1,659     $ 6       18,363,520     $ (551 )   $ 1,180  
 
                                                                 
                                Accumulated              
    Common Stock                     Other     Common Stock        
    Shares             Additional     Retained     Comprehensive     in Treasury        
(As Originally Reported)   Outstanding     Amount     Paid-in-Capital     Earnings     Income (Loss)     Shares     Amount     Total  
 
Balance at September 30, 2002
    61,702,410     $ 4     $ 44     $ 1,456     $ 40       18,621,502     $ (545 )   $ 999  
Comprehensive Income:
                                                               
Net income
                      138                         138  
Foreign currency translation adjustment
                            5                   5  
Net change in unrealized gain (loss) on available for sale securities
                            73                   73  
 
                                                             
Total comprehensive income
                                                            216  
Dividends
                      (62 )                       (62 )
Stock awards and option exercises
    112,563             3                   (112,563 )     3       6  
 
Balance at September 30, 2003
    61,814,973       4       47       1,532       118       18,508,939       (542 )     1,159  
Comprehensive Loss:
                                                               
Net income
                      110                         110  
Foreign currency translation adjustment
                            3                   3  
Net change in unrealized gain (loss) on available for sale securities
                            (114 )                 (114 )
Minimum pension liability